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Abstract 
This PhD project was carried out within the frame of a Marie Curie Network with the 
acronym ‘ClickGene’, which focuses on the development of next-generation gene silencing 
therapeutics. The ‘ClickGene’ project studies the gene knockout mechanism induced by new 
synthesized materials, such as the artifical metallo-nucleases (AMNs). These nucleases offer 
a unique mechanism for inducing DNA damages by oxidative cleavage, which can be 
associated to a specific DNA binding site through an oligonucleotide sequence as shown in 
Figure 1.   
Nowadays, the design of therapeutics that interact specifically with DNA represents a 
paradigm shift for modern medicine due to the fact that this approach allows precise genetic 
modifications in order to correct the underlying causes of many human diseases. The 
concept of aiming at DNA as a target for anticancer drugs inspired the development of 
numerous compounds with DNA-damaging reactivity. Among these novel compounds are 
included metal-containing agents that directly modify DNA bases, intercalate between 
bases, or form crosslinks in DNA. So far, the molecular basis of the drugs mechanism has 
focused primarily on DNA damage, but recently the novel antitumoral strategies highlighted 
the cell membranes as a relevant site of the drug’s multitarget reactivity. The design of 
effective treatments against cancer pointed in understanding the role of membranes, 
particularly the changes induced in the unsaturated lipids, which are important for cell 
membrane properties and functions. 
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Figure 1. Artificial chemical nucleases induce lipid modifications and targeted oxidative DNA 
scission via oxidative/free radical mechanisms. 
 
 
The project carried out in this PhD thesis, in the frame of the activities as Early Stage 
Researcher in the ‘ClickGene’ network, was devoted to the study of the oxidation 
mechanisms of both lipids and nucleic acids induced by free radicals in the presence of one 
representative member of these metallo-nucleases.  
The project was carried out in the ‘Bio Free Radicals’ Group at the Institute of Organic 
Synthesis and Photoreactivity at the National Council of Reaserch in Bologna (‘ClickGene’ 
partner) under the supervision of Dr. Carla Ferreri in collaboration with the Department of 
Pharmacy and Biotechnology of the University of Bologna under the supervision of 
Professor Marinella Roberti. The work first aimed to investigate the lipid reactivity in the 
presence of a metallo-drug. In particular, to simulate the cell membrane a biomimetic model 
of liposomes was designed by different mono- and poly-unsaturated fatty acid moieties in 
order to examine the reactivity in the presence of the novel synthesized metallodrug Cu-
TPMA-Phen and a reducing agent. A variety of conditions was tested and the liposome 
work-up with isolation and characterization of the fatty acid components gave an interesting 
mechanistic picture of the membrane-drug interaction.  
Connected with the fatty acid transformations, the thesis includes the synthesis and the full 
analytical chatacterization of the six mono-trans isomers of docosahexaenoic acid (DHA), 
which is a semi-essential ω-3 palyunsaturated fatty acid. Two different synthetic approaches 
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were combined to obtain a full identification of the six mono-trans isomers and the analysis 
was based on gas chromatography (GC) and nuclear magnetic resonance (NMR). The 
characterization was novel and essential for building-up a molecular reference library. The 
usefulness of such library was tested in an analytical application to identify trans content in 
nutraceutical formulas. 
The second part of the project was carried out at Dublin City University (a ‘ClickGene’ 
partner) in the National Institute for Cellular Biotechnology under the supervision of 
Professor Andrew Kellett. The work focused on artificial metallo-nuclease (AMN) activity 
and their ability for precise cleavage of DNA. The cleavage occurs by DNA oxidation, 
mediated by reactive oxygen species (ROS) and contributes toward therapeutic utility by 
damaging the genome of cancer cells to impede faithful cell replication. In these 
experiments, the damage profiles were studied using major groove  recognition  elements,  
spin-trapping  scavengers  of  reactive  oxygen  species  (ROS),  and DNA  repair enzymes 
with  glycosylase  and/or  endonuclease  activity. Finally, the DNA damage fragments 
produced in DCU were isolated, purified and enzymatically digested to single nucleosides. 
The analytical protocol, previously defined by the CNR group, was applied to identify the 
drug effect regarding the formation of oxidative lesions, such as 8-oxo-dA, 8-oxo-dG, 5′R-
cdA, 5′S-cdA, 5′R-cdG and 5′S-cdG, in double strand DNA fragments. 
 
 
 
 
Figure 2. Oxidatively induced DNA purine lesions. 
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The work carried out in this PhD thesis is multidisciplinary, providing novel insights in 
antitumoral strategies and highlighting the dual effect of the drug towards membrane lipids 
and DNA. In-depth knowledge of several disciplines was acquired related to cutting-edge 
research in liposome formulations, membrane lipidomic approach, nucleic acid chemistry, 
gene therapy and diagnostics. Finally, the results contribute in the fields of free radicals in 
chemistry, bioinorganic chemistry, biology, pharmacology and medicine.  
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Chapter 1: Membrane Lipidomics – A Novel Approach in 
Antitumoral Strategies 
 
1.1. Introduction  
Cancer is the name given to a genetic disease in which some of the body’s cells begin to 
divide without stopping and spread into surrounding tissues in an uncontrolled way.
1
 
 
 
 
 
Figure 3. Cancer starts when cells change abnormally.
2
  
 
 
Cancer has been affecting people for centuries and a variety of treatments has been 
developed through the years. Billions of money has been raised, invested and spent on 
cancer research over many decades, however due to the fact that cancer is a collection of 
highly complex diseases characterized by unregulated cell proliferation that can arise from 
numerous different factors, the therapeutic challenge is remarkable complexed and not yet 
achieved. The World Health Organization (WHO) names cancer as a leading cause of death 
worldwide, accounting for 7.6 million deaths (around 13% of all deaths) in 2008 and 
projected to rise above 13.1 million deaths in 2030. 
 If we consider the fact that the human body is consisted by trillions of cells, cancer can 
initiate almost anywhere. The human cells grow and divide to form new cells regarding to 
the body’s requirements. The cells, which grow old or become damaged, die and new cells 
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are formed. This physiological process might be disrupted when cancer is developed and 
new cells form when they are not needed. In particular, the moment of the cell division 
which requires not only chromosome duplication but also membrane phospholipid 
recruitment is nowadays looked at with attention, since it is evident that in the tumor 
replication both DNA and membrane lipids are necessary.  
 
 
 
  
Figure 4. A dividing lung cancer cell.
3
 
 
Genetic changes that cause cancer can arise during a person’s lifetime, as a result of errors 
that occur not only as cells divide, but also due to DNA damage caused by certain 
environmental exposures. Normally, DNA contain four canonical nucleobases, however is 
possibly to occur chemical alterations on the bases of DNA or the sugar-phosphodiester 
backbone may also suffer various damages. Lesions may be spontaneous, induced 
endogenously (i.e. by reactive oxygen species), by radiations (UV light, X-rays) or by 
chemicals.
4,5
 The lesions in DNA are efficiently repaired by action of numerous repair 
systems. Cell-cycle checkpoint proteins, whose activation induces cell-cycle arrest to 
prevent the transmission of damaged DNA during mitosis, detect high levels of damage to 
DNA.
6
 However, is possible some of these lesions to escape the repair mechanisms, 
therefore they are present when DNA is being replicated. In this case, the risk is the 
generation of mutations at high frequency,
7
 which are able to transform normal cells into 
rapidly proliferating, cancer-type cells.  
Cancer cells have relaxed DNA damage-sensing/repair capabilities and this information 
generated the concept of aiming at DNA as a target of action for the drug.
8
 Therefore, a 
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variety of anticancer drugs were inspired and the development of compounds, such as 
cisplatin,
9
 doxorubicin,
10
 5-fluorouracil,
11
 etoposide,
12
 and gemcitabine
13
 that react 
chemically with DNA is growing constantly.
14
 Among them, the most common metallodrug 
is cisplatin with clinical application as chemotherapeutic agent. However, this compound is 
severely limited by its toxic side effects such as kidney damage, increased risk of getting an 
infection, tiredness, weakness and hair loss.
15,16,17
 This has spurred chemists to employ 
different strategies in the development of new metal-based anticancer agents with different 
mechanisms of action. The research interest was aimed towards compounds able to directly 
modify DNA bases, intercalate between bases, or form crosslinks in DNA leading to stalled 
replication, fork progression and subsequent cell death via apoptosis. 
18,19,20
  
In addition, the scientific advancements revealed the deleterious effects of metal-catalyzed 
reactive oxygen species (ROS) in biological systems and relate them with various 
pathological conditions, such as cancer. The ROS-dependent activation of apoptotic cell 
death, highlight the potential use of ROS as an antitumor agent. This valuable information 
led in the development of the next generation therapeutic compounds with ability in a 
targeted ROS production in the vicinity of nucleic acids. Complexes of redox active metals, 
principally copper and iron, represent an important group of metallodrugs, such as the 
artificial chemical nucleases.
21
 The ligand environment in these complexes allows for the 
tuning of charge, redox potential, chirality and geometry to optimize DNA binding. Under 
aerobic conditions, or in the presence of appropriate intracellular oxidants, these compounds 
can undergo Fenton or Haber–Weiss chemistry to generate reactive oxygen species (ROS). 
If the complex is bound to DNA, then there is a high probability that ROS will oxidize 
DNA, leading to strand breakages.
19 
A well-studied example of ROS-active 
chemotherapeutic drugs is the metal-activated bleomycin, which is able to induce DNA 
single- and double-strand scission via formation of an intermediate metal-complex, 
requiring a metal cofactor such as copper or iron.
22,23
 Due to these properties bleomycin is 
used in cancer treatments and Hodgkin's lymphoma. This in cellulo catalytic production of 
ROS by copper(II) and iron(II) complexes is recognized as a major mechanistic model in 
design of effective inorganic formulated drugs, giving rise in the development of such 
promising materials.  
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The idea of a unique anticancer strategy named “oxidation therapy” has been developed by 
inducing oxidative and free radical chemistry for cytotoxic oxystress as cancer treatment.
24
  
Overproduction of highly reactive oxygen metabolites can initiate lethal chain reactions, 
which involve oxidation and damage to every structure that is present and is able to be 
modified within the cell. Therefore, both DNA and unsaturated lipid components of cell 
membranes, which are crucial for cellular integrity and survival, can be damaged giving rise 
to senescent, degenerative or fatal lesions in cells offering a powerful therapeutic modality 
for future anticancer therapy.
25
  
In fact, the novel antitumoral strategies examine the chemotherapeutic drug’s reactivity as a 
synergic effect towards DNA and cell membrane lipids. Recent studies by our group, both in 
cell cultures and liposomes as representation of the cell membrane, with the anticancer drug 
bleomycin report the formation of a bleomycin-iron complex, highlighting that the free 
radical reactivity does not concern only DNA cleavage mechanism, but involves also the 
moiety of unsaturated lipids, which are present in membranes.
26,27
 Cell membrane plays a 
crucial role in several biological processes and stress situations can enhance the production 
of free radicals.. As described previously, among antitumor active metallodrugs copper(II) 
complexes are particularly interesting due to the redox behavior of Cu
+2 ⟶ Cu+1. 28 This in 
situ electron transfer can give rise in the formation of other radical species. The presence of 
thiols, as biologically relevant reducing agents lead in generation of thiyl radicals, which are 
able to cause damages involving among others the membrane lipids.
29
 These highly active 
species are able to trigger a cascade of reactions, leading in permanent modifications on the 
structure of the membrane constituents.
30 
The monounsaturated fatty acids (MUFAs) and the 
polyunsaturated fatty acids (PUFAs) are highly abundant and essential structural 
components of the cell membrane with important effects on the structure and physical 
properties of localized membrane domains. MUFA and PUFA moieties contain one or more 
double bonds respectively, with cis geometry in their backbone. In the presence of sulfur-
centered radicals, the intraconversion of the cis geometry of unsaturated fatty acids moieties 
is possible to occur and as a result, the corresponding trans lipids are formed. This change in 
membrane architecture is possible to reduce the membrane permeability and fluidity, affect 
the membrane-associated enzymes and altered the ion transport. In addition, the PUFA 
moieties can be partitioned in oxidative and lipid peroxidation pathways leading in a 
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decreased PUFA content in the membrane.
31
 The structural differences in the fatty acid 
moieties result in alterations and direct the cell to an apoptotic pathway. The changes in the 
membrane lipid compositions can be monitored by fatty acid-based lipidomics.
32
 This type 
of analysis in the research field of lipid structures and functions represents a powerful 
diagnostic tool for detection of membrane impairments and correlate them with pathological 
conditions.  
Finally, model studies using liposomes as a simpler representation of the cell membrane 
allow the lipid damage evaluation on the monounsaturated fatty acids (MUFA) and 
polyunsaturated fatty acids (PUFA)-containing phospholipids, under biologically related 
free radical and oxidative conditions.
33
 This approach allows an insight of the metallodrug’s 
chemical reactivity that mediates ROS damage to the moieties of phospholipids, in the 
presence of reductant in order to achieve the electron transfer and the generation of radicals. 
By building up biomimetic models, the radical and oxidative processes can be followed up 
using a variety of reaction conditions, thereby providing a molecular basis to observe and 
study these processes.
34
 
 
 
1.2. Cell Membrane Lipids 
The membranes constitute the cell boundaries, as well as the boundaries of organelles within 
the cell. Membranes are consisted by a hydrophobic matrix, formed by an oriented double 
layer of phospholipids to which proteins are bound in different forms. In 1935, Danielli and 
Davson proposed as representation, the model of a double layer of phospholipids as the basic 
structural element of membranes.
35
 It was assumed that all membranes had a uniform 
thickness and a constant lipid-protein ratio with symmetrical internal – external surfaces. Due 
to limitations of this model in 1972 Singer and Nicolson proposed the structure and dynamics 
of biological membranes with the view of a ‘fluid mosaic’ model as framed in Figure 5.36 
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Figure 5. Cartoon representation of cell membranes as ‘fluid mosaic’.37 
 
Cell membrane is a mixture of fluid state lipids, which are organized in a double layer or 
bilayer, along with proteins and other molecules. As far as concerns the membrane lipids, they 
are amphipathic and they possess both a hydrophobic and a hydrophilic moiety. This occurs in 
phospholipids, glycolipids and sterols.
38
 Because of this amphipathic character, in an aqueous 
medium they can organize themselves on both sides of an imaginary plane, with the 
hydrophobic portions facing each other and the polar moieties oriented to the outer, aqueous 
space.
39
 Both lipids and proteins are in constant motion (hence the fluid mosaic name 
mentioned above) and they rotate around their long axis, under physiological condition. The 
most abundant lipid components are the phospholipids consisting of a L-glycerol molecule, in 
which the hydroxyl groups in positions 1 and 2 are esterified with two fatty acids and the 
hydroxyl group in position 3 is esterified with a phosphate group that is bound to small polar 
molecules such as choline, serine, ethanolamine or inositol. As presented in Figure 6, in the 
phospholipid structure the hydrophobic tails are consisted by fatty acid residues with different 
lengths of aliphatic chain, which can be either saturated or unsaturated.
40
 Taking into account 
the structure of the hydrocarbon chain the fatty acids can be distinguished in: 
 Saturated fatty acids (SFAs), when the aliphatic chain contains no double bond 
 Monounsaturated fatty acids (MUFAs), which have one double bond in the fatty acid 
chain with all of the remained carbon atoms being single-bonded and 
 Polyunsaturated fatty acids (PUFAs), in which the constituent hydrocarbon chain 
possesses two or more carbon–carbon double bonds.41 
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In fact, depending on the position of the double bonds, PUFAs are either omega-3 or -6 
methylene-interrupted fatty acids.
42
 It is important to mention that this classification of 
PUFAs in two different families reflects the fact that they are synthetized starting from a 
common precursor for each family. The precursor for the series of omega-3 linoleic acid (LA, 
9c, 12c, 18:2) and for the omega-6 series is a-linolenic acid (ALA, 9c, 12c, 15c, 18:3). Both 
fatty acids, linoleic and a-linolenic, are considered essentials, which means that they cannot 
be produced via enzymatic pathways, but need to be taken by the diet.
43,44
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Figure 6. Cartoon representation of phospholipid structure and molecular structures of the most 
important components of the main fatty acid families. 
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1.3. Oxidative - Free Radical Chemistry and Fatty Acid Moieties  
There are several definitions of ‘free radical’, as well as debates about whether the word ‘free’ 
is superfluous. A simple definition is that a free radical is any specie capable of independent 
existence (hence the term ‘free’) that contains one or more unpaired electrons. The presence 
of one or more unpaired electrons usually causes free radicals to be attracted slightly to a 
magnetic field (i.e. to be paramagnetic) and sometimes makes them highly reactive, although 
the chemical reactivity of radicals varies widely. Many free radicals exist in living systems, 
although most molecules in vivo are non-radicals. If the above rule is taken into account then 
the diatomic oxygen molecule can be considered itself a free radical since it has two unpaired 
electrons, each located in a different π* antibonding orbital. This is the most stable state or 
ground state of O2 and is the form it takes in the air around us. If one electron is added to the 
ground-state O2 molecule, it enters one of the π* antibonding orbitals and the product is 
superoxide radical, O2
•–
. Addition of another electron to O2
•–
 will give O2
–2
 the peroxide ion, a 
non-radical. Species, like the ones described previously, that derived from molecular oxygen 
and they are more reactive than O2 itself, are well known as reactive oxygen species (ROS).
45
 
The term includes not only superoxide and some other oxygen radicals, but also some non-
radical derivatives of O2, such as H2O2 and hypochlorous acid (HOCl). Hence, all oxygen 
radicals are ROS, but not all ROS are oxygen radicals. ‘Reactive’ is a relative term; O2
•–
 and 
H2O2 are selective in their reactions with biological molecules, leaving most of them 
unscathed, whereas OH
•
 attacks everything around it.
46
 The term reactive species has been 
expanded to include reactive nitrogen, chlorine, bromine, iron and sulphur species.  
Oxidative stress occurs when the production of reactive oxygen species (ROS) is greater than 
the body's ability to detoxify the reactive intermediates.
47
 This imbalance leads to oxidative 
damage to DNA, lipids, proteins, molecules and genes within the body.
48
 Since the body is 
incapable of keeping up with the detoxification of the free radicals, the damage continues to 
spread. The body naturally produces antioxidants like superoxide dismutase, catalase and an 
assortment of peroxidase enzymes, as a means of defending itself against free radicals.
49
 The 
antioxidants neutralize the free radicals, thereby rendering them harmless to other cells. 
Antioxidants have the remarkable ability to repair damaged molecules by donating hydrogen 
atoms to the molecules. Some antioxidants even have a chelating effect decreasing the free 
radical production that is catalyzed by metals.
50
 In this situation, the antioxidant contains the 
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metal molecules so strongly that the chemical reaction necessary to create a free radical never 
occurs. 
Production of O
2•–
 in the presence of NADH or NADPH can occur for the presence of an 
NADPH oxidase enzyme. The O2
•–
/H2O2 produced have the potential to damage nuclear 
components, in particular by conversion into OH• the damage to DNA and consequent 
mutation can occur.
51,52
 Plasma membranes contain redox systems that transfer electrons from 
NADH to external electron acceptors, such as ascorbate but there are cases that also the cell 
membranes suffer from permanent modifications of their components. The above data 
evidenced the necessity to apply a novel strategy when considering the oxidative – free 
radical chemistry within the cell, since targets of the produced radicals is probable to be both 
DNA and membrane lipids each one resulting in a modification leading in pathologic 
conditions or in the case of cancer tumors to induce an apoptotic response.
53,54
  
  
- 24 - 
 
1.4. Transition Metal-Based Drugs  
Metal ions play important roles in biological processes, and the field of knowledge concerned 
with the application of inorganic chemistry to therapy or diagnosis of disease appeals very 
promising. The introduction of metal ions or metal ion binding components into a biological 
system for the treatment of diseases is growing faster, next to general strategies and 
challenges of metallodrug research and development. The metallodrug−DNA adducts, 
together with cellular pathways activated in response to the drug, lead to replication arrest, 
transcription inhibition, cell-cycle arrests, and apoptosis.
55
 
Transition metal ions are of particular interest, because they are qualified as free radicals 
under the definition given previously. Most of the metals in the first row of the d-block in the 
periodic table contain unpaired electrons in its atoms and/or ions and are thus free radicals. 
Indeed, it is appropriate to classify most transition metal ions as radicals, since many of their 
biological effects, whether beneficial or deleterious involve the ability to accept or donate 
single electrons, since the single-electron transfers they promote can overcome the spin 
restriction on direct reaction of O2 with non-radicals. The reduction potentials of transition 
metal ions depend on the ligands to the metal, and thus can be altered in different enzymes to 
allow the same metal to catalyze different reactions.
56
 The danger is that, unless their 
availability is carefully controlled, transition metals will catalyze unwanted free-radical 
reactions such as autoxidation and OH
•
 formation.
57
 Copper has two common oxidation 
numbers, copper (I) and copper (II), as shown below. 
 
 
 
Figure 7. Electron configuration of copper atom and kations in orbitals. 
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Copper (I) readily undergoes self-reaction if it accumulates; Cu
+
 + Cu
+
 → Cu + Cu2+. 
The one-electron difference between Cu
+ 
and Cu
2+
, or Cu
2+
 and Cu (III), allows copper to 
promote radical reactions. Under appropriate conditions, for example, copper ions interact 
rapidly with O2
•–
.  
 
            Cu
2+ 
+ O2
•–
 → Cu+ +O2                                                          k = (5 – 8)×10
9
 M
–1
 s
–1
 
                          H
+
 + Cu
+
 + HO2
•
 → Cu2+ + H2O2                            k ≈ 10
9
 M
–1
 s
–1
 
                         O2
•–
 + Cu
+
 + H2O→ Cu
2+
 + OH
–
 + HO
–2
                 k ≈ 109 M–1 s–1 
                 Net: O2
•–
 + O2
•–
 + 2H
+
 → H2O2 + O2 
 
The copper, by changing its oxidation number, is catalyzing the conversion of two O2
•–
 
radicals and two H
+
 ions to H2O2 and O2. It is known, that several copper ions chelate - react 
with biological molecules. Among these bioactive molecules are the thiols, which act as 
antioxidants. It is highly probable for thiols to react with copper in vivo, leading in formation 
of free radicals. Thiyl radicals are formed when thiols react with carbon-centered radicals, 
with transition metal ions or with several oxygen radicals, including OH
•
, RO
•
, CO3
•–
, RO2
•
.
58
 
For example, 
RSH + OH
•
 → RS• + H2O 
RSH + RO2
•
 → RS• + ROOH 
RSH + Cu
2+
 → RS• + Cu+ + H+ 
 
Once the thiyl radical in the presence of copper (II) is generated, is often assumed that RS
•
 
radical is essentially inert and disappear by dimerization,
59
 e.g. for the glutathione thiyl 
radical, 
GS
•
 +GS
•
 →GSSG             k = 1.5 × 109M–1s–1 
Copper can participate in oxidative or free radical pathways giving rise in formation of ROS, 
which are able to initiate lipid and DNA damage.
60
 Due to these properties, a variety of 
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copper-coordination complexes with nuclease reactivity and site-directed DNA cleavage has 
been developed. Artificial chemical nucleases are biomimetic and rely on simple systems, 
which incorporate well-known enzymatic properties, such as metal coordination, general acid-
base catalysis, and nucleophilic attack to hydrolyze activated phosphodiesters. A well-studied 
chemical nuclease is 1,10-phenanthroline-copper, and the ability of this redox-active 
coordination complex to cleave DNA has been established. One of the striking features of the 
reaction was the specificity of 1,10-phenanthroline ligand and the absolute requirement for 
copper ion. In fact, both the redox chemistry of the copper ion as well as the extrinsic 
stereoelectronic and steric properties of phenanthroline copper complexes are of equal 
importance in the mechanism.
61
 
This new generation of drugs does not concern only copper, a wide range of redox 
metallodrugs has been established in anticancer therapies. Among them, the most popular is 
cisplatin due to the ability to crosslink with the purine bases on the DNA, interfering with 
DNA repair mechanisms, causing DNA damage, and subsequently inducing apoptosis in 
cancer cells.
62
 Nowadays, cisplatin is used as a chemotherapy medication to treat a number of 
cancers.  
Finally yet importantly, bleomycin is another drug that is used and it has a unique mechanism 
of antitumor activity. Bleomycin has both metal binding and DNA binding sites and its 
activity to generate radical species, such as hydroxyl radicals, in the presence of ferrous or 
copper(I) ions and molecular oxygen, is known since long time. The mechanism of its action 
includes the production of oxidative DNA strand scission via formation of OH radicals The 
mechanism includes the binding of five nitrogen atoms with divalent metals such as iron. 
Molecular oxygen, bound by the iron, can produce highly reactive free radicals and Fe(III). 
The free radicals produce DNA single-strand breaks at 3'-4' bonds in deoxyribose.
63
 
In conclusion, platinum-based drugs such as cisplatin are powerful anticancer agents, they 
have undesirable side effects and are effective against only a few kinds of cancers.
64
 There is, 
therefore, a need for new drugs with an improved spectrum of efficacy and lower toxicity. 
Complexes of copper, gold and silver (coinage metals) are potential candidates to fulfill this 
need.
65
 Although metallodrugs are used in antitumoral therapies, the mechanism of reactivity 
is not yet fully explored in many cases. A precise understanding of both the DNA binding 
properties and the chemical reactivity of any scission reagent is essential for site selectivity 
- 27 - 
 
potential application of more synthetic restriction endonucleases. Needless to be mentioned, 
the development of anticancer drugs based on these metals is currently a very active field. 
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1.5. Lipid Geometry  
Double bonds in unsaturated fatty acids, like any alkene, are present in two different 
geometrical configurations; with two of the substituent groups on the same side of the double 
bond plane, called ‘cis’ isomer or on the opposite side, called the ‘trans’ isomer (Figure 8). 
 
 
Figure 8. Cis and trans configuration of double bonds. 
 
Most of the monounsaturated fatty acid (MUFA) residues present in plants and animals 
display cis geometry of the double bond. Double bonds with cis configuration are generated 
during the biosynthesis of MUFAs and PUFAs by the regioselective and stereospecific 
activity of desaturase enzymes, which act only in specific positions of the aliphatic chain and 
always mediate the formation of cis double bonds.
66
 The significance of the ubiquitous cis 
structural feature of the unsaturated lipid double bond is based on its contribution to the 
organization of phospholipids in one of the most important units of living organisms: the cell 
membrane. Indeed, life needs the compartmentalization given by the phospholipid bilayer that 
surrounds the cell, the cis fatty acid is necessary to provide the hydrophobic part with 
favorable properties to organize proteins and other components, rendering membranes active 
components with several functionalities rather than being merely a wall.
67
 The bend 
corresponding to the cis double bond gives quite typical physical characteristics, such as 
melting points or phase transition temperatures, as well as biophysical and biochemical 
properties.
68,69
 It is intriguing that the trans geometry, despite its thermodynamic stability, is 
almost excluded from most of the unsaturated fatty acid structures involved in cellular 
compartments of living organisms. The presence of trans double bonds in fatty acid residues 
H
R R
H
Cis - Same - Zame
H
R H
R
Trans - Opposite - Epposite
Stereoisomers
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produces a dramatic change of the molecular shape from a bent to a linear structure as 
reported in Figure 9.
70
  
 
 
Figure 9. Structural differences of membranes composed by cis PUFA and trans PUFA.
71
 
 
 
Phospholipids are the main components of the cell membranes, therefore their structure 
regulates the supramolecular organization and the properties of the double layer. Considering 
the degree of unsaturation a general rule on lipid assembly is that the lowest the number of 
double bonds, the higher the packing order of lipids. The lipids are assembled with increasing 
rigidity according to the order: saturated > trans unsaturated > cis unsaturated aliphatic chain. 
Modification of lipid composition affects both the physical and chemical properties of the 
membrane and hence allows a fine-tuning of membrane micro viscosity and molecular 
mobility.
72
  
In the last two decades, free radical stress was one of the topics of integrated multidisciplinary 
research directed towards health and aging. These studies led to the individualization of the 
importance of cell membranes in stress management and highlightened how crucial is the 
retention of configuration in the lipid geometry.
73
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1.5.1. Cis-trans Isomerization 
As described previously, the unsaturated fatty acids are important hydrophobic constituents of 
phospholipids present in the cell membrane and are essential for the control of physical 
properties of the lipid bilayer. Under normal conditions in eukaryotic cells most of 
unsaturations are in a cis conformation, which does not introduce perturbation in the relative 
alkyl chain arrangement inside the lipid bilayer. However, there are some prokaryotic cells, 
such as the bacteria Pseudomonas Aeruginosa and Vibrio Cholera, in which under stress 
conditions an enzyme called isomerase can convert the cis double bonds to trans in the 
phospholipid residues geometry.
74,75
 This transformation plays an essential role in adaptation 
responses and the number and geometry of unsaturations are correlated with thermotolerance 
and to adjust in toxic substances. The energy difference between esterified cis and trans fatty 
acids is low (about -1 kcalmol
-1
), and all-trans-fatty acids readily isomerize upon γ-irradiation 
of tert-butanol solutions, or photolysis of di-tert-butyl ketone. Experimental evidence was also 
presented for the cis−trans isomerization occurring at 90−120°C without adding initiator, the 
initiation step being a complex reaction between thiol and alkene through molecule-assisted 
homolysis of the S−H bond. Trans-fatty acids are also produced by aborted catalytic 
hydrogenation and free radicals, in particular thiyl radicals that act as catalysts both in 
homogeneous solution and lipid vesicles and provoke permanent modifications.
76
 Thiyl 
radicals result from sulfur-containing molecules and these species are able to initiate a cis-
trans isomerization type of reaction the mechanism of which is presented in the figure 10 
below.
77,78
 Herein, is reported as an example the addition of 2-mercaptoethanol to methyl 
oleate and the isomerization catalyzed by the corresponding HOCH2CH2S
•
 radical. 
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Figure 10. HOCH2CH2S
• 
radical-catalyzed isomerization of methyl oleate.
[62]
 
 
 
The mechanism is an addition-elimination type reaction, which leads to the conversion of 
stereochemistry. The initial step is the generation of a S-centered radical that is added to the 
double bond. As a result, an unstable radical intermediate is formed, followed by an 
elimination reaction that leads to the formation of the most thermodynamically favorable trans 
isomer. The MUFA isomerization is widely studied and the overall picture is complete, 
however regarding the analogous reaction with PUFA, the reaction is more complexed. Using 
identical reaction conditions with regard to MUFA the time profiles of linoleic acid methyl 
ester (9cis,12cis-C18:2; LAME) disappearance and formation of mono-trans and di- trans 
isomers in these experiments indicated that the cis−trans isomerization occurs stepwise. The 
reaction figure shows the equilibrium situation for a dienoic unsaturated fatty acid structure.
79
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Figure 11. Addition of thiols to dienes.
80
 
 
It must be pointed out that in the biological environment, the cis-trans isomerization of the 
fatty acid moieties is influenced by the supramolecular organization of the phospholipids in 
the bilayer. All the double bonds in the structure of fatty acid residues are not exposed at the 
same way and the thiyl radicals should be diffused in order to approach them. This provide 
evidence that the double bonds are not equivalently reactive and is expected that the ones 
closer to the polar head are easier to be attacked by the radicals, rather than the double bonds 
located in the hydrophobic bilayer.
81,82
  
Trans fatty acids are correlated with a series of harmful effects in human health such as 
inhibition of enzymatic processes, increase plasma concentrations of low-density-lipoprotein 
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cholesterol and reduce concentrations of high-density-lipoprotein, which results in relation 
between the blood lipid concentrations and the risk of coronary artery disease.
83
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1.5.2. Lipid Peroxidation  
In recent years, it has become apparent that the oxidation of lipids, or lipid peroxidation, is 
associated with pathogenesis of several disease states in adult and infant patients.
84
 Lipid 
peroxidation is a process generated naturally in small amounts in the body, mainly by the 
effect of several reactive oxygen species (hydroxyl radical, hydrogen peroxide etc.). Many of 
these free radicals can be generated in vivo, such as carbon-centered radicals, which are 
intermediates in a process called lipid peroxidation. Carbon-centered radicals usually react 
quickly with O2 (rate constants often > 109 M
–1
s
–1
) to form RO2
•
 radicals. Decomposition of 
organic peroxides (ROOH) generates both RO2
•
 and RO
•
. Most peroxides are stable at room 
temperature, but they can be decomposed by heating, exposure to UV light (in some cases), or 
by addition of transition metal ions, such as copper.
85
 
ROOH + Cu
2+
 → RO2
•
 + H
+
 + Cu
+ 
ROOH + Cu
+
 → RO• + OH– + Cu2+ 
ROOH + Cu
2+
 → RO• + OH– + Cu3+ 
These reactions are important in copper ion-stimulated lipid peroxidation. Lipid peroxides 
might also react with HO2
•
 to form RO2
•
,  
HO2 
•
+ ROOH → RO2
•
 + H2O2 
The pro-oxidant effects of ascorbate/Cu
2+
 mixtures have been studied, also for their ability to 
inactivate many enzymes, probably by formation of OH
•
 and/or oxo-copper species and is 
possible to induce lipid peroxidation and other oxidative damage within the cell, a crucial 
capability in antitumoral strategies.
86
 
These reactive oxygen species are readily to attack the polyunsaturated fatty acids of the cell 
membrane, initiating a self-propagating chain reaction. As far as PUFA reactivity is 
concerned, it must be noted that PUFAs have methylene-interrupted double bonds and 
bisallylic positions with a low C−H bond dissociation enthalpy.  
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This reactivity attracted immediate interest for its connection with the role of thiols as active 
biomolecules. Cysteine and glutathione are quite efficient hydrogen donors toward carbon-
centered radicals generated by various pathways of damage in vivo and they are able to react 
with PUFA bisallylic positions via two different pathways. In the literature is suggested that 
thiyl radicals abstract the bisallylic hydrogen, whereas the remaining RS
•
 attack the double 
bond to form a radical adduct.
87
 Because of possible competitive pathways between hydrogen 
abstraction and the reversible thiyl radical addition to the double bonds, it is clear that the 
specific conditions and reactant concentrations are important for the outcome. In presence of 
molecular oxygen, carbon-centered radicals react with it leading to peroxyl radicals that then 
propagate the oxidative chain.  
 
 
 
Figure 12. Mechanisms for the radical-based peroxidation and isomerization processes in unsaturated fatty 
acids. 
 
 
Alteration of membrane lipids and the occurence of lipid peroxidation reactions compromise the 
viability of cells and tissue functioning. Enzymatic (catalase, superoxide dismutase) and 
nonenzymatic (vitamins A and E) natural antioxidant defense mechanisms exist; however, these 
mechanisms may be overcome, causing lipid peroxidation to proceed with a more damaging 
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effect.
88
 Since lipid peroxidation is a self-propagating chain-reaction, the initial oxidation of only 
a few lipid molecules can result in significant tissue damage.
89
 Extensive research in the field of 
lipid peroxidation determined the alteration of the physiological functions in cell membranes and 
the important role in cellular membrane damage.
90  
Lipid peroxidation has been implicated in 
disease states such as atherosclerosis, asthma, Parkinson's disease, kidney damage and others.
91
 
Beyond ROS involvement in carcinogenesis, increased ROS level can inhibit tumor cell growth 
via formation of their products which are also the lipid peroxides. Indeed, in tumors in advanced 
stages, a further increase of oxidative stress, such as that occurs when using several anticancer 
drugs and radiation therapy, can overcome the antioxidant defenses of cancer cells and drive them 
to apoptosis.
92
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1.6. Cell Membrane and Lipidomic Analysis 
The healthcare approach has improved a lot in the last decades due to the understanding of 
signaling and response pathways at the cellular level. As described previously, it is of high 
importance the fatty acid residues of phospholipids to maintain their natural assembly and 
structural integrity. Membranes are necessary to not only divide and form the living cell, but 
represent also a crucial site for regulating exchange of nutrients, oxygen and stimuli inside the 
cell or even between different cells.
93,94
 The cell membrane is a relevant site for receiving and 
emitting signals, inducing an adaptive response in the lipid constituents. The division of lipids 
into lipid classes reinforce the knowledge regarding the membrane composition and its regulation 
by the appropriate mix of fatty acid residues. The total mapping of the membrane components 
allowed a different perspective for understanding the relationship between structures and 
functions, as well as their connection to the status of the organism in a more dynamic and 
functional way. The new technological advancements gave birth in ‘Lipidomics’ that took the 
place of the “old” lipidology with a suffix “-omics,” in order to express the correlation with other 
“-omics” technologies, such as genomics and proteomics.95 Lipidomics address the lipid diversity 
needed for life by analyzing lipid  molecules in a ‘dynamic’ context, following up the changes 
that occur to lipids in a cell  compartment  or  in  whole  organism,  under  physiological  or  
pathological conditions. The fatty acid monitoring opened new frontiers to health prevention and 
disease treatment. To date, the lipidomic analytical strategies are applied to a wide variety of 
biological samples such as blood, plasma, serum, urine and biological tissues derived from animal 
models or clinical patients. This powerful diagnostic tool provides information on quantification 
and qualification of fatty acid constituents for monitoring the membrane remodeling under 
different conditions.
96
 The lipidomic approach is very promising due to a very important 
achievement that includes the contribution in the field of biomarker discovery.
97
 Finally, 
lipidomics enhance the understanding of the increase or decrease of a lipid level and its 
combination with the development of a disease and in fact, can play a key role in risk prediction 
and therapeutic monitoring for several pathologies.
98
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1.7. Liposomes: a Simulation of Cell Membranes 
All the scientific achievements in the field of lipidomics pointed out the importance of cell 
membrane and its components. Once it was clear that fatty acid residues represent important 
vectors of free radicals reactivity with all the harmful consequences mentioned above, the study 
of the lipid behavior under various conditions became a necessity. A simpler representation is the 
liposomes, which serve as excellent model membranes.
99
 Liposomes were first described in the 
mid-60s, they are self-closed structures composed of amphiphilic lipids that form a bilayer 
encompassing an aqueous  compartment  and  have  been  extensively  used  as cell  membrane  
models.
100,101
 Liposomes composed of phospholipids present a membrane structure similar to the 
cellular one, in which the lipophilic hydrocarbon region is sandwiched between two ordered polar 
head group regions. Phospholipids are amphipathic molecules, many of which form liposomal 
structures spontaneously when confronted with excess water. Research on liposome technology 
has progressed from conventional vesicles to ‘second-generation liposomes’, in which long-
circulating liposomes are obtained by modulating the lipid composition, size, and charge of the 
vesicle.
102,103
 Generally, liposomes are definite as spherical vesicles with particle sizes ranging 
from 30 nm to several micrometers,. The liposome size can vary from very small (0.025 μm) to 
large (2.5 μm) vesicles. Moreover, liposomes may have one or bilayer membranes. Based on their 
size and number of bilayers, liposomes can also be classified into one of two categories: (1) 
multilamellar vesicles (MLV) and (2) unilamellar vesicles. Unilamellar vesicles can also be 
classified into two categories: (1) large unilamellar vesicles (LUV) and (2) small unilamellar 
vesicles (SUV), as depicted in Figure 13. In unilamellar liposomes, the vesicle has a single 
phospholipid bilayer as a sphere enclosing the aqueous solution. Multilamellar liposomes have a 
multilayered, onion-like structure. Classically, several unilamellar vesicles will form on the inside 
of the other with smaller size, making a multilamellar structure of concentric phospholipid 
spheres separated by layers of water. 
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Figure 13. Liposome classification and diameter sizes. (SUV = small unilamellar vesicle; LUV = large 
unilamellar vesicle; GUV = giant unilamellar vesicle; MLV = multilamellar vesicle) 
 
 
There is a variety of methods for liposome preparation such as sonication,
104
 french pressure cell: 
extrusion,
105
 freeze-thawed liposomes,
106
 lipid film hydration by hand shaking,
107
 non-hand 
shaking or freeze drying,
108
 micro-emulsification,
109
 membrane extrusion
110
 etc, all methods have 
four common stages:
111
 
1. Drying down lipids from organic solvent. 
2. Dispersing the lipid in aqueous media. 
3. Purifying the resultant liposome. 
4. Analyzing the final product. 
 
Liposomes have been used in a broad range of pharmaceutical applications showing particular 
promise as intracellular delivery systems for anti-sense molecules, ribosomes, proteins/peptides, 
and DNA.
112
 However, despite the liposomes primary use as drug deliverable systems this is not 
their only application.
113
 Liposome models can be used in studies of lipid peroxidation or cis-trans 
isomerization due to the fact that they are a stimulation of the cell membrane, in order to avoid the 
Unilamellar Liposomes Multilamellar Liposomes
SUV
< 100 nm
LUV
> 100 nm
GUV
> 300 nm
MLV
> 100 nm
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complication of possible interference of cell components other than the membrane lipids.
114,115
 
They exhibit ion discrimination, osmotic swelling, and response to a variety of agents that 
accelerate or retard loss of ions or molecules from the spherules in a way that at least qualitatively 
mimics their action on natural membrane-bounded structures. Among others, cell membranes act 
as a physiological barrier for a drug in its path to reach the site of action. The diffusion through 
cell membrane phospholipid bilayer, is a key step in the  absorption  and  distribution  of  a  drug  
as  well  as,  ultimately, its action in the organism. The molecule must enter the membrane within 
the polar head group region, diffuse through the lipophilic hydrocarbon double layer and emerge 
throughout the head group region on the inner side. Even in cases where a specific transporter is 
involved, the drug’s ability to interact with the membrane is often highly correlated with 
structural changes in her components. This ability depends on the drug’s hydrophilic/lipophilic 
equilibrium. The study of the interaction between a drug and the membrane lipids of unilamellar 
liposomes is a novel aspect in antitumoral treatments. Nowadays, this aspect is highlightened 
more and more, providing many distinct advantages and bringing out several important features 
regarding the reaction mechanism and the consequent membrane damage under free radical 
conditions. Applications of liposomes in medicine and pharmacology can be divided into 
diagnostic and therapeutic applications; liposomes containing various markers or drugs, and their 
use as a tool, a model, or reagent in the basic studies of cell interactions, recognition processes, 
and mode of action of certain substances.
116,117,118,119
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1.8. Thesis Overall Objectives  
The overall objective of this PhD thesis was to explore the oxidative/free radical damage 
mechanism induced my novel synthesized metallodrugs using biomimetic models in order to 
simulate the biological system and exploring mechanistic scenarios with targeted experiments of 
lipid cis-trans isomerization and DNA damages.  
The damage mechanism is mediated by ROS, which are able to lead in permanent oxidative 
modifications in cellular components. Due to this reason the research achievements presented in 
this thesis focused on the two most important targets of the antitumoral metallodrug’s reactivity; 
membrane lipids and DNA. Therefore, the experimental work can be divided in two parts 
according to the aspect that is studied.  
 Evaluation of the lipid damage in the presence of the artificial metallo-nucleases 
[Cu(TPMA)(N,Nʹ)]2+. For the purposes of these studies, liposome models were employed 
as representation of the cell membranes. Alterations in the chemical structure of fatty acid 
moieties in the presence of a novel metallodrug and a reducing agent are discussed in 
Chapter 2 as well as, in Chapter 3. In addition, in Chapter 3 is presented the first 
complete synthetic strategy and analytical characterization of the most electron rich fatty 
acid; the docosahexaenoic acid (DHA) which was essential for further investigation 
regarding DHA’s reactivity in lipid damage.  
 
 Evaluation of the DNA oxidation profiles and damage mechanism induced by a novel type 
of [Cu(TPMA)(N,Nʹ)]2+ artificial metallo-nucleases. The detailed examination regarding 
the DNA binding, cleavage ability as well as radical trapping experiments to identify the 
dominant free radical(s) giving rise to SSBs and DSBs of AMNs was determined with 
supercoiled DNA. The results obtainded during the course this analysis are discussed in 
Chapter 4.  
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Chapter 2: Model Studies of Cu-TPMA-Phen-Induced Lipid Damage in 
Liposome Membranes 
 
 
Among metal complexes of therapeutic use as antitumor drugs, copper(II) complexes have a 
particular place due to the fact that they can undergo redox activity with in vivo formation of 
Cu(I) and, together with DNA binding properties to cause DNA cleavage.
 120
 The increased 
requirement of copper in cancer cells for redox metabolism and its oxidative properties to 
generate reactive oxygen species (ROS) are the biological and chemical basis, respectively, for 
the anticancer activity of these metallodrugs acting as artificial nucleases for the sequence specific 
disruption of gene function.
121 The artificial chemical nuclease Cu-TPMA-Phen of the novel 
series [Cu(TPMA)(N,Nʹ)]2 that was used for the studies on lipid damage was synthesized, purified 
and fully characterized by ESR Nicolo Fantoni in Dublin City University a ‘ClickGene’ partner, 
under the supervision of Professor Andrew Kellett.  
As mentioned above, an important aspect of the Cu-TPMA-Phen chemical reactivity is the fact 
that it has a redox behavior of Cu
+2 ⟶ Cu+1 and this in situ electron transfer can give rise in the 
formation of radical species.
122
 In the presence of thiols, which are active biomolecules, this redox 
potential of the copper(II) complex can generate S-centered radicals, able to cause biological 
damages involving among others the membrane lipids.
 123,124
 The outcome of the generation of 
thiyl radicals, is that these species can either catalyse a cis-trans isomerisation of double bonds 
and/or initiate a peroxidation process involving the unsaturated fatty acid residues of 
phospholipids.
124 
Phospholipids are a large family of compounds, they are considered as building 
blocks of the membrane and naturally in eukaryotic cells, the double bond geometry of 
unsaturated fatty acid residues is cis.
125
 However, the intervention of sulfur-centered radicals, can 
lead in a cis–trans isomerization, giving rise to the formation of the more thermodynamically 
stable trans isomer.
126
 The free radical-based drug effect inspired biomimetic studies in membrane 
models, composed of liposomes containing monounsaturated fatty acid residues (such as oleic 
acid, 18:1 cis-9) in the presence of the potential drug [Cu(TPMA)(Phenanthroline)](ClO4)2] and 
different thiols as reducing agents to cause the recycling of the redox state of the complex and 
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incubation at 37°C. In our experiments, we were interested in studying the transformation of cis 
geometry into trans, under a variety of different conditions. The study of the biomimetic model in 
a radical-catalyzed cis-trans isomerization is of high importance, since the trans lipid geometry 
resembles that of saturated lipids and is possible to lead in a permanent modification of the 
membrane and formation of a more rigid bilayer packing.
127,70
  
On the other hand, it is known that the monounsaturated fatty acid moieties are less prone to a 
radical-based oxidative degradation compared with the polyunsaturated fatty acids.
128
 In order to 
evaluate the peroxidation pathway, liposomes formed by soybean lecithin containing different 
percentages of SFA, MUFA and PUFA fatty acids were tested in the presence of the copper 
complex and thiol. These vesicles offer the advantage of studying the competition of free radical 
transformations towards peroxidation and isomerization processes, since the polyunsaturated fatty 
acids can partition in both pathways.
 129
 Comparing the results we obtained by the use of these 
two different liposomal compositions under a variety of conditions concerning the effect of 
concentration both for the copper(II)complex and the thiol, the different thiols used, the addition 
of well known antioxidants and the presence or absence of oxygen an interesting scenario of this 
potential metallodrug reactivity was furnished.  
The biomimetic model of liposomes was designed to follow the fatty acid fate after reaction with 
thiyl radicals, formed in the presence of the Cu-TPMA-Phen and a thiol compound. The model 
studies underlined the crucial role of membranes in antitumoral treatments and the fact that 
membranes are not just spectators but important vectors of the antitumoral’s drug reactivity.130,131 
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2.1. Materials and Methods 
2.1.1. Liposome Experiments 
The first step in our experimental procedure is the addition of POPC in chloroform (53 mg 
dissolved in 3 mL), followed by evaporation in a test tube under argon stream. The thin film that 
is formed, remains under vacuum until it is completely free of solvent and then 1 mL tridistilled 
water is added, in order to obtain a final concentration of 70 mM phospholipid content.
132
 The 
solution is vortexed vigorously under argon stream for 7 min and this procedure yields at large, 
multilamellar liposomes (LMV). Our next step is downsizing LMV dispersions in unilamellar 
vesicles (LUV) with a mean diameter of 156-158 nm using the extrusion technique (LUVET) and 
a 200 nm polycarbonate membrane filter.
133
 This method is chosen since not only it helps prevent 
the membranes from fouling and improves the homogeneity of the size distribution of the final 
suspension, but also because this membrane model represents in the closest way the membrane 
bilayer. The size of the liposomes is measured using DLS and the LUVET stock suspensions are 
transferred into a vial and stored at 4°C for a maximum of 2 weeks.  
The total volume of every reaction is 1 mL with phospholipid concentration of 1 mM. More 
specifically an aliquot of 14.5 μL fatty acid content from the stock solution is added in tridistilled 
water in the reaction vessel. To the liposome suspension, the copper complex is transferred (0.15 
mM) and the reaction remains under stirring for 2 min. From stock solutions in tridistilled water 
and final concentration in the reaction 10 mM, the thiol (2-mercaptoethanol or l-cysteine or 
reduced glutathione) is added drop wise (0.5 mm/min) using a syringe pump. Each reaction vessel 
is incubated at 37°C and in order to follow the formation of trans fatty acid residues, samples are 
analyzed at different times, as reported in Tables 1-9.  
The work-up of the vesicles is made with 2:1 chloroform/methanol, extracting and collecting the 
organic phases dried over anhydrous sodium sulfate and evaporating the solvent under vacuum at 
room temperature. The phospholipids are treated with 0.5 M KOH/MeOH, in a transesterification 
type of reaction for 10 min at room temperature, as shown in Scheme 1.
134
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Scheme 1. Mechanism of transesterification reaction in which the phosphoryl group of phospholipids is 
exchanged with the methyl group of methanol under alkaline conditions. 
 
 
 
The reaction is quenched with addition of tridistilled water and an extraction with n-hexane 
follows. The organic layers containing the corresponding fatty acid methyl esters are analyzed by 
GC for the examination of the FAME content.
135
 For the experiments under anaerobic conditions, 
all the solutions are degassed with argon for 15 min and the addition of all reagents take place 
under argon. The anaerobic conditions are maintained during the incubation period by creating 
pressure of argon inside the reaction vial. 
 
2.1.2. GC Analysis 
Fatty acid methyl esters were analyzed by gas chromatograph (Agilent 6850, Milan) equipped 
with a 60 m Χ 0.25 mm Χ 0.25 μm (50%-cyanopropyl)-methylpolysiloxane column (DB23, 
Agilent, U.S.A.). The instrument has a ﬂame ionization detector (FID) that requires air (450 
mL/min) and hydrogen (40 mL/min) and is maintained at a temperature of 250 °C and applying 
injection temperature at 230 °C. From an initial temperature of 165 °C held for 3 min, followed by 
an increase of 1 °C/min up to 195 °C, held for 40 min. A ﬁnal ramp, with a temperature increase 
of 10 °C/min up to a maximum temperature of 240 °C, was maintained for 10 min for column 
purge. A constant pressure mode (29 psi) was chosen with helium as carrier gas. Methyl esters 
were identiﬁed by comparison with the retention times of commercially available standards or 
trans fatty acid references. 
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2.2. Results and Discussion 
2.2.1. Building-up a Membrane Biomimetic Model  
In order to simulate the cell membrane phospholipid behavior, large unilamellar vesicles were 
formed by extrusion technique (LUVET). In our experiments, two different lipid compositions 
were used at concentration of phospholipid content 1 mM. Firstly, the synthetic phospholipid 1-
palmitoyl-2-oleoyl phosphatidyl choline (POPC) was chosen due to the fact that it represents the 
simplest biomimetic model, containing only two different phospholipid moieties of saturated and 
monounsaturated fatty acids. Moreover, the preparation of vesicles from soybean lecithin was 
made, containing different percentages of SFA, MUFA and PUFA fatty acids residues.       
POPC vesicles are proved ideal for the study of cis-trans isomerization since they are consisted of 
the MUFA moiety of oleic acid (9 cis-18:1). Oleic acid can react with sulfur centered radicals and 
be transformed into its trans geometrical isomer (see Appendix Figure S2), which is elaidic acid 
(9 trans-18:1).
136
 For the best estimation of the copper complex contribution to lipid 
isomerization, also control experiments were carried out in the presence of the potential drug, 
without addition of thiol, in which case no transformation was observed. In addition, the 
efficiency of different thiols, such as 2-mercaptoethanol, l-cysteine and glutathione (reduced) was 
evaluated, under anaerobic and aerobic conditions. Due to its amphiphilic character and the ability 
to diffuse freely in the membrane bilayer, 2-mercaptoethanol gave the highest yields of 
isomerization in every condition tested.  
In the experiments with lecithin liposomes the transformations of MUFA (oleic acid, 9 cis-18:1) 
and PUFA (linoleic acid, 9cis,12cis-18:2) residues to their corresponding geometrical isomers, as 
well as the PUFA consumption by oxidative degradation were evaluated. Depending from the 
reaction conditions, isomerization and peroxidation processes were examined and compared. The 
yield of isomerization for each fatty acid MUFA or PUFA, along with the consumption of PUFA 
was based on the peak areas obtained by GC analysis. Gas chromatography is proved to be a 
valuable analytical tool for the identification of each geometrical isomer providing a clear 
separation (see Appendix Figure S3).  The estimation of PUFA peroxidation, it is based on the 
fact that lecithin is composed, among others, by the saturated fatty acid residue of palmitic acid 
(16:0).  Due to the lack of double bonds in its moiety, palmitic acid is unreactive under free 
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radical conditions and can play the role of internal standard. The quantification of consumption is 
possible using the GC calibration curves made for each fatty acid that was analyzed vs the 
palmitic acid residue. 
In order to understand the mechanism of this metallodrug, it is crucial to gain an insight to the 
electron transfer that occurs between the metal and the thiol compound. For this reason, the UV-
VIS spectra of the Cu-TPMA-Phen, before and after addition of different concentrations of thiol 
were obtained, as presented in Appendix in Figure S1.  
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2.2.2. MUFA-containing Vesicles 
Our first aim was to study if the lipid isomerization is possible to occur on MUFA liposomes, in 
the presence of the copper complex with addition of thiol and incubation at 37 °C.  
 
 
 
Figure 14. In the presence of redox-based antioxidants, such as thiols, the reduction of Cu(II) to Cu(I) 
occurs with the formation of thiyl radicals.
137
 
 
 
 
 
 It is known that sulfur-centered radicals are responsible for the transformation of fatty acid 
residues from the natural cis-configuration to trans, via an addition-elimination type of 
reaction.
138
 
 
 
 
Scheme 2. Reaction mechanism for the cis-trans isomerization catalyzed by thiyl radicals. 
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A variety of conditions was tested in order to achieve the formation of trans isomer of oleic acid 
in POPC liposomes. As presented in the Table 1 below, from our experiments we discovered that 
is essential to make the addition of thiol drop wise, since excess of thiol leads in reaction between 
two molecules of thiol and formation of the corresponding disulfide.
139
  
 
Table 1. Addition of thiol with two different ways in the presence of 0.15 mM Cu-TPMA-Phen and 
incubation for 240 min at 37 °C, leads to various % formation yields of trans 18:1 isomer in POPC 
liposomes. 
  2-Mercaptoethanol (10 mM)   
 Aerobic Conditions Anaerobic Conditions 
Quick 
Addition 
Drop wise 
Addition 
Quick Addition Drop wise  
Addition 
0.154 16.296 0.246 18.883 
 
 
 
In liposomes containing MUFA after addition of the copper complex, the effect of the thiol 
concentration was also tested, in the presence and absence of oxygen (Table 2) and the results are 
reported in Figures 15,16. Moreover, the effect of different concentrations of the copper complex 
was also studied in a specific concentration of thiol (Table 3) as shown in Figures 17,18.   
 
 
 
Table 2. The concentration effect of 2-ME on the % formation of trans 18:1 isomer in POPC liposomes 
after incubation for 240 min at 37 °C. 
 
 
 
 
 
 
 
 
 
 
 Cu-TPMA-Phen (0.15 mM) 
2-Mercaptoethanol (mM) Aerobic Conditions             Anaerobic Conditions 
2.5 0.785 2.163 
5.0 3.425 4.520 
10 16.296 18.883 
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Figure 15. trans 18:1 isomer formation in POPC 
vesicles treated with 0.15 mM Cu-TPMA-Phen and 
different concentrations of 2-ΜE under aerobic 
conditions. 
 
Figure 16. trans 18:1 isomer formation in POPC 
vesicles treated with 0.15 mM Cu-TPMA-Phen and 
different concentrations of 2-ΜE under anaerobic 
conditions.
 
 
 
 
Table 3. The concentration effect of Cu-TPMA-Phen on the % formation of trans 18:1 isomer in POPC 
liposomes after incubation for 240 min at 37 °C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cu-TPMA-Phen (mM)   
2-Mercaptoethanol (10 mM) 
Aerobic Conditions             Anaerobic Conditions 
0.15 16.296 18.883 
0.5 4.837 6.534 
1.0 4.336 4.375 
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Figure 17. trans 18:1 isomer formation in POPC 
vesicles treated with 2-ΜE (10 mM) and different 
concentrations of Cu-TPMA-Phen under aerobic 
conditions. 
 
 
 
Figure 18. trans 18:1 isomer formation in POPC 
vesicles treated with 2-ΜE (10 mM) and different 
concentrations of Cu-TPMA-Phen under anaerobic 
conditions. 
     
 
In the heterogeneous environment of the vesicles, thiols can be incorporated into the bilayer or be 
dissolved in the aqueous phase. Two other thiol compounds, which are hydrophilic, cysteine and 
glutathione, were added in POPC liposomes and their efficiency to interact with the copper 
complex and generate the thiyl radical able to lead in isomerization was tested, as reported in 
Table 4 and in Figures 19,20. In contrast with 2-mercaptoethanol that is able to be diffused freely 
in the liposomes suspension due to its amphiphilic character, the other two thiol compounds that 
were used cannot enter in the hydrophobic region of the membrane and as a result the formation 
yield of the trans 18:1 isomer is significantly lower. Comparison of the three different thiols 
suggests that the isomerization rate follows the lipophilicity order of the three compounds (i.e., 2-
mercaptoethanol > GSH > CySH) and indicates that the CyS• radical is unable to migrate into the 
lipid compartment. 
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Table 4. Time course of cis-trans isomerization of 18:1 residues in POPC liposomes, in the presence of 
0.15 mM Cu-TPMA-Phen using different thiol compounds, under aerobic and anaerobic conditions and 
incubation at 37 °C.
 
 
 
Time 
(min) 
2- Mercaptoethanol (10 mM) l-cysteine (10 mM) Reduced Glutathione (10 mM) 
 
Aerobic 
Conditions 
 
Anaerobic 
Conditions 
 
Aerobic 
Conditions 
 
Anaerobic 
Conditions 
 
Aerobic 
Conditions 
 
Anaerobic 
Conditions 
10 6.191 7.882 0.627 0.428 2.122 1.124 
20 7.202 9.444 0.743 0.866 2.380 1.997 
30 8.322 9.746 0.745 0.893 2.623 3.111 
60 9.381 11.642 0.782 1.171 2.631 3.388 
120 13.604 18.883 0.827 1.322 2.755 5.046 
240 16.296 20.175 1.005 2.963 2.953 7.266 
 
 
 
Figure 19. trans 18:1 isomer formation in POPC 
vesicles treated with 10 mM concentration of 
different thiols, 0.15 mM Cu-TPMA-Phen and 
incubation at 37 
0
C under aerobic conditions. 
 
 
 
 
Figure 20. trans 18:1 isomer formation in POPC 
vesicles treated with 10 mM concentration of 
different thiols, 0.15 mM Cu-TPMA-Phen and 
incubation at 37 
0
C under anaerobic conditions. 
 
 
 
Our experimental data pointed out that after 120 min, the cis-trans isomerization is slower 
probably because the thiyl radical is not present anymore. In fact, as it is previously described, two 
molecules of thiol can react and form the corresponding disulfide. In this case, the thiyl radical is 
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quenched and no longer able to be added in the double bond leading in formation of the trans 
isomer. However, the percentage of trans is increased (Table 5) as reported in Figures 21,22 with 
a new drop wise addition of another amount of thiol after the first 120 min of incubation, proving 
also that Cu(II) is regenerated and can react with a new added thiol to form the Cu(II)-thiol 
complex. 
 
Table 5. Time course of cis-trans isomerization of 18:1 residues in POPC liposomes, in the presence of 
0.15 mM Cu-TPMA-Phen with and without addition of new amount of 2-ME, under aerobic/anaerobic 
conditions and incubation at 37 °C.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Time 
(min) 
Aerobic Conditions Anaerobic Conditions 
 
Without new 
addition of 2-ME 
 
Addition of another 10 
mM 2-ME after 120 min 
 
Without new 
addition of 2-ME 
 
Addition of another 10 
mM 2-ME after 120 min 
10 6.191 6.191 7.882 10.767 
30 8.322 8.322 9.746 12.228 
60 9.381 9.381 11.642 14.386 
120 13.604 13.604 18.883 18.883 
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17.552  21.898 
130 24.257 23.789 
150 25.481 29.658 
240 16.296 26.675 20.175 58.504 
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Figure 21. Time course of trans 18:1 isomer 
formation in POPC vesicles treated with 0.15 mM 
Cu-TPMA-Phen in the presence of oxygen and 
I. 10 mM of 2-ME 
II. 10 mM of 2-ME and addition of another 10 mM 
of 2-ME after 120 min. 
 
Figure 22. Time course of trans 18:1 isomer 
formation in POPC vesicles treated with 0.15 mM 
Cu-TPMA-Phen in the absence of oxygen and 
I. 10 mM of 2-ME 
II. 10 mM of 2-ME and addition  of another 10 mM 
of 2-ME after 120 min.
 
Another experiment was the addition of 2-mercaptoethanol (10 mM) every 60 min, starting from 
10 mM and gradually after 240 min the final concentration of thiol reached 40 mM, as shown in 
the Table 6 and Figure 23.  
 
Table 6. Time course of cis-trans isomerization of 18:1 residues in POPC liposomes, in the presence of 0.15 
mM Cu-TPMA-Phen with and without addition of new amount of 2-ME every 60 min, under aerobic 
conditions and incubation at 37 °C. 
 
 
 
Time (min) 
2-Mercaptoethanol (10 mM) 
 
Without new addition of 2-ME 
 
Addition of 10 mM 2-ME every 60 min 
10 6.191 6.191       (2-ME total = 10 mM) 
30 8.322 8.322       (2-ME total = 10 mM) 
60 9.381 9.381       (2-ME total = 10 mM) 
120 13.604 17.694     (2-ME total = 20 mM) 
180 14.944 23.470       (2-ME total = 30 mM) 
240 16.296 37.417     (2-ME total = 40 mM) 
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Figure 23. Time course of trans 18:1 isomer formation in POPC vesicles treated with 0.15 mM 
Cu-TPMA-Phen in the presence of oxygen and 
I. 10 mM of 2-ME and 
II. addition of 10 mM of 2-ME every 60 min and incubation at 37 °C. 
 
 
 
 
Moreover, under aerobic conditions the same experimental procedure was followed, with the 
difference that this time the drop wise addition of 2-mercaptoethanol, using a syringe pump lasted 
60 min.  Samples were analyzed in different times during the addition, in order to gain an insight 
of the reaction. The work-up was made directly, without incubation at 37 °C and the results are 
reported in Table 7 and Figure 24. 
 
Table 7. Time course of 18:1 trans isomer 
formation in POPC liposomes, the presence of 
0.15 mM Cu-TPMA-Phen and drop wise addition 
of 2-ME with duration 60 min, under aerobic 
conditions. 
2-Mercaptoethanol (10 mM) 
Time (min)   Aerobic Conditions   
10 0.121 
30 0.542 
45 4.772 
60 8.117 
 
Figure 24. Time course of trans 18:1 isomer 
formation in POPC vesicles treated with 0.15 mM 
Cu-TPMA-Phen and drop wise addition of 10 mM 
2-ME during 60 min, under aerobic conditions.
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Another interesting experiment in order to understand the chemical behavior of the copper complex 
was the treatment with antioxidant. More specifically, in the reaction vessel, which contained the 
POPC liposomes and the copper complex, 60 μM of l-ascorbic acid were added and then 10 mM of 
2-mercaptoethanol were transferred dropwisely, under aerobic conditions. Our hypothesis was that 
due to its lipophilic ligands, the complex would not be located in the suspension, but it should be 
incorporated into the phospholipid bilayer, as shown in the Figure 25 below. In this case, after the 
interaction between the complex and the thiol, the formation of the thiyl radical would lead to the 
cis-trans isomerization as described previously.  
 
 
Figure 25. A large unilamellar vesicle (LUV) and insertion of the Cu-TPMA-Phen in the bilayer, followed 
by interaction with the amphiphilic thiol, which leads in generation of thiyl radicals. 
 
 
 
On the other hand, if the copper complex was located on the suspension, once the thiyl radical is 
formed, it should be quenched by l-ascorbic acid and the cis-trans isomerization would not occur. 
Our experiments have shown that indeed the cis-trans isomerization takes place in the presence of l-
ascorbic acid and the results are reported below. 
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Table 8. Cis- trans isomerization of 18:1 residues in POPC liposomes, in the presence of 0.15 mM Cu-
TPMA-Phen addition of 60 μM l-ascorbic acid and drop wise addition of 10 mM of 2-ME, under aerobic 
conditions and incubation at 37 °C. 
 
 
 
 
 
 
We were also interested to compare the isomerization yields of the copper complex Cu-TPMA-Phen 
with the parent compound [Cu(1,10-Phen)2]
2+
 in the presence of 2-mercaptoethanol, under aerobic 
conditions and incubation at 37 °C. These experiments prove that the different ligands, which are 
coordinated in the copper, are possible to affect the yield of isomerization due to stereo chemical 
and electronic reasons. The results regarding this set of experiments are reported in Table 9 and 
Figure 26. 
 
Table 9. Time course of cis-trans isomerization of 18:1 residues in POPC liposomes in the presence of 0.15 
mM Cu-TPMA-Phen or the parent compound [Cu(1,10-Phen)2]
2+
, with 10 mM of 2-ME under aerobic - 
anaerobic conditions and incubation at 37 °C. 
 
 
 
Time (min) 
Aerobic Conditions Anaerobic Conditions 
 
Cu-TPMA-Phen 
 
[Cu(1,10-Phen)2]
2+ 
 
Cu-TPMA-Phen 
 
[Cu(1,10-Phen)2]
2+ 
10 6.191 10.936 7.882 3.670 
30 8.322 13.331 9.746 5.135 
60 9.381 15.173 11.642 6.482 
120 13.604 15.558 18.883 11.613 
240 16.296 15.814 20.175 12.417 
 
2-Mercaptoethanol (10 mM) 
Time (min)   l-Ascorbic Acid (μM) Aerobic Conditions   
120 No 10.740 
120 60 10.591 
240 60 12.219 
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Figure 26. Time course of trans 18:1 isomer formation in POPC vesicles treated with 0.15 mM Cu-
TPMA-Phen and the parent compound [Cu(1,10-Phen)2]
2+
 in the presence of 10 mM 2-ME, under 
aerobic and anaerobic conditions and incubation at 37 °C. 
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2.2.3. MUFA- and PUFA-containing Vesicles 
In our studies liposomes consisted of high purity soybean lecithin containing different percentages 
of saturated, mono- and poly- unsaturated fatty acids were also tested, as presented in Figure 27. 
 
 
Figure 27. Different percentages of SFA, MUFA and PUFA fatty acid residues in liposomes composed 
by soybean lecithin. 
 
 
 
 
 
This type of biomimetic model provides the advantage to investigate both the cis-trans 
isomerization of MUFA (oleic acid can be transformed into elaidic acid) as described previously 
and at the same time to evaluate the pathways of oxidation – isomerization, in which the PUFA 
residues can be partitioned (see Figure S2 in Appendix). The experiments were carried out in the 
presence of 0.15 mM Cu-TPMA-Phen, 10 mM of 2-mercaptoethanol and incubation at 37 °C. 
Under these conditions thiyl radicals (HOCH2CH2S
•
) are generated and these species are able to 
attack the double bonds of the linoleic acid residue. Taking into account the formation yields of 
mono- and di-trans in linoleic acid residue, it is evident that the thiyl radical attack the double 
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bonds in a step-by-step cis-trans isomerization.
140
 Moreover, as presented in Figure 28 the 
mono-trans isomers can be considered as precursors of the di-trans isomers. 
 
 
 
 
Figure 28. Cis-trans isomerization of PUFA catalyzed by thiyl radicals.
140
 
 
 
In our experiments not only the mono-trans isomers were detected, but also the di-trans isomers 
of linoleic acid residue were identified. In the Figures 29, 30 and 31, a detailed study on the 
oleic and linoleic transformations to their corresponding geometrical isomers is reported. 
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Figure 29. Time course of trans 18:1 isomer 
formation in lecithin vesicles treated with 0.15 mM 
Cu-TPMA-Phen drop wise addition of 10 mM 2-
ME and incubation at 37 °C. 
 
 
Figure 30. Time course of total trans 18:2 isomer 
formation in lecithin vesicles treated with 0.15 mM 
Cu-TPMA-Phen, drop wise addition of 10 mM 2-
ME and incubation at 37 °C. 
 
 
 
 
 
Figure 31. Estimation of isomerization in MUFA and PUFA residues in lecithin liposomes in the presence 
of 0.15 mM Cu-TPMA-Phen, 10 mM 2-ME and incubation at 37 
0
C under anaerobic conditions. 
 
 
Apart from the cis-trans isomerization, the moiety of PUFA is prone to further transformations 
by other free radical routes depending on the conditions applied, aerobic or anaerobic. 
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Scheme 3. The parallel involvement of PUFA residues in peroxidation and isomerization processes.
140 
 
 
 
 
 
Our experiments provided strong evidence that in the presence of 0.15 mM Cu-TPMA-Phen, 10 
mM 2-ME and incubation at 37 °C both pathways were clearly operative. An important aspect 
on PUFAs reactivity is the methylene-interrupted double bonds and the presence of bisallylic 
positions from which the hydrogen abstraction is possible to occur. In the conditions applied the 
thiyl radical HOCH2CH2S
•
 that is generated can abstract the bisallylic hydrogen, giving rise in 
the formation of carbon-centered radicals. 
 
 
 
Scheme 4. Mechanism of peroxidation reaction that leads in a decreased PUFA content.   
 
  
 
 
Under aerobic conditions, these carbon-centered radicals react with O2 to give peroxyl radicals 
that propagate the lipid peroxidation, which eventually lead to a decreased PUFA content. Under 
anaerobic conditions, the disappearance of PUFA occurring by peroxidation process was not 
found to be important, while the geometrical isomerization of linoleic fatty acid residue in lipid 
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vesicles appears to be the main process. Our results regarding PUFA peroxidation are reported in 
Figure 32 below. 
 
 
 
 
 
Figure 32. Time profile of total peroxidation in liposomes composed by high purity lecithin, after addition 
of 0.15 mM Cu-TPMA-Phen, 10 mM 2-ME and incubation at 37 
0
C. The estimation of consumption is 
based on the ratio SAT/PUFA, which found as peaks of the GC analysis of their corresponding FAME. 
[Lecithin is consisted by linoleic (9cis,12cis-18:2), which is in abundance, and a-linolenic 
(9cis,12cis,15cis-18:3) fatty acid residue].
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2.3. Conclusions 
The use of copper complexes for redox and oxidative-based mechanisms in therapeutic 
strategies is an important field of multidisciplinary research. Herein, a novel Cu(II) complex’s 
reactivity towards the fatty acid moieties of phospholipids was studied, using the liposome 
model to work in a biomimetic environment. The liposome behaviour confirmed that MUFA 
and PUFA fatty acid moieties, as representation of cellular membranes, are affected by 
oxidative and isomerisation reactions. In parallel, is reported the study of the different 
reactivity of thiyl radicals generated from amphiphilic and hydrophilic thiols in the presence of 
Cu-TPMA-Phen. These experiments give preliminary, but important elements of copper(II) 
complex reactivity in cell membrane models, pointing mainly to the cell membranes that are 
subjects of strong interest for chemotherapeutic activities. The reactivity of copper complexes 
with fatty acids is very important for a metallomic-integrated approach and our results offer 
several new insights for understanding the interactions of the metallome with lipidomics. The 
trans fatty acid formation catalysed by thiyl radicals, generated from the metal-based response, 
can be developed for the investigation of multi-targeted drug design in anticancer therapies, 
including the relevance of the thiol and copper-complex partitions between aqueous and lipid 
phases, as evaluated by the biomimetic model of liposomes.  
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Chapter 3: Trans Lipid Library; Synthesis of Docosahexaenoic Acid (DHA) 
Monotrans Isomers - Regioisomer Identiﬁcation & Model Studies in DHA-
Containing Liposomes 
 
 
Continuing our studies on the artificial chemical nuclease’s reactivity towards the unsaturated 
fatty acid residues, I thought it would be interesting to investigate vesicles composed by the 
most electron-rich polyunsaturated fatty acid, due to an increased probability of lipid damage; 
the docosahexaenoic acid (DHA) which contains six cis double bonds. 
However, in the literature there were not enough data regarding the characterization of the six 
monotrans DHA regioisomers and they were an open issue to address for analytical, 
biological, and nutraceutical applications. Therefore, my research aimed in building-up a 
library of the monotrans DHA isomers. The studies included the preparation, separation, and 
ﬁrst identiﬁcation of each isomer by a dual approach consisting of the following:  
 
1. the direct thiyl radical-catalyzed isomerization of cis-DHA methyl ester and 
2. the two-step synthesis from cis-DHA methyl ester via monoepoxides as intermediates, 
which are separated and identiﬁed by nuclear magnetic resonance spectroscopy, 
followed by elimination for the unequivocal assignment of the double bond position.  
 
The results were published in Chemical Research in Toxicology
141
 Menounou G.‡,Giacometti 
G.,‡ Scanferlato R., Dambruoso P., Sansone A., Tueros I., Amézaga J.,Chatgilialoglu C. and 
Ferreri C.; 2018 31 (3), 191-200, Trans Lipid Library: Synthesis of Docosahexaenoic Acid 
(DHA) Monotrans Isomers and Regioisomer Identification in DHA-Containing Supplements. 
(DOI: 10.1021/acs.chemrestox.8b00021) 
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As discussed in Chapter 1, cis polyunsaturated fatty acids (PUFA) are essential components 
of human fats, particularly important for biological functions, such as for example to form 
membrane phospholipids and signaling molecules. In vivo, the omega-3 fatty acid docosa-
4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic acid (cis-DHA)(Figure 33) is produced through several 
steps of elongation and desaturation from alpha-linolenic acid (octa-9Z,12Z,15Zdecatrienoic 
acid), the essential precursor taken exclusively from the diet.
142
  
 
 
 
 
Figure 33. Structure of DHA (4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid). 
 
 
This nine-step biosynthesis is variably eﬃcient in humans; therefore, the semiessential nature of 
DHA is now worldwide recognized by Health Agencies.
143
 Because of its importance for correct 
human growth, adequate daily intakes of 100−200 mg have been established by the main 
international food safety and health agencies from dietary sources, such as algae or ﬁsh, 
especially in children and pregnant women.
144
 This led to an increased marketing of DHA-rich 
formulas, either as functional foods and supplements. On the other hand, the multiple roles of 
DHA for molecular pathways and signaling have attracted interest in the past decade, all 
biological activities being strictly dependent from the structural requisite of the cis geometry.
145
 
When high temperatures and low pressures are used in deodorization processes,
146
  to eliminate 
the unpleasant ﬁshy smell of oils, the natural cis structure of the polyunsaturated fatty acids is 
aﬀected and the formation of geometrical trans isomers was demonstrated.147,148 The health 
consequences of trans PUFA are matters of several studies that evidenced harmful roles in 
cardiovascular health and pregnancy,
149,150
 whereas it is worth noting that omega-3 
supplementation in persons with cardiovascular diseases
151,152
 and pregnant women
153,154
 is 
highly recommended. In the frame of our research on the free radical modiﬁcations of 
biomolecules, we studied geometrical trans fatty acids (TFA) obtained from an isomerization 
process catalyzed by sulfur-centered radicals, which occurs via an addition−elimination 
mechanism without involving the shift of the double bond, with interesting insights for 
polyunsaturated fatty acids.
155,156 
The number of geometrical isomers for the unsaturated fatty 
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acid is calculated as to 2
n
, where n is the number of double bonds; therefore, in the case of long-
chain PUFA, such as DHA, a high number of isomers can be calculated (2
6
 = 128).  
However, because of the step-by-step mechanism of this reaction, monotrans isomers are the ﬁrst 
and major products, and they are also the most relevant products of radical stress in biological 
systems, where the low radical concentration produced in vivo is able to involve one double 
bond, as examined by using the biomimetic model of membranes in the form of unilamellar 
liposomes. Indeed, monotrans isomers of arachidonic acid in the 5 and 8 positions were found to 
be the most relevant products created during oxidative metabolism with production of thiyl 
radicals, distinguishable from TFA obtained from the dietary intake and metabolic 
transformation of chemically manipulated oils containing trans isomers of linoleic 
acid.
71,157,158,159
 Some attention has been given to the biological eﬀects of speciﬁc monotrans 
isomers, showing diﬀerences from the natural cis analogues.160,161,162,163 However, extension of 
such studies is limited by the availability of TFA molecular library and by the few commercially 
available TFAs. Synthetic routes to PUFA monotrans isomers are useful to build up the trans 
lipid library and address analytical protocols and biological studies. In the past, our group ﬁrst 
characterized the monotrans isomers of arachidonic acid (4 isomers)
140
 and eicosapentaenoic 
acid (EPA, 5 isomers)
164
 using gas chromatography (GC) and carbon-13 nuclear magnetic 
resonance (
13
CNMR) in combination for the assignment of each isomer structure. In the case of 
EPA, the eﬃciency of a dual synthetic approach was tested in order to obtain the ﬁve monotrans 
isomers in comparison with the isomers coming from the free radical-catalyzed isomerization, as 
shown in Scheme 5. 
 
 
 
 
Scheme 5. Dual Synthetic approach to obtain the geometrical trans isomer: From cis-alkene via epoxide 
formation and ring opening, or via radical-based isomerization. 
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The strategy of separation and assignment of the monoepoxide structures, prior to the 
elimination, successfully worked for the ﬁrst unambiguous determination of the trans alkene 
position, integrating previous data in the literature.
165,166,167
 We considered the dual approach 
shown in Scheme 5 to be useful also for the synthesis of the monotrans DHA isomers. Only the 
4E regioisomer is commercially available as methyl ester and can be used as GC reference, 
whereas in literature monotrans DHA isomers were analyzed by several authors after 
deodorization/isomerization reactions of DHA-rich oils, assaying various conditions of GC 
analysis but lacking a speciﬁc regioisomer assignment.147,148,162,166,167 As far as the synthesis of 
the DHA monoepoxides is concerned, the classical epoxidation reaction can lead to these 
compounds,
168
 which are named epoxydocosapentaenoic acid (EDP). 4,5-EDP and 19,20-EDP 
were known
165,169,170,171
 also due to their biological relevance as metabolites of cytochrome  
P450.
172,173
  
The strategy of the separation of the intermediate monoepoxide regioisomers was successful to 
unambiguously individuate the epoxidation of the double bond position, using mono- and 
bidimensional nuclear magnetic resonance (NMR) experiments. Consequently, after ring 
opening, dibromide formation and elimination from each monoepoxide regioisomer double bond 
was unequivocally established, thus allowing for the assignment of the corresponding peaks in 
the GC analysis. This double approach clariﬁed that the direct isomerization by free radical-
catalyzed reaction gives the six isomers as exclusive products within a few minutes. The 
usefulness of such identiﬁcation was then assayed for analysis of ﬁsh oil and its isomerization 
products, also in view of applying the analytical route to the purity of ﬁsh oil preparations, which 
is a hot topic of food research.
148,174,175
 Trans-containing triglycerides were studied and it was 
highlightened that NMR represents a powerful analytical methodology to apply directly on the 
oil without transformation to fatty acid methyl esters.
176
  
Moreover, DHA due to its unique effect of altering membrane composition, is often regarded as 
the major omega-3 fatty acid involved in anticancer activity.
177
 Although use of DHA as an 
anticancer drug to prevent or treat human cancer in clinical settings has not yet been well 
established, recent studies suggest that DHA can be very effective as an adjuvant with other 
anticancer agents.
178
 There are studies reporting that oxidized DHA leads to DNA adduct 
formation, therefore this induced oxidative DNA damage triggers cell cycle arrest and apoptosis 
in cancer cells.
179,180
 Several in vitro and animal studies suggest combining DHA with other 
anticancer agents often improves efficacy of anticancer drugs as well as reduces therapy-
associated side effects.
181
 Docosahexaenoic acid (DHA), in vitro and in vivo, used along with 
anticancer drugs, has improved cancer treatment outcome. In fact, there are clinical studies in the 
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literature reporting positive results with omega-3 supplements in oncologic patients.
182
 There are 
beneficial effects of omega-3 fatty acids supplements in patients undergoing chemotherapy 
and/or radiotherapy on different outcomes, being the preservation of body composition the most 
evident.
183
 Incorporation of DHA in cellular membranes improves drug uptake, whereas 
increased lipid peroxidation is another mechanism for DHA-mediated enhanced efficacy of 
anticancer drugs.
184,185
 In 1998, Hawkins et al. reported that apoptotic death of human Mia-PaCa-
2 pancreatic cancer cells induced by PUFAs varies with double bond number and involves an 
oxidative mechanism.
186
 They found correlations between the number of fatty acid double bonds 
and the proportion of apoptotic cells. This information trigger our experimental design towards 
DHA-containing liposomes as biomimetic model of cell membranes, since DHA represents the 
most electron rich and crucial PUFA.  
The monotrans DHA library and GC characterizations were firstly applied to the analysis of 
omega-3 containing supplements in capsules commercially available in Italy and Spain, 
evidencing trans isomer contamination in the oil ingredients. Secondly, the cis-trans 
isomerization process was examined in DHA-containing liposomes in the presence of Cu-
TPMA-Phen and 2-mercaptoethanol as reducing agent to evaluate the altered configuration of 
DHA. 
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3.1. Materials and Methods 
Chloroform, methanol, n-hexane, 2-propanol, and acetonitrile were purchased from Merck 
(HPLC purity). Absolute ethanol was purchased from BDH Prolabo VWR (AnalaR 
NORMAPUR) and 2-mercaptoethanol was purchased from Aldrich. Silver nitrate, 30% aq 
NHOH and anhydrous sodium sulfate (Na2SO4) were purchased from Carlo Erba. All fatty acid 
methyl esters (FAME) used as reference standard for GC analyses were purchased from Aldrich, 
Fluka, or Sigma and used without further puriﬁcation. 4E,7Z,10Z,13Z,16Z,19Z DHA-
methylester was purchase from Lipidox (Lidingo, Sweden). Deuterated benzene and deuterated 
CDCl3 were purchased from Eurisotop (France). Silica-gel thin-layer chromatography (analytical 
and preparative) was performed on Merck silica gel 60 plates (0.25 and 2 mm thickness, 
respectively). 
Regarding the experimenrs with liposomes, vesicles composed by 20% 18:0-22:6 PC/POPC in 1 
mM concentration were prepared. Samples were degassed under argon for 15 min. In addition, 
the stock solution of 2-mercaptoethanol was prepared (the water was degassed for 15 min and 
then 2-ME was added under argon stream). The anaerobic conditions were maintained during the 
incubation period by creating pressure of argon inside the reaction vial. 
 
 
GC Analyses. Fatty acid methyl esters were analyzed by gas chromatograph (Agilent 6850, 
Milan) equipped with a 60 m Χ 0.25 mm Χ 0.25 μm (50%-cyanopropyl)-methylpolysiloxane 
column (DB23, Agilent, U.S.A.). The instrument has a ﬂame ionization detector (FID) that 
requires air (450 mL/min) and hydrogen (40 mL/min) and is maintained at a temperature of 250 
°C. Two identical equipment conditions were used for the analyses, applying the same injection 
temperature (230 °C) but diﬀerent oven conditions and carrier gas. 
Method A: from an initial temperature of 165 °C held for 3 min, followed by an increase of 1 
°C/min up to 195 °C, held for 40 min. A ﬁnal ramp, with a temperature increase of 10 °C/min up 
to a maximum temperature of 240 °C, was maintained for 10 min for column purge. A constant 
pressure mode (29 psi) was chosen with helium as carrier gas. Methyl esters were identiﬁed by 
comparison with the retention times of commercially available standards or trans fatty acid 
references, obtained as described elsewhere.  
Method B: temperature started from 195 °C, held for 26 min, followed by an increase of 10 
°C/min up to 205 °C, held for 13 min, followed by a second increase of 30 °C/min up to 240 °C, 
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held for 10 min. A constant pressure mode (29 psi) was chosen with hydrogen as carrier gas. 
GC/MS spectra were recorded on a Clarus 500 GC apparatus equipped with a Clarus 560S mass 
spectrometer (GC/MS transfer line temperature 230 °C) and a 60 m Χ 0.25 mm Χ 0.25 μm 
(50%cyanopropylphenyl)-dimethylpolysiloxane column (DB225 ms, Agilent, U.S.A.), using an 
injector temperature of 230 °C, a split ratio of 50:1, and helium as carrier gas at a constant ﬂow 
of 1.2 mL/min, with the following oven conditions: temperature started from 195 °C, held for 52 
min, followed by an increase of 3 °C/min up to 205 °C, held for 10 min, followed by a second 
increase of 3 °C/min up to 225 °C, held for 15 min and a ﬁnal increase of 5 °C/min up to 230 °C, 
held for 10 min. 
Photolysis. Photolysis was carried out in a quartz photochemical reactor (Sigma-Aldrich) 
equipped with a 5.5 W low-pressure mercury lamp. The temperature was maintained at (22 ± 
2)°C by means of a thermostat bath. Nuclear Magnetic Resonance (NMR). All NMR spectra 
were collected with a fully automated Agilent NMR system, consisting of a 54 mm bore, 500 
MHz (11.7 T) Premium Shielded superconducting magnet, a DD2 Performa IV NMR console, 
and the Agilent OneNMR probe. All samples were dissolved in C6D6 and transferred in 3 mm 
thin wall NMR tubes (Wilmad 335-PP-8). After having calibrated each sample of pw90, the 
following seven NMR experiments were collected 
on each sample (2D experiments were collected with 50% NUS and F2 sw (
1
H): 10 ppm, from 
−0.5 to 9.5 ppm): 
 1H NMR spectra: pw90 was calibrated for each sample, sw: −0.5 to 9.5 ppm 
 one gHSQC: F1 sw (13C) 135 ppm, from 5.0 to 140 ppm; nt = 32; ni = 512; res: 33 Hz (0.26 
ppm.) F2 sw (
1
H): 10 ppm, from −0,5 to 9,5 ppm, NUS: 50%. 
  two bsgHSQCAD: first F1 sw (13C): 60 ppm, from 5.0 to 65 ppm; nt = 32; ni = 512; res: 15 
Hz (0.12 ppm). F2 sw (
1
H): 10 ppm, from −0.5 to 9.5 ppm, NUS: 50%. second: F1 sw (13C): 
20 ppm, from 120.0 to 140 ppm; nt = 32; ni = 512; res: 5 Hz (0.04 ppm). F2 sw (
1
H): 10 
ppm, from −0.5 to 9.5 ppm, NUS: 50%. 
 one gHMBCAD: F1 sw (13C): 175 ppm, from 5.0 to 180 ppm; nt = 64; ni = 512; res: 43 Hz 
(0.34 ppm). F2 sw (from −0.5 to 9.5 ppm, NUS: 50%. 
 two bsgHMBC: first F1 sw (13C): 60 ppm, from 5.0 to 65 ppm; nt = 64; ni = 512; res: 15 Hz 
(0.12 ppm). F2 sw (
1
H): 10 ppm, from −0.5 to 9.5 ppm, NUS: 50%. second: F1sw(13C): 60 
ppm, from 120.0 to 180 ppm; nt = 64; ni = 512; res: 15 Hz (0.12 ppm). F2 sw (
1
H): 10 ppm, 
from −0.5 to 9.5 ppm, NUS: 50%. 
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3.2. Epoxidation of Methyl All-(Z)-4,7,10,13,16,19-docosahexaenoate 
3.2.1. Synthesis of Epoxydocosapentaenoic Acid Methyl Ester (EDP-Me) 
Regioisomers 
A 5.84 mM solution of meta-chloroperoxybenzoic acid in dichloromethane (2.5 mL 
corresponding to 0.0146 mmol; 2.51 mg) was added dropwise to a solution of DHA methyl ester 
1 (50 mg; 0.146 mmol) in dichloromethane (2.5 mL). After the addition was completed, the 
mixture was stirred for 10 min at room temperature under argon atmosphere, following the 
formation of monoepoxides with traces of diepoxides by TLC. Eluent: 7/3 n-hexane/diethyl 
ether; DHA-Me Rf = 0.9, ﬁrst mixture (5, 6 and traces of 4) R= 0.7, second mixture (3 and 7) Rf 
= 0.6, pure isomer (2) Rf = 0.5): bisepoxides Rf  ≤ 0.4). Work-up was carried out by addition of 5 
mL of ice-cold NaHCO3 (25% w/v) stirred for 2 min. Then, the reaction mixture was transferred 
in a separating funnel, the aqueous layer was discarded and the organic layer was washed two 
times with NaHCO3, deionized H2O and dried over Na2SO4. The crude was puriﬁed with ﬂash 
chromatography (eluent: 9/1 n-hexane/diethyl ether) to give a ﬁrst fraction containing an 
inseparable mixture (colorless oil; 8 mg; 0.0223 mmol; 15.3% yield) containing 13,14-EDP-Me 
(5), 16,17EDP-Me (6) with traces of 10,11-EDP 4 and of residual starting material (1). 
Structures 5 and 6 in Figure 34, were found in a 29:71 ratio, respectively, as calculated by the 
integration of protons of C-22 on 
1
H NMR spectrum (trace II in Figure 37). EDP-Me 
regioisomers 5 and 6 were further puriﬁed by preparative TLC using 100 mL toluene/500 μL 
isopropanol as the eluent: (Rf = 0.5, pure isomer 6, and Rf = 0.4, pure isomer 5) to give pure 6 (3 
mg; 0.0084 mmol; 37.5% yield) with only traces of 4. 
The second fraction contained an inseparable mixture of 7,8-EDPMe (3) and 19,20-EDP-Me (7) 
(colorless oil; 7 mg; 0.0195 mmol; 13.4% yield) found in a 43:57 ratio, respectively, as 
calculated by the integration of protons of C-22 on 
1
H NMR spectrum (trace III in Figure 37). 
The subsequent fraction contained pure 4,5EDP-Me (2) regioisomer (colorless oil; 5 mg; 0.0134 
mmol; 9.2% yield) identiﬁed as shown in Figure 37 (trace IV) for the C22 triplet at 1H NMR. 
The starting material DHA-Me (1) recovered was 30 mg (0.0877 mmol; 60% recovered yield). 
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Figure 34. Structures of the six EDP regioisomers (left) and the corresponding monotrans DHA methyl 
ester isomers (right). 
 
 
 
The structural assignment of each regioisomer in the fractions was performed by dissolving the 
fractions in C6D6 as NMR solvent in which they are stable and carrying out mono- and 
bidimensional experiments. Table S1 and Figure S5 in Appendix report the detailed 
1
 H and 
13
C 
NMR resonances attributed to the regioisomers, as well as to cis-DHA methyl ester. For the 
1
H 
NMR of the monoepoxides, see Figures S7, S10 and S11 in the Appendix. 4,5-EDP (2) and 
19,20-EDP (7) were previously reported in CDCl3 (cf. Table S1). The 2D NMR experiments for 
the assignment of the C and H resonances in the EDP regioisomers are also shown (Figures S8 
and S9). Here below, a summary of the main NMR spectroscopy for the EDP regiosiomers 
assignment is provided. 
  
Methyl (Z)-13,14-Epoxy-all-(Z)-4,7,10,16,19-docosahexaenoate (5). 
1
H NMR (C6D6, 500 MHz): 
δΗ 5.25 - 5.55 (m, 10H), 3.31 (s, 3H), 2.72 - 2.83 (m, 8H), 2.25 - 2.41 (m, 4H), 2.12 (s, 4H), 1.93 
- 2.00 (m, 2H), 0.88 (t, J = 7.30 Hz, 3H). 
13
C NMR (C6D6, 126 MHz): δC 172.35 (C1), 131.90 
(C20), 130.53 (C17), 130.19 (C10), 129.02 (C5), 128.32 (C8), 128.11 (C4), 127.87 (C7), 126.82 
(C19), 124.76 (C11), 124.55 (C16), 55.66 (C14), 55.65 (C13), 50.65 (C1`), 33.63 (C2), 26.35 
(C15), 26.34 (C12), 25.78 (C9), 25.68 (C18), 25.57 (C6), 22.75 (C3), 20.53 (C21), 14.03 (C22). 
Methyl (Z)-16,17-Epoxy-all-(Z)-4,7,10,13,19-docosahexaenoate (6). 
1
H NMR (C6D6, 500 MHz): 
δΗ 5.25 - 5.55 (m, 10H), 3.31 (s, 3H), 2.72 - 2.83 (m, 8H), 2.25 - 2.41 (m, 4H), 2.12 (s, 4H), 1.87 
- 1.94 (m, 2H), 0.86 (t, J = 7.30 Hz, 3H). 
13
C NMR (C6D6, 126 MHz): δC 172.35 (C1), 133.81 
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(C20), 130.19 (C13), 129.02 (C5), 128.40 (C10), 128.32 (C8), 128.11 (C4), 127.87 (C7), 127.70 
(C11), 124.76 (C14), 123.66 (C19), 55.79 (C17), 55.65 (C16), 50.65 (C1`), 33.63 (C2), 26.34 
(C15), 26.22 (C18), 25.78 (C12), 25.66 (C9), 25.57 (C6), 22.75 (C3), 20.53 (C21), 14.00 (C22). 
Methyl (Z)-7,8-Epoxy-all-(Z)-4,10,13,16,19-docosahexaenoate (3). 
1
H NMR (C6D6, 500 MHz): 
δH 5.35 - 5.51 (m, 10H), 3.30 (s, 3H), 2.69 - 2.85 (m, 8H), 2.19 - 2.32 (m, 4H), 2.08 - 2.14 (m, J 
= 7.30 Hz, 4H), 1.93 - 2.04 (m, 2H), 0.89 (t, J = 7.50 Hz, 3H). 
13
C NMR (C6D6, 126 MHz): δC 
172.30 (C1), 131.82 (C20), 130.17 (C11), 130.08 (C4), 128.35 – 127.80 (C13, C14, C16 and 
C17), 127.06 (C19), 125.77 (C5), 124.78 (C10), 55.65 (C8), 55.63 (C7), 50.66 (C1`), 33.51 (C2), 
26.35 (C9), 26.23 (C6), 25.78 (C12), 25.75 – 25.60 (C15), 25.58 (C18), 22.83 (C3), 20.55 (C21), 
14.07 (C22). 
Methyl (Z)-19,20-Epoxy-all-(Z)-4,7,10,13,16-docosahexaenoate (7). 
1
H NMR (C6D6, 500 MHz): 
δH 5.25 - 5.52 (m, 10H), 3.31 (s, 3H), 2.73 - 2.86 (m, 9H), 2.60 (dt, J = 4.20, 6.40 Hz, 1H), 2.25 - 
2.37 (m, 3H), 2.04 - 2.16 (m, J = 7.30 Hz, 3H), 1.40 (ddq, J = 7.30, 7.30, 14.10 Hz, 1H), 1.28 
(ddq, J = 6.10, 7.30, 13.50 Hz, 1H), 0.84 (t, J = 7.70 Hz, 3H). 
13
C NMR (C6D6, 126 MHz): δC 
172.32 (C1), 130.03 (C16), 129.06 (C5), 128.35 – 127.80 (C7, C8, C10, C11, C13 and C14), 
128.08 (C4), 124.96 (C17), 57.38 (C20), 55.75 (C19), 50.65 (C1`), 33.64 (C2), 26.31 (C18), 
25.79 (C15), 25.75 – 25.60 (C9 and C12), 25.58 (C6), 22.76 (C3), 21.10 (C21), 10.45 (C22). 
Methyl (Z)-4,5-Epoxy-all-(Z)-7,10,13,16,19-docosahexaenoate (2). 
1
H NMR (C6D6, 500 MHz): 
δH 5.23 - 5.55 (m, 10H), 3.29 (s, 3H), 2.65 - 2.88 (m, 10H), 2.13 - 2.27 (m, 3H), 1.95 - 2.09 (m, 
3H), 1.68 - 1.76 (m, 1H), 1.58 - 1.68 (m, 1H), 0.89 (t, J = 7.63 Hz, 3H). 
13
C NMR (C6D6, 126 
MHz): δC 172.35 (C1), 131.89 (C20), 130.27 (C8), 128.63/128.38/128.11/128.96 (C13, C14, C16 
and C17), 128.42 (C11), 127.95 (C10), 127.19 (C19), 124.78 (C7), 56.07 (C5), 55.32 (C4), 50.85 
(C1`), 30.76 (C2), 26.38 (C6), 25.86 (C9), 25.75 (C12 and C15), 25.66 (C18), 23.42 (C3), 20.66 
(C21), 14.17 (C22). 
Methyl All-(Z)-4,7,10,13,16,19-Docosahexaenoate (1). 
1
H NMR 
1
H NMR (C6D6, 500 MHz): δH 
5.24 - 5.47 (m, 12H), 3.31 (s, 3H), 2.73 - 2.88 (m, 10H), 2.29 (dddd, J = 0.80, 1.40, 7.34, 14.70 
Hz, 1H), 2.29 (dddd, J = 0.80, 1.40, 7.30, 14.70 Hz, 1H), 2.11 (t, J = 7.40 Hz, 2H), 1.95 - 2.03 
(m, 2H), 0.89 (t, J = 7.61 Hz, 3H). 
13
C NMR (C6D6, 126 MHz): dC 174.32 (C1), 131.78 (C20), 
129.08 (5), 128.50 (C17), 128.22 (C14), 128.15 (C8, C10 and C11), 128.11 (C7, C13 and C19), 
128.06 (C4), 127.91 (C16), 50.65 (C1`), 33.65 (C2), 25.67 (C15), 25.66 (C9), 25.65 (C18), 25.57 
(C6), 25.56 (C12), 22.75 (C3), 20.54 (C21), 14.08 (C22). 
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3.2.2. Transformation of EDP-Me Regioisomers to Monotrans DHA-Me Isomers 
The reaction is described for 16,17-EDP-Me and 13,14-EDP-Me (ﬁrst fraction of the EDP 
chromatographic separation) and the same steps were followed for the other isolated EDP-Me 
fractions. 
 
Step 1. (Bromination of Epoxide) 
 
To a freshly prepared solution of triphenylphosphine dibromide (7 mg; 0.0167 mmol) in dry 
dichloromethane (50 μL) a solution containing a mixture of EDP regioisomers, 6 and 5, (3 mg; 
0.0084 mmol containing traces of 10,11-EDP 4) in dry dichloromethane (100 μL) and pyridine 
(1 μL) was added, stirring at 0 °C under argon atmosphere. The mixture was left stirring 
overnight at 5 °C, and then was quenched with a 1 M aqueous solution of hydrochloric acid (0.5 
mL) and extracted three times with chloroform/ethanol (4/1). The reaction was monitored by 
TLC for the ring opening as dibromide (7/3 n-hexane/diethyl ether, starting material Rf = 0.7 and 
dibromide product R = 0.4). The organic layers were collected, dried over Na2SO4 and 
evaporated under vacuum. The crude containing methyl 16,17-dibromo-(4Z,7Z,10Z,13Z,19Z)-
docosapentaenoate and 13,14-dibromo-(4Z,7Z,10Z,16Z,19Z)-docosapentaenoate (with traces of 
the 10,11-dibromoderivative) was used for the next step. The same reaction was also performed 
for the inseparable mixture of the EDP-Me regioisomers 3 and 7 and for the EDP-ME 
regioisomer 4. In all cases, the reaction crude was used for the next step. 
 
Step 2. (Elimination) 
 
To an ice-cooled slurry of activated zinc (4.7 mg; 0.072 mmol), acetic acid (2 μL), and N,N-
dimethylformamide (150 μL), a solution of methyl 16,17-dibromo(4Z,7Z,10Z,13Z,19Z)-
docosapentaenoate and traces of 13,14-dibromo-(4Z,7Z,10Z,16Z,19Z)-docosapentaenoate (3 mg; 
0.0060 mmol) in N,N-dimethylformamide (100 μL) was added, and the mixture was stirred at 0 
°C for 14 h. The reaction was monitored by TLC (eluent: 7/3 n-hexane/diethyl ether) evidencing 
the formation of alkenes (R = 0.9) in the presence of traces of starting material (Rf = 0.4). At this 
point, the reaction was stopped by addition of a 1 M aqueous hydrochloric acid solution (1 mL), 
and the precipitate was ﬁltered oﬀ. The ﬁltrate was extracted three times with a mixture of 
chloroform/ methanol (3/1). The organic layers were collected and dried over Na2SO4. The 
solvent was removed under vacuum to aﬀord a colorless oil (1.5 mg; 0.0044 mmol; 73% yield). 
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The reaction crude was analyzed by Ag-TLC (eluent: 1/9 n-hexane/diethyl ether with 0.4% 
MeOH) evidencing the presence of two spots, referred to monotrans DHA-Me and cis DHA-Me 
(see Figure S12b in Appendix). The other two crude reaction mixtures of dibromides were 
treated for elimination as described above. The debromination reaction occurred also in the 
second fraction transformed into the dibromide intermediates aﬀording methyl  
(4Z,7Z,10Z,13Z,16Z,19E)docosahexaenoate and methyl (4Z,7E,10Z,13Z,16Z,19Z)-
docosahexaenoate (colorless oil; 3.5 mg; 0.0010 mmol; 86% yield), as well as, for the last EDP 
fraction aﬀording methyl (4E,7Z,10Z,13Z,16Z,19Z)docosahexaenoate (colorless oil). 
The elimination products were then analyzed by GC taking advantage of the parallel NMR 
assignments of regioisomers, thus allowing for the attribution of the trans double bond position. 
Figures S15−S17 in Appendix are the GC traces of the elimination of the three EDP fractions, in 
comparison with the trans isomer mixture obtained by photolysis and with literature 
data.
147,148,162,166,167
 The assignment of the monotrans isomer peaks in the GC analysis was 
obtained on the basis of the starting monoepoxide assignment (Figure 36). 
The Scheme 6 below summarizes the formation of monoepoxides and the chromatographic 
separation of fractions that underwent the bromination-elimination step aﬀording the separation 
of the monotrans regioisomers. 
 
 
 
Scheme 6. Two-Step Transformation of All-Cis DHA-Me into Monotrans Isomers.
a 
a
Yields of the products are in parentheses: (a) m-CPBA, DCM, RT, 10 min; (b) dry DCM, pyridine, 
Ph3PBr2 ,5°C, overnight followed by (c) DMF, activated Zn, AcOH, 0°C, 10 h. 
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3.3. Synthesis of Monotrans DHA-Me Isomers by Photolysis 
A 15 mM solution of DHA-Me ester (20 mg, 0.058 mmol) in 2-propanol (3.87 mL) was 
transferred into a quartz photochemical reactor (Sigma-Aldrich) equipped with a 5.5 W low-
pressure mercury lamp. The reaction mixture was degassed with argon for 20 min, then an 
aliquot of a previously degassed stock solution of 2-mercaptoethanol in 2-propanol was added 
(0.03 mmol) and the UV lamp was turned on for 5 min at the temperature of 22 ± 2 °C, kept by 
means of a thermostat bath. The reaction was monitored by Ag-TLC, spraying the plate with 
cerium ammonium sulfate/ammonium molybdate reagent (CAM), to evidence the formation of 
the monotrans fraction together with ditrans, tritrans products, in order to stop the reaction when 
monotrans isomers were prevalently formed in the presence of remaining cis-DHA (see Figure 
S12a in Appendix). The solvent was removed under vacuum, and addition of chloroform with 
further evaporation under vacuum helped the removal of 2-mercaptoethanol. The crude of the 
reaction was subsequently dissolved in 1 mL of n-hexane and loaded onto a preparative Ag-TLC 
plate. A rapid and eﬃcient separation was obtained using 1:9 n-hexane/diethyl ether with 0.4% 
MeOH as mobile phase. After elution, the plate portion corresponding to the monotrans isomer 
fraction (Rf = 0.58), detected by spraying a small portion of the plate with CAM, was scraped 
oﬀ. Silica was washed with chloroform (3 Χ 5 mL). The solvent was evaporated to give a solid 
material, which is the Ag-fatty acid complex insoluble in n-hexane. This material was dissolved 
in a 5% aqueous solution of NH4OH, vigorously stirred (600 rpm) for 10 min and extracted with 
aliquots of n-hexane (3 Χ 5 mL). Finally, the organic phase was dried over Na2SO4, ﬁltered and 
evaporated. The unreacted all-cis DHA-Me was recovered and subjected to a second 
isomerization cycle. This procedure leaded to the collection of a colorless oil that corresponded 
to the monotrans DHA methyl ester isomer mixture (5.2 mg, 0.0152 mmol, and overall yield 
from two isomerization cycles 26%). GC analysis was carried out under the conditions described 
in Materials and Methods (see trace II, Figure 36 or trace II in Figure 38). 
13
C NMR (Figures 
S13 and S14 in Appendix) of the mixture of monotrans DHA-Me isomers obtained from the 
isomerization and from the puriﬁcation were also performed. 
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13
C NMR (C6D6) δ 10.94, 13.72, 14.12, 20.44, 20.56, 22.76, 25.26, 25.57, 25.66, 27.12, 28.01, 
28.17, 28.57, 29.24, 30.39, 33.67, 33.71, 35.64, 45.29, 50.64, 50.73, 61.17, 126.93, 127.12, 
127.48, 127.67, 
127.86, 128.14, 128.48, 128.78, 128.81, 129.28, 129.37, 131.66, 131.68, 131.71, 131.75, 131.97, 
131.99, 132.00, 132.23, 132.27, 132.49,132.52, 132.55, 172.35, 172.37. 
After puriﬁcation the 13C NMR of the pure monotrans fraction was carried out (see Figure S14 
in Appendix): 
13
C NMR (C6D6) δ 14.10, 20.55, 22.75, 30.40, 33.65, 50.65, 127.47, 127.67, 
127.86, 131.68, 131.72, 131.77, 132.02, 132.28, 172.33. 
 
 
3.4. Isomerization of Fish Oil by Photolysis 
A sample of commercially available ﬁsh oil, used as omega-3 containing ingredient for food and 
nutraceutical preparation, was isomerized following the procedure above described for the DHA-
Me isomerization. After 30 min, 30% of total trans content was obtained as determined after 
transesteriﬁcation to the corresponding FAME and GC analysis. In Appendix, the 13C NMR of 
the oil prior and after isomerization are reported (Figures S25 and S26). By GC analysis of the 
FAME obtained from the triglyceride transesteriﬁcation the cis and trans fatty acid contents were 
also determined. In Figure 38 of the main text the GC separation of the DHA isomers is shown, 
in comparison with the monotrans DHA methyl ester isomer library. In Figures S27−S30 in 
Appendix, two diﬀerent GC methods were used with hydrogen or helium as carrier gas in order 
to evidence the best fatty acid separation. 
 
 
3.5. Analysis of Monotrans DHA Isomers from Commercially Available 
Supplements  
Available Supplements: Nineteen DHA-containing supplements in soft-gel capsules were 
examined for their cis and trans fatty acid contents, being six products commercially available in 
Italy and 13 in Spain. The oily content was taken from the capsules, and the lipids were extracted 
according to the Folch method.
187
 Brieﬂy, approximately 3 mg of each sample was dissolved in 
2:1 chloroform/methanol (3 mL) and partitioned with brine (1 mL); the extracted organic phases 
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(3 Χ 3 mL) containing lipids were joined and dried with anhydrous Na2SO4. After ﬁltration, the 
solvent was eliminated using a rotary evaporator and the oily residue was left under vacuum for 
10 min to remove any possible trace of water. The lipid extract was checked by TLC (mobile 
phase: n-hexane/diethyl ether 7:3) and then treated with freshly prepared 0.5 M KOH/MeOH 
solution for 30 min at room temperature under stirring. Reaction was quenched using brine and 
fatty acid methyl esters (FAME) were extracted using n-hexane (3x 3 mL); the organic phase 
was collected and dried with anhydrous Na2SO4. After ﬁltration and solvent evaporation, the 
FAME mixture was dissolved in 10 μL n-hexane and 1 μL was injected for GC analysis. Tables 
S2 and S3 in Appendix report the FAME content: products 1−6 are omega-3 supplements 
present in the Italian market and products 7−19 are present in the Spanish market. 
 
 
3.6. LUVET Preparation 
A mixture of 20 % 1-stearoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine/1-palmitoyl-2-
oleoylphosphatidylcholine in chloroform solution (111 μL of 18:0-22:6 PC with 11.1 mg of 16:0-
18:1 PC dissolved in 1 mL chloroform) was evaporated to a thin film in a test tube under a stream 
of argon and then kept under high-vacuum for 30 min at room temperature.  
In order to obtain a final concentration of 70 mM phospholipid content, 250 μL tridistilled water 
were added and by vortexing for 7 min under an argon atmosphere multilamellar vesicles were 
formed. Large unilamellar vesicles (LUV) with a mean diameter of 156-158 nm were prepared by 
extrusion technique using LiposoFast and a 200 nm polycarbonate membrane filter as described 
previously.
133
 The size of the liposomes was measured using dynamic light scattering (DLS) 
methodology. The LUVET stock suspensions were transferred into a vial and stored at 4 °C for a 
maximum of two days.  
 
3.6.1. Isomerisation vs Peroxidation of PC in LUVET 
The total volume for every reaction was 1 mL of LUVET stock (phospholipid concentration of 1 
mM). More specifically an aliquot of 14.5 μL fatty acid content from the stock solution was added 
in tridistilled water in the reaction vessel. To the liposome suspension, the copper complex was 
transferred (0.15 mM) and the reaction remained under stirring for 2 min. From stock solutions in 
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tridistilled water and final concentration in the reaction 10 mM, the thiol, 2-mercaptoethanol was 
added to the reaction drop wise (0.5 mM/min) using a syringe pump. Each reaction vessel was 
incubated at 37 °C and, in order to follow the formation of trans fatty acid residues, samples were 
analysed at different times. The work-up of the vesicles was made with 2:1 chloroform/methanol, 
extracting and collecting the organic phases dried over anhydrous sodium sulphate and 
evaporating the solvent under vacuum at room temperature. The phospholipid extracts were 
treated with 0.5 M KOH/MeOH, in a transesterification type of reaction for 10 min at ambient 
temperature. The reaction was quenched with addition of tridistilled water and an extraction with 
n-hexane followed. The organic layer containing the corresponding fatty acid methyl esters 
(FAME) was analysed by GC for the determination of the content.  
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3.7. Results and Discussion 
3.7.1. Dual Synthetic Approach for DHA Transformation and Monotrans DHA 
Isomer Identiﬁcation 
According to Scheme 5 we approached the dual synthetic strategy ﬁrst by carrying out the direct 
radical-catalyzed isomerization of DHA methyl ester, as described previously by our group for 
EPA,
163
 thus obtaining a mixture of the six monotrans DHA isomers (Figure 34). Ag-TLC was 
used to purify the monotrans DHA isomers from the starting material (Figure 35, lane C).  
 
 
Figure 35. Ag-TLC (eluent: 1/9 n-hexane/diethyl ether with 0.4% MeOH) of the transformation of one 
monoepoxide fraction (second fraction) via bromination and elimination reactions. A: standard all-cis 
DHA-Me. B: elimination reaction showing the presence of all-cisDHA-Me and monotrans isomers (19E 
and 7E) of DHA-Me. C: mixture of monotrans DHA-Me obtained by thiyl-radical catalyzed 
isomerization after puriﬁcation as reported in Experimental Section. 
 
 
The recognition of each monotrans isomer was not realizable at this stage, however satisfactory 
separation of these isomers could be obtained by gas chromatography, the GC trace showing ﬁve 
out of six separable peaks, meaning that only two isomers are superimposed. It is also worth 
noting that one monotrans DHA isomer elutes similarly to cis-DHA (Figure 36, GC trace II). 
GC analysis, under the conditions described in Materials and Methods (trace II, Figure 36) gave 
a pattern of peaks similar to those described in literature.
147,148,166,168
 At this point the assignment 
of each monotrans isomer could not be performed. Only by elution of the commercially available 
4E-DHA-Me, the third eluting peak could be assigned to this isomer (Figure 36, trace V). By the 
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second synthetic route DHA methyl ester was transformed in two-steps to give the corresponding 
monotrans alkenes (Scheme 5), via monoepoxide formation, ring-opening of the epoxide, using 
the stereoselective formation of the dibromide derivatives, followed by elimination reaction, that 
provide the trans geometry of each starting double bond. In this strategy, the key step is the 
separation and characterization of the monoepoxide products, in order to assign the double bond 
position for the subsequent elimination step. Meta-chloroperoxybenzoic acid (m-CPBA) 
epoxidation followed by puriﬁcation by ﬂash chromatography (with 9/1 n-hexane/diethyl ether 
as the eluent; see TLC separation with 7/3 n-hexane/diethyl ether in Figure S4 in Appendix, 
provided three fractions of monoepoxide regioisomers. The structures of the six regioisomers are 
shown in Figure 34. Under our experimental conditions, described in the Materials and 
Methods, the 4-monoepoxide (compound 2) was isolated in pure form as a third fraction of the 
chromatography. The other regioisomers were obtained in the ﬁrst and second chromatographic 
fractions, each fraction as a mixture of two compounds.  
EDPs are biologically relevant compounds obtained from DHA by cytochrome P450 enzyme, 
exhibiting a variety of biological eﬀects in inﬂammation, pain, angiogenesis and cancer.172 
Actually cytochrome P450 is able to provide the stereoselective epoxidation of DHA, preferably 
at the last double bond obtaining 19,20-EDP.
170
 However, also 16,17-EDP, 13,14-EDP, 10,11-
EDP, and 7,8-EDP have been detected and separated by HPLC analysis, whereas 4,5-EDP was 
reported to be unstable.
173
 We were interested to carry out mono- and bidimensional NMR 
experiments in order to assign the epoxide position in each compound of the reaction mixture. It 
is worth noting that the use of deuterated benzene (C6D6) as NMR solvent is required, in order to 
avoid decomposition during the experiment in the slightly acidic environment of deuterated 
chloroform. We performed also the spectrum of DHA-Me in deuterated benzene for examining 
the epoxidation results using the same experimental conditions (see Figure S5 in Appendix). 
Table S1 in Appendix collects the 
13
C NMR data of the EDP isomers and the 10,11-EDP 
regioisomer is not presented because it was formed only in traces. The reasons for the scarce 
formation of this stereoisomer in the epoxidation reaction were not investigated. In Appendix, 
Figure S5 shows the structures of the ﬁve EDP isomers with their proton and carbon atom 
resonances as assigned in this study using deuterated benzene as solvent. The NMR spectra of all 
the ﬁve EDP isomers are reported in the Materials and Methods. In order to assign the 
monoepoxide resonances, we examined 
1
H and 
13
C NMR resonances comparing with DHA-Me 
for each fraction separated by column chromatography. The subsequent transformation of 
monoepoxides, forming in situ the corresponding dibromides followed by elimination to the 
corresponding alkenes, was performed in one step for each fraction. The latter reaction sequence 
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was adapted for DHA methyl ester from a procedure described for arachidonic acid methyl ester 
71,160
 and successfully applied to eicosapentanoic acid methyl ester (EPA).
164
 During the in situ 
transformation of epoxides to dibromide derivatives and the subsequent elimination to trans 
alkenes, the concerted elimination is not the only occurring mechanism for which the double 
bond can be formed. Therefore, the presence of cis-DHA was detected in all the resulting 
elimination crude mixtures. Having recognized in each starting fraction the monoepoxide 
structures as major and minor isomers, as described in the NMR section and summarized in 
Scheme 6, the assignment of the corresponding monotrans DHA isomers could be satisfactorily 
carried out examining the peaks present in the GC traces of the DHA-Me isomers after the two-
steps synthesis, as shown in Figure 36 (traces II, IV, V). 
 
 
 
Figure 36. GC chromatograms of the 39.0−42.5 min region referred to (I) all cis-DHA methyl ester; (II) 
mixture of monotrans DHA methyl ester isomers obtained by photolysis in the presence of thiyl radicals; 
(III) 16E-isomer superimposed with all cis-DHA methyl ester, 13E and traces of 10E; (IV) 19E, all cis-
DHA methyl ester and 7E; and (V) 4E (commercially available product). 
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The isomer overlapping with DHA-Me is the 16E monotrans DHA-Me, and the 7E and 10E 
monotrans DHA-Me are also superimposed (lanes (III) and (IV) corresponding to the conversion 
of these two monoepoxide fractions according to Scheme 6). It is worth recalling that the 10E 
isomer was obtained from the traces of the 10,11-EDP, formed with the lowest yield among all 
EDP isomers, as ascertained by the study of the NMR spectra reported in the following section. 
Finally, the following GC order of elution could be assigned:  
 
19E <16E = all-cis < 4E <13E <7E =10E 
 
This is the ﬁrst time the assignment of monotrans geometrical isomers of the omega-3 fatty acid 
DHA is made, by a combination of Ag-TLC, NMR spectroscopy, gas chromatography, and this 
result contributes to the library of noncommercially available trans isomers developed by us for 
the long-chain polyunsaturated fatty acids (LC-PUFA) omega-6 and omega-3. 
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3.7.2. NMR Study of the EDP Isomers and the Monotrans DHA Isomers 
 As previously mentioned, the 
1
H and 
13
C NMR spectra of the EDP and monotrans DHA-Me 
isomers obtained in this work (Figure 37) were carried out in C6D6, primarily used to avoid 
decomposition of the monoepoxide compounds. The 
1
H NMR spectra of the EDP regioisomers 
was very diagnostic for the terminal methyl group (C-22), that appears as triplet in the 0.80−0.91 
ppm region and is inﬂuenced by the relative position of the epoxide functionality. As shown in 
Figure 37, in the starting material, DHA-Me the triplet is centered at 0.885 ppm (trace I), 
whereas the pure 4,5-EDP isomer (isolated by chromatography) shows the triplet centered at 
0.888 ppm (trace IV).  
 
 
 
Figure 37. 
1H NMR region (0.81−0.91 ppm) related to the terminal methyl group (C-22) of EDP 
regioisomers (spectra run in C6D6). The triplet is centered at diﬀerent ppm in relationship with the 
position of the epoxide along the fatty acid chain; (I) DHA-Me all-cis; (II) mixture of 13,14-EDP 5, 
16,17-EDP 6 (traces of 10,11-EDP 4); (III) mixture of 7,8-EDP 3 and 19,20-EDP 7; (IV) 4,5-EDP 2. 
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Two other fractions obtained from the chromatographic separation contained four other isomers 
(see Scheme 6): (i) a mixture with the 16,17-EDP isomer with the triplet centered at 0.853 ppm 
and the 13,14-EDP isomer with the triplet centered at 0.880 ppm, with traces of the 10,11-EDP 
isomer (Figure 37, trace II); (ii) a mixture with the 19,20-EDP isomer with the triplet at 0.838 
ppm (major isomer) and the 7,8-EDP isomer with the triplet at 0.892 ppm. The assignment of the 
triplet was made by correlation experiments, crossing the 
1
H and 
13
C resonances of the methyl 
group and epoxide carbon atoms, respectively (see Figure S9 in Appendix). Examining the 
13
C 
NMR spectrum of the EDP regioisomers and using the assigned resonances of starting DHA-Me, 
the carbon atom resonances of the epoxide function were determined. In fact, for the 16,17-
monoepoxide, two peaks at 55.79 and 55.65 ppm can be assigned to the carbon atoms of the 
epoxide function, because at the same time in the spectrum are absent the chemical shifts of the 
ethylenic carbon atoms assigned at the C16−C17 double bond of DHA-Me (128.50 and 127.91 
ppm, respectively). The 13,14-EDP has two peaks at 55.66 and 55.65 ppm assigned to the 
epoxide function, because the C13−C14 double bond resonances of DHA-Me at 128.22 and 
128.11 ppm are not present. The 19,20-EDP has the epoxide carbon atoms at 57.38 and 55.75 
ppm, and correspondently the chemical shifts at 131.78 and 127.11 ppm (C19−C20 of DHA-Me) 
are absent. In the 19,20-EDP regiosiomer, the chemical shift of the C-22 is noticeably moved at 
10.45 ppm (instead of the range 14.08−14.00 ppm for all the other EDP regioisomers), indicating 
an upﬁeld shift due to a diﬀerent electronic distribution inﬂuencing the end of the carbon atom 
chain (i.e., the ω position). The 7,8-EDP showed the chemical shifts of the epoxy carbon atoms 
at 55.65 and 55.63 ppm, corresponding to the absence of the resonances at 128.15 and 128.11 
ppm (C7−C8 in the DHA-Me). Finally, for the EDP in the position 4,5, the epoxy function was 
individuated by the chemical shifts at 56.07 and 55.32 ppm corresponding to the absence of the 
peaks at 129.08 and 128.06 ppm (C4−C5 of DHA-Me). Bidimensional experiments can also be 
performed to acquire more data on these assignments. A representative description of the 
assignment of resonances to 7,8- and 19,20-EDP isomers obtained by HSQC/HMBC 
experiments is shown in Appendix (Figure S9). By this additional information, we could 
increase data on the epoxide assignments; however, the above-described 
1
H and 
13
C NMR 
characteristics satisfactorily individuated the EDP regioisomers. As far as the DHA monotrans 
isomers are concerned, they were obtained from the EDP two-step transformation as shown in 
Scheme 5, as well as mixture of the six isomers by radical catalyzed isomerization of the all-cis 
DHA-Me. This latter mixture was examined by NMR and Figure 38 shows a trace of the 
enlargement of the 
13
C NMR region corresponding to the C-20 resonance (traces I and II, panel 
b), which was found to be diagnostic for the geometrical isomers. 
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Figure 38. (Panel a) Partial GC traces of: (I) all-cis DHA-Me; (II) the six DHA-Me monotrans isomers 
and all-cis DHA-Me; (III) FAME obtained from the transesteriﬁcation of DHA-containing ﬁsh oil. The 
presence of monotrans DHA isomers as contaminants is visible when the trace is expanded (Χ 10); (IV) 
DHA-Me isomers obtained after isomerization and transesteriﬁcation of ﬁsh oil (this mixture contains 
mono-, di-, and tri-trans isomers). (Panel b) Enlargement of the 
13
C NMR region (131.5−132.5 pm) 
corresponding to the C-20 ethylenic carbon atom of: (I) all-cis DHA-Me; (II) the six DHA-Me monotrans 
isomers and all-cis DHA-Me; (III) DHA-containing triglycerides from ﬁsh oil; (IV) DHA-containing 
triglycerides from ﬁsh oil after isomerization (this mixture contains mono-, di-, and tri-trans isomers). 
 
 
 
The C-20 atom is the most deshielded among the oleﬁnic peaks, and its distance from the 
position of the trans double bond in the fatty acid chain inﬂuences its chemical shift. Five 
diﬀerent chemical shifts for this carbon atom could be individuated in the monotrans isomer 
mixture isolated from the isomerization (trace II in Figure 38, panel b), one of them representing 
two overlapped resonances, and they are clearly diﬀerent from the C-20 of DHA-Me appearing 
at 131.78 ppm (cf. trace I in Figure 38, panel b). The importance of the last vinylic carbon atom 
of the PUFA fatty acid chain was previously described for arachidonic and eicosapentaenoic 
acids.
 157,164
 The present data support the use of NMR spectroscopy for the analysis of natural 
and marine oils, as already shown by other groups
188,189,190
 and recently reviewed.
191
 The herein 
described chemical synthesis of monotrans DHA isomers, as well as our previously published 
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work on trans lipid library,
71,140,156,157
 certainly increase availability of reference compounds and 
will help to gather more information by the powerful NMR methodology. 
 
 
3.7.3. Isomerization of DHA-Containing Fish Oil and Determination of the 
Monotrans DHA Isomer Content in Commercially Available Supplements 
Natural oils are important sources of cis PUFA, and trans isomers of EPA and DHA are 
contaminants after deodorization or distillation procedures that are used in order to eliminate the 
ﬁshy odor. PUFA isomerization in oils has been described by heating procedures147,167 or p-
toluene sulﬁnic acid treatment,174 whereas we reported the isomerization of some oils by thiyl 
radical catalyzed process,
176
 but not of ﬁsh oils. The isomerization of a sample of DHA-
containing ﬁsh oil commercially available as raw material for food or supplements was 
performed. The reaction was carried out as described in the Materials and Methods, and GC 
analysis was performed after transesteriﬁcation of the triglycerides into the corresponding 
FAMEs. Figure 38 (panel a) shows the GC regions corresponding to FAMEs from ﬁsh oil in the 
starting material (trace III), and it is worth noting that in this sample monotrans DHA isomers are 
already present as contaminants, as it can be seen by comparison with the FAME of the oil after 
free radical-catalyzed isomerization (trace IV), and related cis and monotrans DHA-Me isomers 
(traces I and II). In the same Figure 38 (panel b), the enlarged region of the 
13
C NMR spectra 
corresponding to the C-20 (ethylenic carbon atom) resonance is shown for the DHA-containing 
triglycerides of ﬁsh oil (trace III) in comparison with the all-cis DHA-Me (trace I). It is 
gratifying to see that the C-20 chemical shift is similar for FAME and triglycerides that contains 
the DHA moieties. Moreover, after ﬁsh oil isomerization, trans-DHA-containing triglycerides 
show strong similarity of the C20 resonances for the monotrans DHA-Me isomers that were 
previously described. In Appendix, the full 
13
C NMR spectra of the ﬁsh oil triglycerides before 
and after the isomerization are shown (Figures S25 and S26). It is worth mentioning that the GC 
resolution of monotrans isomers achieved under our analytical conditions, using a speciﬁc oven 
program with a 60 m Χ 0.25 mm Χ 0.25 μm (50%-cyanopropyl)-methylpolysiloxane column, 
were obtained after testing several gas chromatographic conditions, in particular concerning the 
carrier gas. Using natural sources of fatty acids as marine oils, it was envisaged that other long-
chain fatty acids can elute in the region of the DHA-Me and its monotrans isomers. This was the 
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case of C22-PUFAs, such as 22:5 ω-3 (DPA) and 22:6 ω-6, as well as long chain saturated and 
monounsaturated fatty acids, such as C24:0 and C24:1. In Appendix, Figures S27−30 show the 
peak resolution connected with the two GC experimental conditions that are described in 
Materials and Methods. We were aware that a very careful study was carried out with a 200 m 
SLB IL111 ionic liquid column verifying the accuracy of the proposed method using Standard 
Reference Material (SRM) 3275 “Omega-3 and Omega-6 Fatty Acids in Fish Oil” from the 
National Institute of Standards and Technology (NIST).
175
 We could compare the reported 
results with our method using hydrogen as carrier gas (Figure S29 in Appendix), and it was 
gratifying to see that interferences with other fatty acids can be avoided also under our 
conditions. As already shown for EPA isomers,
164
 the use of hydrogen as carrier gas together 
with speciﬁc oven temperature program is satisfactory, in terms of no interferences by C22-
PUFAs and long chain saturated and monounsaturated fatty acids.  
The combination of GC and 
13
C NMR analyses, the latter using the resonance of the C-20, can 
be of diagnostic value for individuating monotrans DHA isomers, with the advantage that 
13
C 
NMR can be performed directly on the triglycerides without any transformation. In this case, it is 
also worth noting that by studying the region between 130.40 and 132.60 ppm, also in diﬀerent 
NMR solvents, the overview of omega-6 and omega-3 monotrans isomer content can be 
obtained. This overall picture can be relevant for further developments in metabolomics research. 
The analysis of the triglyceride fractions contained in DHA-containing supplements available on 
the markets in Italy and Spain was performed. As matter of fact, analytical protocol to run 
quality control of supplements are increasingly addressed for the safety of producers and 
consumers, and researchers raised problems of oxidized or trans contaminants by evaluating 
commercial products of diﬀerent countries.174,175 Table 10 shows our results in terms of fatty 
acids, such as omega-3 DPA, DHA, the DHA monotrans isomers and the monounsaturated 24:1, 
detected in some representative supplements available in Italian and Spanish markets, presenting 
low and high-content of monotrans DHA isomers.  
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Table 10. Representative Fatty Acid Contents in Terms of DPA, DHA, 24:1, and Monotrans DHA 
Isomers Eluting in the GC Time Window of 37−41.5 min (See Figure 23 and Figures S23−26) Obtained 
from Natural Oils of Commercially Available Supplements in Italy and Spain
a
. 
 
a
The values are expressed as percentages relative to 100% of the fatty acid peak areas identiﬁed in the GC 
analysis. In Tables S2 and S3 (Supporting Information), the complete analysis for 19 products is 
reported. 
 
 
 
The values of these fatty acids are shown as relative percentages (% rel) in the whole fatty acid 
composition determined on the natural oil ingredient of the capsules. The full fatty acid analysis 
referred to 19 products of Italian and Spanish markets are available in Appendix (Tables S2 and 
S3 and Figures S27−30 of representative GC chromatograms).  
In Table 10 is shown that the percentage of monotrans DHA isomers was found between 0.11% 
and 2.70%, with the highest trans contents contained in the DHA-richest formulas (cf. product 19 
and product 2 in Table 10). This would suggest that the procedures in order to enrich DHA 
content in the oil be responsible of raising the isomer presence in the resulting material. Our 
studies on the trans lipid library support previously reported analyses of PUFA-containing oils 
and supplements, discovering contaminations either as oxidation and isomerization 
products,
147,148,166,167,174,175
 addressing the important issue of the precise monotrans isomer 
identiﬁcation in case of EPA and DHA. This is strongly needed especially because health 
beneﬁts are highly discussed for omega-3 supplements, whereas contaminants can certainly 
annihilate positive eﬀects in a dose-proportional manner, as shown by us in a murine model.161  
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3.7.4. Model Studies in DHA-Containing Liposomes and Cu-TPMA-Phen-Induced 
Lipid Damage 
In 20 % 18:0-22:6 PC/16:0-18:1 PC liposome composition the chemical reactivity of the MUFA 
residue of oleic versus the PUFA residue of DHA was compared. In the Scheme 7 is presented 
the general approch. 
 
 
 
 
 
Scheme 7. Cartoon presenting the incorporation of the Cu-TPMA-Phen in the liposome bilayer, 
the generation of the thiyl radical and subsequent attack to the MUFA and PUFA residues. 
 
 
In the absence of oxygen the cis-trans isomerization was the main process depicted and different 
time points were evaluated during the reaction. In fact, after 8 hr of incubation at 37 °C in the 
presence of 0.15 mM Cu-TPMA-Phen and 10 mM 2-mercaptoethanol the monotrans isomers of 
DHA represented the 3.099 %, whilst the trans isomer of oleic the 7.305 % of the total fatty acid 
+
RSH
RS
+
9
4
7
10
13
16
19
16:0-18:1 PC 18:0-22:6 PC
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composition. These values are reported as relative percentages (% rel) of the total fatty acid peak 
areas detected in the GC analysis.  
We were interested in evaluating the changes in stereochemistry induced by the conversion of the 
double bond from cis to trans geometry under the reaction applied. In Figure 39 is reported the 
cis-trans isomerization yields of MUFA and PUFA residues. The numbers shown were obtained by 
the relative % of the GC area and the conversion of cis fatty acid residue to each trans isomer was 
calculated separetely.  
 
 
 
Figure 39. Reactivity of oleic versus DHA acid residues. The results obtained after incubation of liposomes 
composed by 20% 18:0-22:6 PC/16:0-18:1 PC at 37 °C under  anaerobic conditions, in the presence of 0.15 
mM Cu-TPMA-Phen and 10 mM 2-mercaptoethanol at different time points. 
 
The mixture of the monotrans DHA methyl ester isomers, obtained previously by photolysis, was 
employed as reference for the recognition of the positional monotrans DHA isomers (see Figure 
S30 in Appendix). Based on the fully characterized analytical GC library, the DHA isomers 
formed in the phospholipid bilayer after treatment with Cu-TPMA-Phen and 2-ME, appeared to be 
products of a regioselective thiyl radical attack.
192
 The DHA’s supramolecular organization of 
vesicles has a profound effect on the isomerization outcome, involving the differentiation of the 
double-bond reactivity depending on its location. The amphiphilic thiyl radical HOCH2CH2S
•
, 
diffusing from the aqueous phase to the hydrophobic region of the membrane bilayer, starts to 
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isomerize the double bonds nearest to the glycerol backbone,
193
 that is nearest to the aqueous 
phase. 
As reported in Figure 40, in this studied model the preferential positional order of conversion of 
stereochemistry and formation of monotrans double bonds in DHA’s residues is the following  
4E > 19E > 13E. 
 
 
 
Figure 40. The influence of the phospholipid organization in 20 % 18:0-22:6 PC/16:0-18:1 PC liposome 
membranes leads in a regioselective formation of monotrans DHA isomers. 
 
  
The double bonds in positions 13 and 19 are located in the terminal part of the 
hydrophobic fatty acid chain and it could be expected their position in the deeper part of 
the bilayer. But if the location is in the “membrane core”, then it would be expected 19E 
to be formed in a low percentage during the isomerization process given by the diffusing 
thiyl radical. There are a few studies of the DHA conformational changes as free fatty 
acid in model vesicles, where the different positions of the six double bonds of this PUFA 
are considered.
194,195,196 
The rotational dynamics of omega-3 fatty acids are modulated by 
surrounding phospholipids and it has been demonstrated that DHA is able to change 
conformations quickly (nanosecond time scale) in a membrane environment.
194
 In our 
case the DHA is one of the four residues of the membrane phospholipids and the location 
of the double bonds are not known. In the literature are reported studies on model 
membrane structure and electron density that have shown the DHA increased electron 
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density in the phospholipid head group region presumably due to DHA-surface 
interactions associated with a coincident electron density reduction in the membrane 
hydrocarbon core.
195
 In Figure 41 is presented the time-averaged conformation of DHA 
in which the double bond in position 19 is located in closer proximity to the bilayer 
borders explaining the reason of the preferential isomerization and formation of 
monotrans 19E. 
 
 
 
Figure 41. Schematic illustration of the proposed conformation of DHA on membrane structure. 
DHA interact with distinct regions in the headgroup region of the membrane lipid bilayer, due to 
rapid conformational changes associated with its chemical structure.
195
 
 
 
As far as concerns the consumption via peroxidation pathway, the presence or absence of oxygen 
appeared to be critical for the reaction’s outcome and the results are reported in Figure 42.  
In particular, under anaerobic conditions in the presence of 0.15 mM Cu-TPMA-Phen and 10 mM 
2-mercaptoethanol, PUFA were decreased by 15 % after 8 hr of incubation at 37 °C. The main 
process depicted was the cis-trans isomerization of both MUFA and PUFA with the yields 
discussed above. 
However, under aerobic conditions, the consumption of the PUFA content was much more evident. 
In fact, the loss of PUFA was estimated 18 % after 2 hr of incubation and the content was strongly 
diminished up to 59 % after 8 hr of incubation at 37 °C. 
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Figure 42. Peroxidation pathway in liposomes composed by 20 % 18:0-22:6 PC/16:0-18:1 PC, after addition 
of 0.15 mM Cu-TPMA-Phen, 10 mM 2-ME and incubation at 37°C at two different time points, where also 
the presence or absence of oxygen is evaluated. The estimation of consumption is based on the ratio 
16:0/22:6, which found as peaks of the GC analysis of their corresponding FAME. 
 
 
These results concerning the oxidative and cis-trans lipid isomerisation processes, obtained in the 
biomimetic model of 20 % DHA-containing vesicles, are informative of the molecular reactivity of 
the complex. Thereby explaining at least in part, the absence of trans isomers in the presence of 
oxygen.  
Our results can contribute to the understanding of the behaviour of metal complexes as antitumoral 
drugs and their association with the lipid damage effect, in particular indicating the interactions of 
metallome with membrane lipids as indicated by these novel biomimetic studies. 
  
- 96 - 
 
3.8. Conclusions 
In conclusion, here we showed the extension of the trans lipid library to include an important long 
chain PUFA such as DHA, with the individuation of its structural changes due to chemical 
treatment as well as free radical reactivity, converting the cis geometry into trans. It is expected that 
this new knowledge will successfully integrate other analytical methodologies for the quality 
control of trans fats in health care and food products needed by regulatory bodies all over the world.  
The valuable spectra obtained and fully characterized were in benefit of our research towards the 
investigation of the artificial chemical nuclease’s Cu-TPMA-Phen interaction with DHA fatty acid 
residues in model studies. The monotrans mixture obtained from the free radical catalyzed 
isomerization of DHA methyl ester was used as reference for recognition of the positional isomers 
that were formed in the presence of a thiol and the artificial chemical nuclease. 
The above described results represent preliminary observations of the regioselective cis-trans 
isomerization of DHA in biomimetic models of cellular membranes and furnish an aspect of the 
mechanistic scenario of DHA’s important role in antitumoral treatments. Our studies provide an 
insight of the novel metallodrug Cu-TPMA-Phen molecular mechanism via free radical production 
in the presence of DHA composed liposomes. Using a 20 % 18:0-22:6 PC/16:0-18:1 PC liposome 
composition, the ability of MUFA and PUFA residues to partition between isomerisation and 
consumption processes was investigated and it was evidenced that the supramolecular organization 
of phospholipids in the membrane is related to the geometrical isomerism. 
As a chemical biology model for antitumoral strategies, liposomes highlight the role of cell 
membranes, with synergic roles for chemotherapeutic effects. Fatty acid recruitment and membrane 
formation are attracting a lot of interest in cancer, and in this context the loss of the natural cis 
geometry and the oxidation-induced lipid remodelling are worthy of deeper studies in anticancer 
strategies. Finally, our results indicate the dual drug’s effect towards not only the DNA but also the 
membrane lipids.  
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Chapter 4: Novel Artificial Chemical Nucleases Induce DNA Cleavage 
 
The project described in this chapter was carried out in the frames of my secondment at 
Dublin City University, in the National Institute for Cellular Biotechnology under the 
supervision of Professor Andrew Kellett. The synthesis, purification and full spectroscopic 
characterization of the complexes used was achieved by ESR Nicolo Fantoni. The results 
obtained by my work were focused on the AMN’s series [Cu(TPMA)(N,Nʹ)]2 reactivity and 
the induced DNA damage. I examined the ability of these materials for precise cleavage of 
DNA along with the oxidation properties. Finally, DNA damage fragments were produced in 
DCU laboratories after treatment with AMN. The isolation, purification and enzymatic 
digestion to single nucleosides was achieved in CNR, Bologna along with the studies of 
lesions by stable isotope dilution LC-MS / MS analysis. 
The majority of the results presented in this Chapter were published in Chem. Eur. J.; Zuin 
Fantoni, N. , Molphy, Z. , Slator, C. , Menounou, G. , Toniolo, G. , Mitrikas, G. , McKee, V. , 
Chatgilialoglu, C. and Kellett, A. (2018), Polypyridyl‐based Copper Phenanthrene 
Complexes: A New Type of Stabilized Artificial Chemical Nuclease. 
(doi:10.1002/chem.201804084). 
 
4.1. Introduction  
A very promising strategy against diseases such a cancer, is the insertion of molecules 
between the planar bases of DNA with ultimate goal to inhibit DNA replication in rapidly 
growing cancer cells.
19
 This process is well known as intercalation and the outcome is 
correlated with structural distortions towards the DNA helix. Small molecules that cleave 
DNA play important roles in gene editing and cancer chemotherapy such as the metallo-
intercalators, which are complexes of a metal cation with polycyclic aromatic ligands.
196
 The 
mechanism of intercalation was proposed for the first time by Leonard Lerman in 1961, as it 
follows.
197
 In aqueous isotonic solution, the cationic intercalator is attracted electrostatically 
to the surface of the polyanionic DNA. The negative charges of oxygen atoms in the 
phosphate groups across the DNA’s structure are balanced by sodium and/or magnesium 
cations, which play the role of a "condensation cloud".  In the case of metallo-intercalators, 
the metal center displaces these cations that surround DNA and as a result, a weak 
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electrostatic association is formed between the metallo-intercalator and the outer surface of 
DNA.
198
 From this position, the planar ligand diffuses along the surface of the DNA and may 
slide into the hydrophobic environment found between two base pairs that may transiently 
"open" to form an intercalation site. This process allows the intercalator to move away from 
the hydrophilic environment surrounding the DNA into the intercalation site.
199
 The base pairs 
transiently form such openings due to energy absorbed during collisions with solvent 
molecules. In Scheme 8 is presented the dynamically open space between the DNA base pairs 
by unwinding, in order for the potential metallointercalator to fit in. 
 
 
Scheme 8. Novel metallodrug’s Cu-TPMA-Phen reactivity as intercallator. 
 
 
 This unwinding initiate a cascade of local structural changes to the DNA strand, such as 
lengthening or twisting of the base pairs. Once the structural modifications occur, functional 
changes of DNA are inevitable.
200
 These changes are mediated by reactive oxygen species 
often leading in inhibition of transcription and replication, as well as other DNA repair 
processes, which makes intercalators high potential anticancer therapeutics.
201 
Moreover, 
since ROS are generated in the vicinity of nucleic acids, are able to react with the sugar part 
of the nucleosides by an electron abstraction, leading to long range electron transfer (ET) 
reactions across the  double helix. The intercalators might either donate electrons to, or accept 
electrons from, the double helix, thus actively participating in ET reactions.
202 
During this 
process among the ROS formed, superoxide ion can abstract an electron to form a DNA base 
radical cation, commonly termed a “hole”. These holes can migrate by electron transfer (ET) 
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over quite long distances along the DNA double helix, generally ending at guaninerich 
regions because of their lower oxidation potential.
203
 As presented in Figure 43 below, the 
resulting guanine radical cations (G•) can be removed by a variety of reactions, for instance 
by further oxidation to 8-oxoguanine and subsequent repair. There is evidence that G-C rich 
areas of the DNA can act as electron sinks to remove “holes” from important coding 
regions.
204
  
 
 
 
Figure 43. Cartoon showing how ROS such as superoxide ion interact with DNA to form a radical 
cation (“hole”) that can subsequently migrate by ET along the double helix. Migration generally 
terminates at a G-C rich region where the radical cation is removed by other oxidation reactions. 
However, it may also interact with and influence the action of DNA binding proteins. The presence 
of an intercalated DNA binding drug, acting as either electron donors or electron acceptors, can 
potentially modulate ET reactions.
202
 
 
 
Alternatively, a more potent ROS such as a hydroxy radical might abstract hydrogen from 
the sugar moiety of DNA, initiating a sequence that results in DNA cleavage.
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4.2. Copper Complexes as Intercalators with Endonuclease Reactivity   
In general, metallo-intercalators mimic the cleavage portion of natural endonuclease 
machinery by cutting DNA molecules at or near specific base sequences.
205
 As they are 
versatile and amenable to engineering, coordination compounds with artificial metallo-
nuclease (AMN) activity are an attractive alternative to natural nucleases where, despite their 
sequence specificity, limited selectivity impedes precise cleavage of longer DNA 
fragments.
143,206,207 
The advantage of metallo-nucleases is the fact that induce cleavage in 
DNA by targeting the cancer cells and impeding faithful cell replication by an oxidation 
pathway, mediated by formation of ROS.
21,208,209
 Once the DNA damage occurs is generally 
irreversible and relies on binding of the activated AMN to its requisite target site via groove 
binding, insertion or intercalation interactions.
210
 Copper compounds are attractive choices for 
AMNs given their biologically-accessible redox properties and wide structural variability.
65
 
Another factor is the bioavailability and essentiality of copper to the human body where a 
daily uptake of between 1.0 – 3.0 mg is required.211 Copper ion homeostasis may, therefore, 
facilitate both tolerance and the active transport of exogenous copper based AMNs.
212
 A wide 
range of copper(II) AMNs are known,
213,214,215
 but one of best studied examples is Sigman’s 
reagent [Cu(1,10-phenanthroline)2]
2+
 (Cu-Phen), which oxidises DNA in the presence of a 
reductant and/or oxidant. The mechanism of Cu-Phen, in its reduced Cu(I) form, includes 
intercalation in A-T rich sites in the minor groove before abstracting a hydrogen atom from 
the C1′ position of deoxyribose to mediate strand excision.216,217,218,219,220  
Inspired by Cu-Phen, heteroleptic systems were designed with phenazine intercalators (e.g. 
dipyridoquinoxaline (DPQ), dipyridophenazine (DPPZ), and benzo[i]dipyridophenazine 
(DPPN))
 221,222
 together with TPMA due to the stabilisation and coordination flexibility of this 
ligand, as presented in Figure 44. 
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Figure 44. Structures of the five [Cu(TPMA)(N,Nʹ)]2+ complexes. 
 
 
 The complexes are effective AMNs when reduced to Cu(I) and the damage profiles show 
enhanced activity compared to classical Sigman and Fenton reagents. In our studies, we 
investigated the DNA oxidation properties of the [Cu(TPMA)(N,Nʹ)]2+ complex series. More 
specifically, using supercoiled pUC19 DNA the efficiency of single-strand breaks (SSBs) and 
double-strand breaks (DSBs) in a concentration range for each complex, presence / absence of 
reductant and different incubation time points was determined with the use of gel 
electrophoresis. An interesting scenario regarding the mechanism of action of these novel 
intercalators was furnished in the presence of major groove recognition elements, spin-
trapping scavengers of reactive oxygen species (ROS) and DNA repair enzymes with 
glycosylase and/or endonuclease activity.  
 
[Cu(TPMA)(Bipy)](ClO4)2 [Cu(TPMA)(PD)](ClO4)2
[Cu(TPMA)(Phen)](ClO4)2 [Cu(TPMA)(DPQ)](ClO4)2
[Cu(TPMA)(DPPZ)](ClO4)2
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4.3. AMN’s Reactivity and Formation of Lesions  
As discussed previously, the artificial chemical nucleases interact with DNA in a targeted 
manner and is expected a site-specific modification via oxidative/free radical chemistry. We 
thought to investigate the DNA damage mechanism and the formation of specific oxidative 
lesions of nucleic acids,
223
 such as 8-oxo nucleotide formation, as well as a characteristic 
modification of purine nucleosides, the 5’,8–cyclo-2’-deoxyadenosine (cdA) and 5’,8–cyclo-
2’-deoxyguanosine (cdG), which are considered biomarkers of radical stress.224,225 5,8-
cyclopurines, both adenosine and guanosine are identified as lesions in human cellular DNA 
and they are proven to be highly mutagenic. These lesions are known to accumulate with 
aging in a tissue specific manner
226
 and are recognized by the human nucleotide excision 
repair system.
227,228
 cPu are formed by the action of hydroxyl radicals (•OH) and they are 
considered as tandem lesions due to the fact that the damage occurs at two sites, both the 
sugar part of the molecule and also at the purine base.
229
 The mechanism that these lesions are 
formed, is described in the following scheme.  
 
 
 
Scheme 9. Purine 2’-deoxynucleoside (1) reacts with hydroxyl radical (HO) yielding the purine 5’,8-
cyclo-2’-deoxynucleoside (cPu, 4) via cyclisation of C5’ radical (2⟶3). 
 
It is known that the initial step towards their formation is the abstraction of the H5’ hydrogen 
atom of the 2’-deoxyribose moiety by hydroxyl radical, followed by intramolecular 
cyclization between C5’ and C8 and subsequent oxidation of the N7 radical.230,231 When this 
intramolecular cyclization takes place it is possible to achieve the formation of the two 
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diastereoisomers 5’R and 5’S of the 5′,8-cyclo-2′-deoxyadenosine (cdA) and 5′,8-cyclo-2′-
deoxyguanosine (cdG), these structures are presented in Scheme 10.  
 
 
 
Scheme 10. Structures of 5’,8-cyclo-2’-deoxyadenosine (cdA) and 5’,8-cyclo-2’-
deoxyguanosine (cdG) in their 5’S and 5’R diastereomeric forms. 
 
 
In contrast to sugar H-atom abstraction, both hydroxyl radical and superoxide radical anion 
attack on purine base moieties is widely known to generate lesions of 8-oxo-dG and 8-oxo-dA 
(Scheme 11), that impact on genome structural integrity, mutagenicity, excision repair, and 
polymerase fidelity.
232,233
 
 
 
 
Scheme 11. Purine 2’-deoxynucleosides react with hydroxyl radicals yielding in 8-oxo-dG and 8-oxo-
dA lesions. 
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We thought to treat supercoiled plasmid DNA with two different AMN’s Cu-TPMA-Phen or 
Cu-Oda in the presence of reductant and incubation at 37 °C for 1 hr. Reagarding Cu-Oda, 
this agent’s ability to catalyze intracellular superoxide (O2
•-
) and singlet oxygen (
1
O2) 
formation, as radical species mediating the oxidative DNA damage, was recently 
demonstrated.
234
 The radical specie mediating the scission mechanism of Cu-TPMA-Phen is  
superoxide (O2
•-
) as discussed previsously. We were interested to examine if the formation of 
the lesions described above occurs after treatment with these two metallodrugs.  
 
 
 
 
Figure 45. Molecular structures of Cu-TPMA-Phen and di-nuclear copper complex Cu-Oda. 
 
 
The DNA damage fragments were extracted, isolated, and purified for oxidative lesion 
quantification analysis. These fragments were enzymatically hydrolyzed to single nucleosides 
and analyzed by stable isotope liquid chromatography with tandem mass spectrometry for the 
determination of the oxidatively-induced purine lesions (8-oxo-dA, 8-oxo-dG, 5′R-cdA, 5′S-
cdA, 5′R-cdG and 5′S-cdG) in accordance to the protocol established by our group.235,236 The 
quantification of the lesions (in lesions/10
6
 normal nucleosides units) in the digested samples 
(spiked with the isotopic labelled internal standards of 8-oxo-dA, 8-oxo-dG, 5′R-cdA, 5′S-
cdA, 5′R-cdG and 5′S-cdG prior to digestion) was based on the parallel quantification of the 
unmodified nucleosides after HPLC clean-up and sample enrichment and the quantification of 
the single lesions by stable isotope dilution LC-MS/MS analysis. 
  
[Cu(TPMA)(Phen)](ClO4)2 trans-Cu-Oda
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4.4. Materials and Methods 
4.4.1. DNA Binding Studies 
 
Topoisomerase I Inhibition Assay 
400 ng of pUC19 plasmid DNA (NEB, N3041) were exposed to varying concentrations of 
each copper complex (0.1 - 400 µM) for 30 min at room temperature (~20 °C) in a final 
volume of 20 µL containing 80 mM HEPES buffer (pH 7.2), 10Χ CutSmart® buffer (NEB, 
B7204), and 100Χ BSA (NEB, B9000). 1 unit of topoisomerase I (E. coli) (NEB, M0301) 
was added to the reaction mixture and incubated for 20 min at 37 °C to ensure relaxation of 
supercoiled plasmid DNA. The reaction was stopped through the addition of 0.25% SDS and 
250 µg/mL protein kinase (Sigma Aldrich). To remove protein from the DNA, samples were 
then incubated for 30 min at 50 °C. DNA supercoiling was assessed by agarose gel 
electrophoresis in the absence of EtBr. 6Χ loading dye was added and topoisomers of DNA 
were separated by electrophoresis in 1Χ TBE buffer at room temperature for 240 min at 40 V 
and 180 minutes at 50 V. The agarose gel was post-stained using an EtBr bath and 
photographed using a UV transilluminator.
237
  
   
4.4.2. DNA Damage Studies 
 
DNA Cleavage in the Presence of Added Reductant 
Stock solutions of the complexes were initially prepared in DMF and further dilutions 
prepared in 80 mM HEPES buffer (pH 7.2). 400 ng superhelical pUC19 plasmid DNA was 
exposed to increasing concentrations of each test complex in the presence of 25 mM NaCl and 
1 mM Na-L-ascorbate. Reaction mixtures were vortexed and incubated at 37 °C for 30 min. 
6Χ loading buffer (Fermentas) containing 10 mM Tris-HCl, 0.03% bromophenol blue, 0.03% 
xylene cyanole FF, 60% glycerol, 60 mM EDTA was added to each sample before loading 
onto a 1.2 % agarose gel containing 4 µL EtBr. Electrophoresis was carried out at 70 V for 90 
minutes in 1Χ TAE buffer and photographed using a UV transilluminator.221   
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DNA Cleavage in the Presence of Non-Covalent DNA Binding Agents 
400 ng pUC19 was pre-incubated with 25 mM NaCl, 1 mM Na-L-ascorbate and 8 µM of 
methyl green in 80 mM HEPES for 45 min at 37 °C. Samples were vortexed and varying 
concentrations of test complexes were then introduced (Cu-TPMA: 10, 15, 20, 25 µM and 
Cu-TPMA-Phen / CuTPMA-DPQ / Cu-TPMA-DPPZ: 1, 2.5, 5, 7.5 µM). The reaction 
mixture was further incubated at 37 °C for 30 min and subjected to gel electrophoresis 
(prepared and stained as previously described).
238
 
 
DNA Cleavage in the Presence of ROS Scavangers 
The assay was conducted according to the method recently reported by Slator et al.
234
 Briefly, 
to a final volume of 20 µL, 80 mM HEPES, 25 mM NaCl, 1 mM Na-L-ascorbate, and 400 ng 
of pUC19 DNA were treated with varying drug concentrations (Cu-TPMA: 5, 10, 15, 20, 25 
µM and Cu-TPMAPhen / Cu-TPMA-DPQ / Cu-TPMA-DPPZ: 1, 2, 3, 4, 5 µM) in the 
presence ROS scavengers; 4,5dihydroxy-1,3-benzenedisulfonic acid (Tiron) (10 mM), D-
Mannitol (10 mM), N′-dimethylthiourea (10 mM), L-Methionine (10 mM), KI (10 mM), 
DMSO (10 %) and EDTA (100 µM).239 Reactions were vortexed and incubated at 37 °C for 
30 min and electrophoresis carried out as previously stated.  
   
DNA Cleavage in the Presence of Repair Enzymes 
Supercoiled pUC19 DNA (400 ng) in 8 mM HEPES, 25 mM NaCl, 1 mM Na-L-ascorbate in 
a final volume of 20 μL, was pre-incubated with test series for 30 min at 37 °C at various 
concentrations. The following reactions were supplemented with associated buffers as per 
manufacturer recommendations; those with Fpg contained 1 mg/mL BSA and 1Χ NEB Buffer 
1, Endo III with 1Χ NEB Buffer 1, Endo IV with 1Χ NEB Buffer 3, Endo V with 1Χ NEB 
Buffer 4 and hAAG with 1Χ ThermoPol. Subsequently, 2U of repair enzymes FpG (NEB, 
M0240S), endonuclease (Endo) III (NEB, M0268S), Endo IV (NEB, M0304S), Endo V 
(NEB, M0305S) and hAAG (NEB, M0313S) were added to the reaction mixture and 
incubated for 30 min, 37 °C. Samples were denatured with 0.25 % SDS, 250 µg/mL 
proteinase K and heated to 50 °C for 20 min. Reactions solutions were loaded onto a 1.2% 
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agarose gel (4 µL EtBr) with 6Χ loading buffer and subjected to electrophoresis at 70 V for 
70 min and imaged using UV transilluminator.   
 
4.4.3. Identification and Quantification of 8-oxo-Pus and cdPus Lesions In The 
Presence of AMNs 
Nuclease P1 from Penicillium Citrinum, phosphodieasterase I and II, alkaline phosphatase 
from bovine intestinal mucosa, DNase I and DNase II, benzonase 99%, BHT, deferoxamine 
mesylate and pentostatin were purchased from Sigma-Aldrich, RNase T1 was from Thermo 
Fisher Scientific and RNase A from Roche Diagnostic GmbH, (Mannheim, Germany). The 3 
kDa cut-off filters were obtained from Millipore (Bedford, USA). Solvents (HPLC-grade) 
were purchased from Fisher Scientific.  
 
pUC19 Pasmid DNA Treated with Cu-TPMA-Phen or Cu-Oda to Induce Cleavage 
Stock solutions of the complexes were initially prepared in DMF and further dilutions 
prepared in 80 mM HEPES buffer (pH 7.2). 400 ng superhelical pUC19 plasmid DNA was 
exposed to 2.5 μM concentration of Cu-TPMA-Phen or Cu-Oda in the presence of 25 mM 
NaCl and 1 mM Na-L-ascorbate. Reaction mixtures were vortexed and incubated at 37 °C for 
60 min. Reactions were repeated to generate sufficient stocks of nicked and linear pUC19 for 
subsequent experiments. Nicked and linearized dsDNA were then purified from the 
enzymatic reaction using QIAquick purification (QIAGEN, Baltimore, MD), eluted in pure 
water, and quantified using the NanoDrop (ND-1000) spectrophotometer.
240 
 
 
Enzymatic Digestion of the dsDNA Samples (SC, OC, L) to Nucleosides 
About 20 μg isolated DNA were dissolved in 100 μL of Ar flushed 10 mM Tris-HCl (pH 7.9), 
containing 10 mM MgCl, 50 mM NaCl, 0.2 mM pentostatin, 5 μM BHT and 3 mM 
deferoxamine and the internal standards were added ([
15
N5]-5’S-cdA, [
15
N5]-5’R-cdA, [
15
N5]-
5’S-cdG, [15N5]-5’R-cdG and [
15
N5]-8-oxo-dA). Three units of benzonase (in 20 mM Tris-
HCl pH 8.0, 2 mM MgCl2 and 20 mM NaCl), 4 mU phosphodiesterase I, 3 U DNase I, 2 mU 
of phosphodiesterase II and 2 U of alkaline phosphatase were added and the mixture was 
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incubated at 37 °C. After 21 h, 35 μL of Ar flushed buffer containing 0.3 M AcONa (pH 5.6) 
and 10 mM ZnCl2 were added along with 0.5 U of Nuclease P1 (in 30 mM AcONa pH 5.3, 5 
mM ZnCl2 and 50 mM NaCl), 4 mU PDE II and 125 mU of DNase II and the mixture was 
further incubated at 37 °C for extra 21 h. A step-quenching with 1% formic acid solution 
(final pH 7) was followed, the digestion mixture was placed in a microspin filter (3 kDa) and 
the enzymes were filtered off by centrifugation at 14.000 g. (4 °C) for 20 min. Subsequently, 
the filtrate was freeze-dried before HPLC analysis, clean-up and enrichment.
241
 
 
Analysis by High-Performance Liquid Chromatography, Clean-up and Enrichment 
HPLC-UV clean-up and enrichment of the enzyme free samples were performed on a 4.6 mm 
x 150 mm Atlantis® dC18, 100 Å column (5 μm particle size, Waters) loaded with a 4.6 mm 
x 20 mm Guard Column 2pK (Atlantis® dC18 5μm, Waters) on a Waters Alliance® HPLC 
System (Waters e2695 Separations Module) including a Waters 2998 Photodiode Array 
(PDA) detector. The Empower 3 software was used for the chromatographic instrument 
control and data processing. The gradient program used an eluent composed by 2 mM 
ammonium formate (solvent A), acetonitrile (solvent B) and methanol (solvent C) and the 
flow rate was set at 1 mL/min. Briefly, the gradient program initiated with 99% solvent A, 
increasing solvent B from 1% to 30% within 35 min, then immediately solvent C from 0% to 
40% for 5 min, closing with initial conditions for 5 min re-equilibration. The fractions 
containing the lesions were collected (the time windows were identified by injection of a pure 
standard of a lesions mixture). The collected fractions were freeze-dried, pooled, freeze-dried 
again, and redissolved in Milli-Q water before been injected for LC-MS/MS analysis. The 
quantification of the unmodified nucleosides was based on their absorbance at 260 nm.
233b
  
 
Measurement of Modified Nucleosides by LC-ESI-MS/MS 
An LC-MS/MS system Finnigan TSQ Quantum Discovery Max triple-stage quadrupole mass 
spectrometer (Thermo, USA), equipped with electrospray ionization (ESI) source in positive 
mode was employed for the detection and quantification of the lesions in the enzymatically 
digested DNA samples. Separation of target analytes was achieved with a Finnigan Surveyor 
LC system, equipped with a Finnigan Surveyor AS autosampler (Thermo, USA). The 
Xcalibur software 2.1 SP 1160 was used to control the mass spectrometric parameters and for 
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data acquisition. The collected fractions after HPLC analysis were subsequently injected to 
the LC-MS/MS system loaded with a 2.1 mm × 150 mm Atlantis dC18, 100 A column (3 lm 
particle size, Waters) guarded by a 2.1 mm × 10 mm Guard Column 2pK (Atlantis® dC18 3 
μm, Waters). The gradient elution program used for the chromatographic separation of the 
DNA lesions initiated with 99% of 2 mM ammonium formate (solvent A) and 1% acetonitrile 
(solvent B) (held for 1 min), increasing solvent B from 1% to 9.8% within 20 min and then 
immediately to 15% solvent B (held for 5 min), closing with initial conditions for 10 min re-
equilibration. The flow rate remained constant at 0.2 mL/min, the injection volume was 30 μl 
and column temperature was set at 30 °C. Detection was performed in multiple reaction 
monitoring mode (MRM) using the two most intense and characteristic precursor/product ion 
transitions for each DNA lesion.
233b
 
 
Statistical Analysis 
A two-tailed p-value < 0.05 was considered to indicate a statistically significant difference. 
Statistical analysis was performed using t-test by comparing the means of DNA sample 
treated with one of the two artificial chemical nucleases (Two-Sample Assuming Unequal 
Variances) and error bars represent standard deviation of the mean, calculated from three 
independent samples.*denotes a statistically significant difference (p ≤ 0.05), **denotes a 
statistically significant difference p ≤ 0.001 and ***denotes a statistically significant 
difference p ≤ 0.0001 between the groups. 
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4.5. Results and Discussion 
 
4.5.1. DNA Binding Studies - Topoisomerase I-Mediated Relaxation 
The five [Cu(TPMA)(N,N')]
2+
 complexes have broadly similar structures and in the Figure 46 
below the  structural characteristics of each artificial chemical nuclease is presented. All 
organic ligands were characterized by 
1
H and 
13
C nuclear magnetic resonance and also by 
Fourier transform infrared (FTIR) spectroscopies. Each Cu(II) complex was isolated in order 
to moderate to high yields and characterized by elemental analysis, ESI-MS, UV-Vis and cw-
EPR was employed to analyze the copper complex solution structures. 
  
 
Figure 46. (A) Perspective view of Cu-TPMA-Phen cation highlighting the numbering scheme of 
non-carbon atoms and table outlining the six Cu—N distances found in Cu-TPMA-Bipy, Cu-TPMA-
PD, Cu-TPMA-Phen, Cu-TPMA-DPQ and Cu-TPMA-DPPZ complexes respectively; (B) perspective 
views of the complexes (anions and hydrogen atoms omitted for clarity and the long Cu1—N40 bond 
is shown as a thin line. Colour scheme: copper, green; nitrogen, blue; carbon, black; oxygen, red); and 
(C) space filled view of the complex series (Colour scheme: copper, green; nitrogen, blue; carbon, 
plum; and oxygen, red). 
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Among the experiments performed towards the investigation of these novel metallodrugs’ 
mechanism, are the ones regarding the DNA binding. Although several biochemical and 
biophysical methods are available to study the intercalation of a small molecule between two 
consecutive base pairs of DNA, the topoisomerase I-mediated DNA relaxation assay was 
chosen.
242
 This assay is highly efficient and in the test supercoiled plasmid (pUC19) DNA is 
used to mimic the topological constraints of genomic DNA. Topoisomerase I is fundamental 
in biological systems as DNA supercoiled is generated during cellular processes including 
gene transcription, DNA replication, recombination and repair; this enzyme acts by forming a 
transient break in the DNA phosphodiester backbone permitting topological relaxation to 
occur prior to strand resealing. Topoisomerase I is capable of manipulating DNA structures 
via formation of a protein / DNA complex (referred to as the “cleavable complex”) in a 1:1 
stoichiometry able to cut one strand of the double DNA helix.
243
 Subsequently, a reversible 
nicking reaction occurs from a nucleophilic attack between the free 5Ά-OH group of the 
opened strand and the 3Ά-phosphotyrosyl bond, to give back a native and relaxed DNA helix 
and a functional free topoisomerase I enzyme, ready to initiate a new enzymatic cycle. 
Topoisomerase is described like a hand as it surrounds with its fingers tightly clamped around 
the DNA helix,244 and the enzymatic reaction cycle is presented in Scheme 12 below. 
 
 
Scheme 12. Cartoon representation of topoisomerase I enzymatic reactivity.
245
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The unwinding assay using topo I relies on the ability of the enzyme to efficiently relax the 
plasmid with its bound intercalator followed by the resupercoiling of the plasmid upon 
removal of the intercalator.
246
 Circular DNA can assume different degrees of supercoiling 
ranging from the fully relaxed form to the fully supercoiled form.  The degree of supercoiling 
defines distinct forms of the plasmid referred to as topoisomers. Topoisomers can be 
separated as more or less discrete bands using gel electrophoresis since resistance to 
migration through such gels decreases with degree of supercoiling. The degree of supercoiling 
present after treatment reflects the degree of intercalation.
247 
 
In our studies unwinding by copper(II) complexes was examined between 0.1 – 400 µM and 
the results pointed out that although Cu-TPMA-Phen could not unwind pUC19 below 50 µM, 
Cu-TPMA-DPQ and Cu-TPMA-DPPZ complexes fully relaxed (0) the plasmid at 1.0 µM 
with higher concentrations generating a positively (+) supercoiled DNA indicating a strong 
propensity to intercalate as presented in Figure 47. 
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Figure 47. Release of topological tension from supercoiled plasmid DNA using the topoisomerase I-
mediated relaxation assay in the presence of increasing concentrations of A Cu-TPMA-Phen; B Cu-
TPMA-DPQ and C Cu-TPMA-DPPZ along with space-filling view of respective complex. Color 
scheme: copper, green; nitrogen, blue; carbon, plum; and oxygen, red). 
 
This type of assay proves the ability of compounds to unwind negatively supercoiled DNA 
plasmid upon intercalative binding.  
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4.5.2. Artificial Chemical Nuclease Activity 
In the next steps, the studies regarding the DNA cleavage occurred. As discussed previously, 
in the absence of exogenous reductant no reaction took place, even over an extended 
concentration range as evidenced by electrophoresis (see Appendix Figure S31). The in situ 
generation of copper(I)
248
 is crucial in order the artificial chemical nuclease to initiate the 
mechanism of cleavage and it has been demonstrated that the mixing of ascorbate and Cu(II) 
generates very active oxygen species, which have DNA scission reactivity.
249,250 
Once 
copper(I) is formed, it can be linked with an oxygen atom of the phosphate group in the 
nucleobase structure and spontaneously the aromatic ligand of the complex intercalates via π 
stacking interactions with the desoxyrribose.
251
   
The most suitable conditions to compare the copper complexes involved the addition of 
exogenous reductant (ascorbate) to the complex, followed by 30 min incubation with pUC19. 
Under these conditions Cu-TPMA (10 – 25 µM) was found to nick DNA and fully convert 
supercoiled (SC) to open circular (OC) DNA (Figure 48, lanes 1 – 5), while Cu-TPMA-Bipy 
and Cu-TPMA-PD were incapable of mediating appreciable oxidative DNA damage 
(Appendix Figure S-32). Cu-TPMA-Phen, Cu-TPMA-DPQ and Cu-TPMA-DPPZ complexes 
however, all produced OC DNA at lower concentrations (1.0 – 7.5 µM) with linear 
conformations (L) arising with Cu-TPMA-Phen and Cu-TPMA-DPQ complexes (Figure 48, 
lanes 6-20).  
 
 
 
Figure 48. Cartoon representation of nuclease experiment where 400 ng pUC19 supercoiled DNA was 
treated with increasing concentrations of Cu-TPMA (lanes 2-5), Cu-TPMA-Phen (lanes 7-10), Cu-
TPMA-DPQ (lanes 12-15) and Cu-TPMA-DPPZ (lanes 17-20) in the presence of 1 mM Na-L-
ascorbate. 
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The overall trend in chemical nuclease activity is  
Cu-TPMA-Phen > Cu-TPMA-DPQ > Cu-TPMA-DPPZ >> Cu-TPMA 
that indicates the ancillary N,N′ phenanthrene group is critical to ROS catalysis at the DNA 
interface.   
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4.5.3. Oxidative DNA Cleavage in the Presence of Non-Covalent DNA Binding 
Agents 
In an attempt to determine DNA cleavage site speciﬁcity, the major groove (methyl green, 
MG) binder was pre-incubated with pUC19 DNA prior to the addition of test complex in the 
presence of reductant. MG significantly enhanced the oxidative chemical nuclease activity of 
Cu-TPMA-Phen (Figure 49 lanes 7-10) and Cu-TPMA-DPQ (Figure 49 lanes 12-15) when 
compared with MG-free experiments (Figure 48 lanes 10 and 15). Here, plasmid DNA was 
completely degraded by 7.5 µM of Cu-TPMA-Phen with extensive shearing evident in the 
Cu-TPMA-DPQ treated sample (Figure 49 lanes 9-10 and 14-15). MG-directed enhancement 
of Cu-TPMA and Cu-TPMA-DPPZ complexes also occurred where the emergence of linear 
(L) DNA with 25 µM treatment of Cu-TPMA (Figure 49 lane 5), and full conversion of SC to 
OC by 5.0 µM of Cu-TPMA-DPPZ (Figure 49 lane 20) was observed. These results indicate 
the minor groove as the main site of oxidative DNA damage; by limiting access to the major 
groove with MG, the minor groove becomes ‘primed’ for DNA-metal complex interactions 
and, for this series significant additional damage was observed. 
 
 
 
Figure 49. A) Cartoon representation of nuclease experiment where 400 ng pUC19 supercoiled DNA 
was treated with increasing concentrations of Cu-TPMA (lanes 2-5), Cu-TPMA-Phen (lanes 7-10), 
Cu-TPMA-DPQ (lanes 12-15) and Cu-TPMA-DPPZ (lanes 17-20) in the presence of 1 mM Na-L-
ascorbate. B) Cartoon representation of DNA cleavage in the presence of non-covalent agent methyl 
green when 400 ng pUC19 supercoiled plasmid was pre-treated with the major groove binding agent 
methyl green prior to the introduction of Cu-TPMA (lanes 2-5), Cu-TPMA-Phen (lanes 7-10), Cu-
TPMA-DPQ (lanes 12-15) and Cu-TPMA-DPPZ (lanes 17-20) in the presence of 1 mM Na-L-
ascorbate.  
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4.5.4. DNA Damage Mechanism 
The one-electron difference between Cu(II) and Cu(I) allows copper to promote radical 
reactions, giving rise in the formation of ROS in the DNA interface. A variety of experiments 
was carried out including pre-incubation with ROS specific scavengers such as 4,5-dihydroxy-
1,3-benzenedisulfonic acid (tiron), D-mannitol, L-methionine, and N,N′-dimethylthiourea 
(DMTU). These compounds were employed to probe the role of superoxide (O2
•−
), the hydroxyl 
radical (
•
OH), hydrogen peroxide (H2O2), hypochlorous acid (HOCl) or a combination. The 
objective of this investigation was to gain an insight of the generated species that represent an 
important aspect of the mechanism. The results shown in Figure 50, point out that O2
•−
 is the 
most prevalent radical specie involved in the cleavage mechanism as in all cases, pre-incubation 
with tiron significantly impeded AMN activity. In these experiments, delayed onset of OC-DNA 
formation, inhibition of L-DNA, and protection of SC-DNA were evident. H2O2 is also 
generated as part of the mechanism as DMTU somewhat impeded chemical nuclease activity. 
 
 
 
 
Figure 50. A) Cartoon representation of nuclease experiment where 400 ng pUC19 supercoiled DNA 
was treated with increasing concentrations of Cu-TPMA (lanes 2-5), Cu-TPMA-Phen (lanes 7-10), 
Cu-TPMA-DPQ (lanes 12-15) and Cu-TPMA-DPPZ (lanes 17-20) in the presence of 1 mM Na-L-
ascorbate. B) Table showing ROS scavenging species employed in this study where 400 ng pUC19 
supercoiled DNA was treated with increasing concentrations of Cu-TPMA (lanes 1-5), Cu-TPMAPhen 
(lanes 6-10), Cu-TPMA-DPQ (lanes 11-15) and Cu-TPMA-DPPZ (lanes 16-20) in the presence of 1 
mM Na-L-ascorbate and 10 mM scavenging species 4,5-Dihydroxy-1,3-benzenedisulfonic acid 
(Tiron). 
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Interestingly, as evidenced in Figure 51 scavenging the OH radical had no influence on DNA 
cleavage and these results were validated in two independent experiments using D-mannitol and 
DMSO.  
 
 
Figure 51. 400 ng pUC19 supercoiled DNA was treated with increasing concentrations of A) Cu-TPMA, 
B) Cu-TPMA-Phen, C) Cu-TPMA-DPQ and D) Cu-TPMA-DPPZ (lanes 1-6) in the presence of 1 mM 
Na-Lascorbate and 10 mM scavenging species 4,5-Dihydroxy-1,3-benzenedisulfonic acid (Tiron) (lanes 
7-11) and D- Mannitol (lanes 12-16). 
 
It is suggested that since the 
•
OH radical is not significant, the AMN activity of this class departs 
from classical Fenton-type or Haber-Weiss pathways.  
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4.5.5. DNA Repair Enzyme Recognition  
In another interesting series of experiments, DNA repair enzymes with glycosylase/endonuclease 
activity were used in order to demonstrate the distinctive DNA oxidation chemistry. In excision 
repair (BER) mechanism, repair enzymes are intrinsic check-points able to restore spontaneous 
DNA decomposition and mis-incorporation of mismatch sites, oxidized lesions and/or alkylated 
bases during the cell cycle.
252
 A range of enzymes isolated from both prokaryotic and eukaryotic 
sources are able to recognize specific nucleoside modifications and excize the damage site to 
prime for subsequent repair processes. Cleavage experiments to identify the mechanism of 
oxidative damage utilizing a selected range of repair enzymes. Repair proteins with sole or 
combined lesion recognition, known as glycoylases, can incise DNA by removing the base and 
generating abasic sites (AB). Glycoylases and several repair endonucleases also recognise AP 
(apurine / apyrimidine) sites and mediate strand nicking adjacent to the base-free lesion (Figure 
52) which can be identified by increased nicked, linear, and sheared forms of plasmid DNA. The 
enzymes used with endonuclease activity are reported below, as well as the nucleotide sequence 
recognized for cleavage for each restriction site. 
 Fpg (formamidopyrimidine [fapy]-DNA glycosylase) (also known as 8-oxoguanine DNA 
glycosylase) acts both as a N-glycosylase and an AP-lyase. The N-glycosylase activity 
releases damaged purines from double stranded DNA, generating an apurinic (AP site). The 
AP-lyase activity cleaves both 3´ and 5´ to the AP site thereby removing the AP site and 
leaving a 1 base gap. Some of the damaged bases recognized and removed by Fpg include 7, 
8-dihydro-8-oxoguanine (8-oxoguanine), 8-oxoadenine, fapy-guanine, methy-fapy-guanine, 
fapy-adenine, aflatoxin B1-fapy-guanine, 5-hydroxy-cytosine and 5-hydroxy-uracil.
253,245
 
 Endo III Endonuclease III (Nth) protein from E. coli acts as both N-glycosylase and a AP-
lyase. The N-glycosylase activity releases damaged pyrimidines from double-stranded DNA, 
generating a basic (AP site). The AP-lyase activity of the enzyme cleaves 3´ to the AP site 
leaving a 5´ phosphate and a 3´ ring opened sugar. Some of the damaged bases recognized 
and removed by Endouclease III include urea, 5, 6 dihydroxythymine, thymine glycol, 5-
hydroxy-5 methylhydanton, uracil glycol, 6-hydroxy-5, 6-dihdrothimine and 
methyltartronylurea.
245,254
 
 Endo IV Endonuclease IV can act on a variety of oxidative damage in DNA. The enzyme is 
apurinic/apyrimidinic (AP) endonuclease that will hydrolyse intact AP sites in DNA. AP 
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sites are cleaved at the first phosphodiester bond that is 5´ to the lesion leaving a hydroxyl 
group at the 3´ terminus and a deoxyribose 5´-phosphate at the 5´ terminus. The enzyme also 
has a 3´ -diesterease activity and can release phosphoglycolaldehyde, intact deoxyribose 5-
phosphate and phosphate from the 3´ end of DNA.255,256 
 Endo V Endonuclease V is a repair enzyme found in E. coli that recognizes deoxyinosine, a 
deamination product of deoxyadenosine in DNA. Endonuclease V, often called deoxyinosine 
3´ endonuclease, recognizes DNA containing deoxyinosines (paired or not) on double-
stranded DNA, single-stranded DNA with deoxyinosines and to a lesser degree, DNA 
containing abasic sites or urea, base mismatches, insertion/deletion mismatches, hairpin or 
unpaired loops, flaps and pseudo-Y structures. It is believed that Endonuclease V needs 
another protein to repair the DNA, as it does not remove the deoxyinsoine or the damaged 
bases. Endonuclease V cleaves the second phosphodiester bonds 3´ to the mismatch of 
deoxyinosine (2), leaving a nick with 3´-hydroxyl and 5´-phosphate.257,258,259,260 
 hAAG Human Alkyladenine DNA Glycosylase (hAAG) excises alkylated and oxidative 
DNA damaged sites, including 3-methyladenine, 7-methylguanine, 1,N-ethenoadenine and 
hypoxanthine. hAAG catalyzes the hydrolysis of the N-glycosidic bond to release the 
damaged base. hAAG is also known as methylpurine DNA glycosylase (MPG) or 3-
methyladenine-DNA glycosylase (ANPG).
254,261
 
 
Reaction conditions for Cu-TPMA-Phen, Cu-TPMA-DPQ, Cu-TPMA-DPPZ (0.5 – 2.5 µM) 
complexes were optimized to initiate cleavage of pUC19 SC-DNA to OC and L forms (Figure 
53) prior to repair enzyme addition (Figure 52A). These reactions were compared to 1 h 
exposure of pUC19 to each complex in the absence of repair enzymes (lanes 1-4, Figure 52C 
and D). Overall, enhanced cleavage activities in the order 
 
hAAG > Endo V > Endo III > Fpg 
 
were identified with limited change or inhibition occurring in the presence of Endo IV (Figure 
52D).  Control experiments involving Cu-Phen (0.5 – 2.5 µM), Cu-TPMA (1.0 – 20.0 µM) and 
the hydroxyl radical (•OH) generated from a Cu+/2+/ H2O2 / Fenton system were examined for 
comparative purposes (Figure 52C and Figure S 33). Here, enhanced activity by Cu-Phen in the 
presence of Endo III (APyrimidine) but not FpG (APurine) indicates preferential oxidative 
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damage of thymine residues. pUC19 in the presence of Fenton’s reagent underwent additional 
cleavage by FpG, Endo III, and Endo IV which supports formation of oxidized purine and 
pyrimidine bases together with abasic sites by the •OH radical. Interestingly, DNA damage by 
phenanthroline-containing complexes (Cu-TPMA-Phen and Cu-Phen) was attenuated upon 
addition of Endo IV and we propose this inhibition arises from covalent stabilization of the DNA 
adduct Endo IV complex. Additionally, since Endo IV had limited effects with Cu-TPMA, 
CuTPMA-DPQ, and Cu-TPMA-DPPZ this interaction seems phenanthroline ligand-
specific.
219,262 
These results are in good agreement with that work since trapping O2
•− 
with tiron 
and stabilizing Endo IV with Phen complexes reduces oxidative DNA damage. hAAG enhanced 
the cleavage activity of [Cu(TPMA)(N,N′)]2+ complexes but not [Cu(TPMA)]2+ and, when 
combined with observations of additional DNA damage with Endo V,  it
 
seems reasonable to 
suggest deoxyinosine (dI) or free-base hypoxanthine is generated by these ternary
 
compounds. dI 
is a naturally occurring noncanonical base that arises from deamination of adenine,
263 
however it 
can be formed from radical generation of Ade-N6-yl.
264 
The Ade-N6-yl radical may also be 
generated by Cu
2+
/H2O2 with elegantly designed immuno-spin trapping experiments establishing 
its formation via a 5,5ʹ-dimethyl-1-pyrroline N-oxide (DMPO) nucleoside adduct.
265
 The extent 
of hAAG-mediated DNA damage observed here is dependent on the ancillary ligand choice with 
bulkier intercalators giving rise to more extensive shearing (DPPZ > DPQ > Phen) suggesting a 
possible alternative deoxyinosine oxidation pathway. 
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Figure 52. A) Cartoon representation of repair enzyme experiments. B) Table highlighting base lesion 
recognized or excised by respective repair enzymes. Abbreviations are as follows: A = adenine, G = 
guanine, T= thymine, C = cytosine, U = uracil, Pu = purines (A and G), Py = pyrimidines (C, T and U), 
Me = methyl, OH = hydroxy, H = hydro, dH = dihydro, FaPy = formamidopyrimidine, dHyd = 
deoxyhydanton, Me-Tar-U = methyltartronylurea, dI = deoxyinosine, dU = deoxyuracil. C) 400 ng 
pUC19 supercoiled DNA treated with increasing concentrations of Cu-TPMA and Cu-Phen (lanes 2-4) in 
the presence of 1 mM Na-L-ascorbate and 2U repair enzymes Endo IV (lanes 5-7), Endo V (lanes 8-10) 
and hAAG (lanes 11-13). Hydroxyl radical generated from Cu
2+
 / H2O2 Fenton-system (lanes 2-4) in the 
presence of 1 mM Na-L-ascorbate and 2 U repair enzymes Fpg (lanes 5-7), Endo III (lanes 8-10) and 
Endo IV (lanes 11-13). D) Cu-TPMA-Phen, Cu-TPMA-DPQ and Cu-TPMA-DPPZ (lanes 2-4) in the 
presence of 1 mM Na-L-ascorbate (lanes 2-4) in the presence of 1 mM Na-L-ascorbate and 2U repair 
enzymes Endo IV (lanes 5-7), Endo V (lanes 8-10) and hAAG (lanes 11-13). 
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Figure 53. 400 ng pUC19 supercoiled DNA was treated with increasing concentrations of A) Cu-TPMA; 
B) Cu-TPMA-Phen; C) Cu-TPMA-DPQ; D) Cu-TPMA-DPPZ; E) CuPhen and F) •OH - generated from 
Cu
2+ 
/ H2O2
 
/ Fenton-system (lanes 2-4) in the presence of 1 mM Na-L-ascorbate and in the presence of 
2U of either FpG (lanes 5-7), Endo III (lanes 8-10), Endo IV (lanes 11-13), EndoV (lanes 14-16) or 
hAAG (lanes 17-19). 
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4.5.6. AMNs-induced Oxidative Cleavage in Supercoiled Plasmid DNA 
Plasmid pUC19 DNA was pre-incubated with Cu-TPMA-Phen or Cu-Oda at 37 °C for 1 h and to 
achieve the optimum annealing conditions a concentration range of the chemical nuclease in the 
presence of Na-L-ascorbate, as reducing agent (Figure 54) was tested by gel electrophoresis. The 
concentration pattern for the two complexes were identical and here as an example is presented 
the concentration range of gel electrophoresis regarding the Cu-TPMA-Phen.  
 
 
 
 
Figure 54. A) 400 ng pUC19 supercoiled DNA was treated with increasing concentrations of Cu-
TPMA-Phen in the presence of 1 mM Na-L-ascorbate (Supercoiled (SC), relaxed (OC), and linear (L) 
pUC19 tertiary dsDNA structures). B) Conformation changes of the circular plasmid DNA.  
C) Identification of Supercoils and Nicks with gel electrophoresis. 
  
 
 
The nuclease activity at 2.5 μΜ resulted in a satisfactory profile of DNA cleavage for both 
compounds. The reactions were repeated in order to generate sufficient stock of superhelical, 
nicked, and linear pUC19 for deoxynucleoside lesion experiments. At the end of each reaction, 
the nicked and linearized dsDNA obtained, was extracted and further purified using QIAquick 
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purification (QIAGEN, Baltimore, MD), eluted in pure water and quantified in triplicate using 
the NanoDrop (ND-1000) spectrophotometer.  
 
Quantification of Purine Lesions in dsDNA Conformers 
The double stranded DNA samples were analysed for both detection and quantification of the 
oxidative leisions 5′,8-cyclo-2′-deoxyadenosine (cdA) and 5′,8-cyclo-2′-deoxyguanosine (cdG), 
7,8-dihydro-8-oxo-2′-deoxyguanosine (8-oxo-dG) and 7,8-dihydro-8-oxo-2′-deoxyadenosine (8-
oxo-dA). Many efforts have been devoted during the last two decades to the identification and 
measurement of cdA and cdG lesions in DNA samples. As discussed previously, the initial step 
for the formation of these lesions is H5′ abstraction by HO• followed by an intramolecular attack 
of C5′ radical to the purine moiety. We were interested in evaluating these cyclopurine lesions 
along with 8-oxo-dG and 8-oxo-dA, due to the fact that they are “pure” hydroxyl radical-derived 
products and cannot derive from accidental oxidation of the material or other mechanistic 
pathways.  The absence or presence of these modified nucleosides would provide strong evidence 
reagarding the artificial chemical nucleases mechanism and the ability of these materials to lead 
in formation of hydroxyl radical. In the experiments plasmid pUC19 supercoiled DNA was 
treated with 2.5 µM of Cu-TPMA-Phen or Cu-Oda in the presence of 1 mM Na-L-ascorbate and 
the DNA samples were incubated at 37 °C for 1 hr. As reported in the Table 11 and 12 regarding 
the cdPus lesions there were no differences among the control and the treated with copper 
complexes samples. 
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Table 11. The levels (lesions/10
6
 nucleosides) of 5’S-cdA, 5’R-cdA, 5’S-cdG, 5’R-cdG, 8-oxo-dG and 8-
oxo-dA in plasmid pUC19 supercoiled DNA. The samples were treated with 2.75 µM of Cu-TPMA-Phen 
or Cu-Oda in the presence of 1 mM Na-L-ascorbate and were incubated at 37 °C for 1 hr. The numbers in 
the boxes represent the values of cdPus and 8-oxo-Pus levels from the measurement of the DNA samples 
treated with the corresponding artificial chemical nuclease. 
 5’R-cdG 5’R-cdA 5’S-cdG 8-oxo-dG 5’S-cdA 8-oxo-dA 
Control_1 
 
1,136845 0,781867 0,544125 51,04514 0,726369 2,469849 
Control_2 
 
1,076143 0,798517 0,559943 51,86645 0,692755 2,518789 
Control_3 
 
1,002763 0,739285 0,545907 49,7245 0,66878 2,334653 
Cu-Oda_1 
 
1,099999 0,74943 0,557849 65,48203 0,696774 2,84609 
Cu-Oda_2 
 
1,020544 0,81555 0,528505 65,80299 0,717631 2,886687 
Cu-Oda_3 
 
1,087859 0,749696 0,553309 67,78948 0,723262 2,82568 
Cu-TPMA-Phen_1 
 
0,948632 0,822891 0,566882 52,42743 0,678022 2,52534 
Cu-TPMA-Phen_2 
 
1,0793 0,795448 0,533879 51,63888 0,6807 2,528848 
Cu-TPMA-Phen_3 
 
1,004791 0,734759 0,531472 51,69227 0,675909 2,434307 
 
 
 
Table 12. The levels (lesions/10
6
 nucleosides) of 5’S-cdA, 5’R-cdA, 5’S-cdG, 5’R-cdG, 8-oxo-dG and 8-
oxo-dA in plasmid pUC19 supercoiled DNA treated with Cu-TPMA-Phen or Cu-Oda. The numbers in the 
boxes represent the mean value (± standard deviation) of cdPus and 8-oxo-Pus levels from the 
measurement of three DNA samples. 
 5’R-cdG 5’R-cdA 5’S-cdG 8-oxo-dG 5’S-cdA 8-oxo-dA 
Control 
 
1,072  ± 0,067 0,773 ± 0,031 0,550 ± 0,009 50,879 ± 1,081 0,696 ± 0,029 2,441 ± 0,095 
Cu-Oda 
 
1,069  ± 0,043 0,772 ± 0,038 0,547 ±0 ,016 66,358 ± 1,250 0,713 ± 0,014 2,853 ± 0,031 
Cu-TPMA-Phen 
 
1,011 ± 0,066 0,784 ± 0,045 0,544 ± 0,020 51,920 ± 0,441 0,678 ± 0,002 2,496 ± 0,054 
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Figure 55. Levels of four cPu measured by LC-MS/MS in plasmid pUC19 supercoiled DNA treated 
with Cu-TPMA-Phen or Cu-Oda. Error bars represent standard deviation of the mean, calculated from 
three independent samples. 
 
 
 
The results presented in Figure 55 regarding Cu-TPMA-Phen are in good agreement with the 
results obtained from the gel electrophoresis, in which using D-mannitol or DMSO as OH radical 
scavengers had no influence on DNA cleavage. Three independent experiments evidence that 
•OH radical is not significant and the AMN activity does not follow the classical Fenton-type 
mechanism.  
The reaction to obtain the DNA damage fragments was not carried out under anaerobic 
conditions. Therefore, in the presence of molecular oxygen and due to the redox potential of the 
copper complex the superoxide anion is generated, as suggested by the inhibition of damage in 
DNA when scavenging with tiron. Superoxide anion is the precursor of hydrogen peroxide
266
  
giving rise in the formation of 8-oxo-dA and 8-oxo-dG lesions. In the literature it is known that 
oxidative damage, such as 8-oxodeoxyguanosine (8-oxodG) lesions in DNA, is generated by 
endogenous by-products of cellular metabolism, such as hydrogen peroxide (H2O2).
267
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Figure 56. Levels of 8-oxo-dA and 8-oxo-dG measured by LC-MS/MS in plasmid pUC19 supercoiled 
DNA treated with Cu-TPMA-Phen or Cu-Oda. Statistical analysis was performed using t-test by 
comparing the means of DNA sample treated with one of the two artificial chemical nucleases (Two-
Sample Assuming Unequal Variances) and error bars represent standard deviation of the mean, calculated 
from three independent samples.*denotes a statistically significant difference (p ≤ 0.05), **denotes a 
statistically significant difference p ≤ 0.001 and ***denotes a statistically significant difference p ≤ 
0.0001 between the groups. 
 
 
The overall 8-oxo lesion formation, regardless of topology, followed 8-oxo-dG ≫ 8-oxo-dA 
(Figure 56) after treatment with both AMNs. However, statistically significant difference was 
observed only in the presence of the di-nuclear copper complex Cu-Oda. These results point out 
that the ligand groups on the metallodrug play an important role. Although scavenger 
experiments showed that both AMNs are able to generate superoxide radical anion, the bulky 
ligand of TPMA can interfere and act as a block; ROS formation might not be in the vicinity of 
nucleic acids therefore the oxidative DNA damage does not occur.    
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4.6. Conclusions 
The experiments presented proved that copper(II) artificial chemical nucleases are very 
promising materials as therapeutic agents especially when combined with specific scaffolds, 
essential for controlling stability and reactivity. DNA binding was identified and 
topoisomerase I-mediated  relaxation revealed the importance of N,N′ ligand choice to 
intercalation as Cu-TPMA-DPQ and Cu-TPMA-DPPZ complexes unwound supercoiled 
pUC19 DNA with greater efficiency. Further analysis showed the minor groove as the 
preferred site for AMN activity as pre-exposure to a major groove binder (methyl green) 
enhanced overall oxidative damage sensitivity to supercoiled pUC19 DNA. In terms of the 
oxidative mechanism, trapping experiments show that the complexes do not follow classical 
Fenton-type or Haber-Weiss processes but instead generate superoxide- and, to a somewhat 
lower extent, hydrogen peroxide during the catalytic ROS process. To delineate this activity 
from that of classical copper-bis-1,10-phenanthroline (Cu-Phen), Fenton-type systems, and 
the [Cu(TPMA)]
2+
 cation, DNA repair enzyme recognition experiments were conducted. 
DNA damage lesions formed by Cu-TPMA-Phen, -DPQ, and -DPPZ complexes were not 
recognized by FpG or Endo III, which suggests—in contrast with Cu-Phen and Fenton’s 
reagent—an oxidation pathway independent of oxidized purine and pyrimidine bases, 
respectively. The activity of Endo IV, which recognizes both apurine and apyrimidine sites, 
was inhibited by Cu-Phen and Cu-TPMA-Phen and it appears likely, therefore, that a covalent 
DNA-complex-enzyme adduct is realized. The role of deoxyinosine (dI) in the DNA damage 
process was established since hAAG and Endo V both  enhanced cleavage activity of 
[Cu(TPMA)(N,N′)]2+ complexes; the ancillary ligand choice is important here with bulkier 
intercalators giving rise to more extensive hAAG-mediated shearing in the order DPPZ > 
DPQ > Phen.  
In addition, cyclopurine lesions and 8-oxo-purines were identified and quantified on dsDNA 
mixtures of supercoiled (SC), open circular (OC), and linear (L) conformation, after treatment 
with Cu-TPMA-Phen or Cu-Oda in the presence of reductant. In the enzymatically digested 
nucleosides an HPLC clean-up protocol was applied and the fractions of interest containing 
the lesions, were collected and analyzed by LC-MS/MS. We focused on the four cPu lesions 
that are correlated directly with HO
•
-induced DNA damage due to the fact that they are strong 
candidate biomarkers in cancer diagnostics, particularly for their stability during the analytical 
procedures. However, the levels of these lesions were identical with the control proving that 
the hydroxyl radicals are not generated in the presence of these chemical nucleases. Finally, 
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the 8-oxopurine lesions appeared to have statistically significant differences in respect with 
the control; an interesting outcome that can be explained if we take into account the 
stereochemical factor of the bulky TPMA ligand in respect with the linear Cu-Oda. These 
results pointed towards the generation of hydrogen peroxide during the catalytic ROS process 
and the oxidation pathway induced by AMNs.  
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Appendix 
 
Part I – Studies on Lipid Damage 
 
5.1. UV-VIS Spectra 
 Reduction of Cu(II) to Cu(I) in Cu-TPMA-Phen and Formation of Thiyl Radical 
As shown in Figure S1 regarding the d-d metal absorptions of Cu(II) complex a maximal 
absorbance at 626 nm was recorded, which falls after adding the thiol and at the same time a 
new absorbance at to 412 nm rises. An intermediate complex of Cu(II)-thiol is generated, 
since the thiol is coordinated temporarily on the metal. In the following step via a redox-
based mechanism Cu(I) is generated from Cu(II) and thiyl radical is formed. Probably small 
structural adjustments are necessary so that the copper(II) will be able to bind with the thiol. 
However, due to the multidentate ligand ability of this synthetic material any side effect on 
the overall stability of the complex was not noticed. 
 
 
 
Figure S1. Selected spectra are shown after mixing the copper(II) complex with 2-ME at room 
temperature. As the reaction proceeds and the copper is reduced more and more by the addition of 
thiol, the fluorescence intensity is also increased. 
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5.2. Gas Chromatography 
The phospholipids from 1-palmitoyl-2-oleoylphosphatidylcholine or soybean lecithin were 
examined by GC after transesterification to fatty acid methyl esters (FAME). The calibration of 
the gas chromatographic peak areas was effected by using the peak area of palmitic acid as the 
internal standard to quantify the corresponding presence of the unsaturated fatty acids and 
establish their reaction yields after the experiments.  
After the reaction under the conditions described in Chapter 2 was performed, GC was used to 
separate cis and trans isomers. In particular, in the figure below is reported the result of the 
experiment regarding the MUFA containing liposomes, under aerobic conditions prior and after 
treatment with Cu-TPMA-Phen and thiol (2-mercaptoethanol) and incubation at 37 °C for 60 
min. In this figure it is evidenced the isomerization of oleic acid residue into its trans isomer, 
which is elaidic acid. 
 
 
 
Figure S2. GC chromatogram of FAMEs obtained before and after incubation of POPC liposomes at 37 
°C for 60 min, under aerobic conditions in the presence of 0.15 mM Cu-TPMA-Phen and 10 mM 2-ME. 
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In the experiments with the MUFA composed liposomes, no peroxidation was observed neither 
in aerobic nor in anaerobic conditions, due to the fact that the MUFA moiety of oleic acid (9cis-
18:1) is not so prone to oxidation as PUFAs are. Therefore, this fatty acid residue can be 
targetted by thiyl radical only in a catalysed isomerization pathway.  
On the other hand, in lecithin liposomes the PUFA can be partitioned both in isomerization or 
peroxidation pathways. We decided to monitor the 18:1 and 18:2 fatty acids under different 
liposome incubation conditions, since these two fatty acids are the most representative 
unsaturated moieties of the mixture. In Figure S3, is shown the GC chromatogram of lecithin 
FAMEs without any treatment (starting material) trace I, also traces II and III, report the two 
different profiles depending on the presence or absence of oxygen after treatment with Cu-
TPMA-Phen and thiol (2-mercaptoethanol) and incubation at 37 °C for 480 min. 
 
 
 
 
Figure S3. GC chromatogram of FAMEs obtained before any treatment (trace I); after incubation of 
lecithin liposomes at 37 °C for 480 min in the presence of 0.15 mM Cu-TPMA-Phen and 10 mM 2-
mercaptoethanol under anaerobic conditions (trace II); same reaction conditions but under aerobic 
conditions (trace III). 
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5.3. Thin Layer Chromatography (T.L.C.) 
Formation of Epoxydocosapentaenoic (EDP) Acid Methyl Esters and Separation of 
Regioisomers 
The formation of the DHA mono-epoxide regioisomers as described in Chapter 3 was 
monitored by TLC using 7/3 n-hexane/Et2O as mobile phase. The fractions were separated by 
column chromatography and used for the analytical characterization.   
 
 
                     
Figure S4. TLC after DHA-Me epoxidation and column separation. LEFT TLC: (A) Reaction mixture, 
(B) all-cis DHA-Me. RIGHT TLC: DHA-Me and epoxide fractions: 1-2-3 mono-epoxide fractions and 
assignment, as described in the main text separated using 7/3 n-hexane/ diethyl ether as mobile phase. 
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5.4. NMR Assignments of EDP Isomers Methyl Esters 
The NMR spectra were carried out in C6D6 for stability reasons. The C resonances were 
attributed by comparison with the DHA assignment individuating five EDP regioisomers for the 
resonances for the carbon atoms of the epoxy functionality. The 
13
C NMR in CDCl3 of two 
epoxy-isomers 4,5-EDP and  19,20-EDP were described in the literature and they are reported in 
the table below. 
 
Table S1. 
13
C NMR Resonances of EDP isomers methyl esters. 
 
Literature Data (in CDCl3)                                               This work (in C6D6) 
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Figure S5. Summary of the 
1
H and 
13
C resonances assignments for the all-cis DHA-Me and EDP 
regioisomers. 
 
All-(Z)-4,7,10,13,16,19-DHA-Me (1).  
 
 
16,17-EDP-Me (6).  
 
 
13,14-EDP-Me (5).
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19,20-EDP-Me (7).  
 
 
7,8- EDP-Me (3).  
 
 
4,5- EDP-Me (2).  
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Figure S6. 
1
H NMR spectrum (C6D6) of the second fraction after epoxidation reaction (mixture of the 
monoepoxides 7, major, and 3, minor; major/minor ratio: 57:43). 
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Figure S7. 2D NMR experiment (HSCQ / HMBC) in C6D6 on the EDP second fraction for the 
assignment of the 7,8-EDP regioisomer (connections follow the left lane a-n, then the right lane o-s). 
 
a. The bsgHSQCAD 5-70 shown that H1’ (3.31 
ppm) corresponds to C1’ (50.65 ppm) (fig. A) 
 
A.  
 
 
 
b. The gHMCBAD attributes C1 (172.32 ppm) 
also individual signals (2.11 e 2.29 ppm) of H2 
and H3 that will be attributed bellow (fig. B).  
 
B. 
 
 
 
c. The gHMCBAD shows the attribution of H2 
(2.11 ppm), H3 (2.29 ppm) to C4 (128.08 ppm) 
and C5 (129.06 ppm) since H2 interacts only 
with C1 (170.32 ppm) and C4, while H3 
interacts C1, C4 and C5 (fig. C). 
g. The bsgHSQCAD 5-70 shown that H22 (0.84 ppm) 
corresponds to C22 (10.45 ppm) (fig. G). 
 
G. 
 
 
 
h. In gHMCBAD is shown C21 (21.10 ppm) and C20 (57.38 
ppm) (fig. H). 
 
H. 
 
 
 
i. The bsgHSQCAD 5-70 confirmed the two diastereotopics 
protons H21 (1.40 – 1.28 ppm) (Fig 10) and H20  (2.60 ppm; 
Fig I, 1-2) 
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C. 
 
 
 
d.The bsgHSQCAD 5-70 shows C2 (33.64 ppm) 
and C3 (22.76 ppm) (fig. D). 
 
D. 
 
 
 
 
e. In bsgHSQCAD 110-140 the protons H4 
(5.29 ppm) andH5 (5.38 ppm) are shown (fig. 
E). 
 
I1. 
 
Fig I2. 
 
 
 
 
l. The gHMCBAD shows C19 (55.75 ppm; Fig 12) and the 
bsgHSQCAD 5-70 confirms H19 (2.75 ppm; Fig 13) (figs. 
L1, L2) 
 
L1. 
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E. 
 
 
 
f. From gHMCBAD is confirmed that H6 (2.79 
ppm) interacts with C4 (129.06 ppm; fig F1) and 
also from bsgHSQCAD 5-70 is shown C6 
(25.58ppm, fig F2). 
 
F1. 
 
 
 F2. 
 
 
 
L2. 
 
 
 
m. From gHMCBAD the two diastereotopic protons H18 are 
confirmed (2.29 – 2.10  ppm; Fig M1) and bsgHSQCAD 5-
70 shows C18 (26.31 ppm; Fig M2) 
 
M1. 
 
M2. 
 
 
n. From gHMCBAD C17 and C16 were identified (130.03 
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At this point, the overlapping of the signals 
made the attributions difficult, and for this 
reason we proceed with the attribution starting 
from the C22. 
 
and 124.96 ppm, fig N1), while bsgHSQCAD 110-140 
attributes the corresponding protons (130.03/5.46 ppm; 
124.96/5.44 ppm, fig N2). Finally, gHMCBAD shows that 
H17 is attached (5.44 ppm) to C19 (fig N3). 
 
 
Fig N1.  
 
Fig N2. 
 
Fig N3. 
  
o. From gHMCBAD proton H15 was identified (2.78 ppm, 
fig O1) and bsgHSQCAD 5-70 provides strong evidence that 
H15 is attached to C15 (130.03/5.46 ppm; fig O2). 
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Fig. O1 
 
Fig. O2 
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Figure S8. Relevant correlations in the 2D NMR experiment (HSCQ / HMBC) in C6D6 for the 
assignment of the 19,20-EDP regioisomer (connections follow the left lane a-f, then the right lane g-o). 
a. The bsgHSQCAD 5-70 shown that the 
proton H1’ (3.30 ppm) corresponds to  C1’ 
(50.66 ppm) (Fig. A) 
 
Fig A.  
 
 
 
b. The gHMCBAD shows the attribution of 
C1 (172.30 ppm) and also the individual 
signals (2.09 e 2.21 ppm) correspond to the 
protons H2 and H3. 
 
 
Fig B. 
 
 
 
c. The gHMCBAD shows the attribution of 
H2 (2.09 ppm), H3 (2.21 ppm), C4 (130.08 
ppm) and C5 (125.77 ppm). In addition, H2 
interacts with C1 (170.30 ppm) and C4, while 
H3 interacts with C1, C4 and C5. 
o. The bsgHSQCAD 5-70 shows that proton 
H22 (0.89 ppm) corresponds to C22 (14.07 
ppm). 
 
Fig. O1 
 
 
 
p. The gHMCBAD indicates C21 (131.82 
ppm) and C20 (20.55 ppm). 
 
Fig. P1 
 
 
 
Q. The bsgHSQCAD 5-70 indicates H21 
(1.99 ppm) (Fi. Q1) and bsgHSQCAD 110-
140 indicates H20  (5.39 ppm; Fi. Q2) 
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Fig C. 
 
 
 
d. From bsgHSQCAD 5-70 C2 was identified 
(33.51 ppm) and also C3 (22.83 ppm). 
 
Fig D. 
 
 
 
 
e. The bsgHSQCAD 110-140 shows H4 
(5.35 ppm) and H5 (5.42 ppm). 
 
 
Fig. Q1 
 
Fig. Q2 
 
 
 
 
 
r. The gHMCBAD indicated C19 (127.06 
ppm; Fig. R1) and with bsgHSQCAD 110-
140, H19 was identified (5.30 ppm; Fig. R2) 
 
Fig. R1 
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Fig E. 
 
 
 
f. With gHMCBAD the proton H6 was 
identified (2.26 ppm) which interacts with C4 
(130.08 ppm) and C5 (125.77 ppm).  
 
Fig. F 
 
 
 
g. From bsgHSQCAD 5-70 it was confirmed 
C6 (26.23 ppm) and the other individual H6 
(2.12 ppm) which is diasterotopic.  
 
 Fig. G 
 
 
 
h. The gHMCBAD concerns C7 (55.63 
ppm). 
 
Fig. R2 
 
 
 
s. The gHMCBAD shows C18 (25.58 ppm; 
Fig. S1) and with bsgHSQCAD 5-70 we 
manage to identifyH18 (2.79 ppm; Fig. S2) 
 
Fig. S1 
 
FigS2 
 
 
At this point, the exact attribution of the 
- 147 - 
 
 
Fig. H 
 
 
i. With bsgHSQCAD 5-70 the proton H7 was 
characterized (2.73 ppm). 
 
Fig. I 
 
 
 
l. At gHMCBAD C7 interacts with H9 (2.31 
and 2.12 ppm) which are diastereotopic, and 
also with C8 (55.65 ppm) (fig. L1). The 
correlations proton – carbon are assigned 
with bsgHSQCAD 5-70 (figs. L2-L3). 
remaining resonances could not be done due 
to the overlapping of the signals. 
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Fig. L1 
 
Fig. L2 
 
Fig. L3 
 
 
 
M. In gHMCBAD the two protons H9 
interact only with the two vinyl carbons C10 
(124.78 ppm) and C11 (130.17 ppm) (Fi. 
M1), which relative protons are attributed 
with bsgHSQCAD 110-140 (Fig. M2), and 
their position is attributed through HMCBAD 
(Fig. M3) 
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Fig. M1 
 
 
Fig. M2 
 
Fig. M3 
 
 
 
n. In gHMCBAD both C10 and C11 interact 
with H12 (2.76 ppm; Fig. N1) whose carbon 
(25.78 ppm) is attributed by bsgHSQCAD 5-
70 (Fig.N2). 
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Fig. N1 
 
Fig. N2 
 
 
 
 
 
 
 
 
The same 2D NMR experiments were also performed for the first and the third fraction 
collected from the column in order to assign the peaks and characterize the epoxides.  In the 
next figures the protons NMR are presented. 
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Figure S9. 
1
H NMR spectrum of the first fraction in C6D6 as a mixture of 4 different compounds: 
16,17-EDP (6)and 13,14-EDP (5) were the principal components of the mixture and were fully NMR 
characterized, evaluatingalso the (6)/(5) ratio of 71:29. In the first fraction, traces of residual DHA and 
of 10,11-EDP were identified. 
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Figure S10. 
1
H NMR spectrum of the third fraction in C6D6 after epoxidation reaction (pure 4,5-EDP, 2). 
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5.5. Ag-Thin Layer Chromatography  
TLC Comparison of the Mono-Trans DHA Isomers from the Dibromide Elimination and from 
the DHA Isomerization 
As described in the main text, the trans-alkenes obtained from the steps of mono-epoxidation-
dibromination - elimination were examined by Ag-TLC. Also the monotrans alkene isomer 
mixture obtained by the radical catalyzed isomerization was examined under the same condition 
(Figure S11, a). Figure S11 b shows a representative separation on Ag-TLC of the elimination 
products obtained from the second fraction of the monoepoxidation reaction (Figure S4) in 
comparison with the mono-trans isomer mixture obtained by isomerization (right lane) and the 
starting DHA methyl ester (left lane).       
               
 
Figure S11. (a) Ag-TLC (eluent: 1/9 n-hexane/diethyl ether with 0.4% MeOH) showing the formation of 
monotrans (II) in the presence of traces of di-trans (III) and tri-trans (IV) isomers of DHA-Me (panel a, 
lane C), in comparison with the isolated monotrans DHA-Me fraction (lane B) and the starting DHA-Me. 
(b) Ag-TLC showing the mixture obtained from the bromination/elimination reaction of the 
monoepoxide fraction II corresponding to 19E and 7E monotrans DHA-Me (central lane) in comparison 
with all-cis DHA-Me and the isolated monotrans DHA-Me isomers. 
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Figure S12.
 13
C NMR spectrum (in C6D6) of the trans DHA-Me isomer mixture after isomerization. 
 
 
 
 
Figure S13. 
13
C NMR spectrum (in C6D6) of the monotrans DHA-Me isomer mixture after purification. 
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5.6. Gas Chromatographic Analysis of DHA Isomers 
GC Chromatograms of Mono-Trans DHA-Me Isomers Obtained from the EDP-Me Elimination   
The three fractions of EDP-Me regioisomers isolated from the epoxidation were separately 
transformed and the alkene mixture was analysed by GC (see Figure 36 in the main text).  
 
 
 
 
 
Figure S14. GC chromatographic region corresponding to monotrans DHA isomer obtained from the 
dibromination-elimination reaction on EDP-Me regioisomers isolated in the first fraction. The 
regioisomer assignment of this monoepoxide fraction was made on the basis of the NMR experiments 
(see above), therefore the resulting alkene can be assigned to as 16E-DHA, whereas the minor alkene 
product can be assigned to as 13E-DHA, with traces of the alkene 10E-DHA. 
 
 
 
 
Figure S15. GC chromatographic region corresponding to monotrans DHA isomers obtained from the 
dibromination-elimination reaction on EDP-Me regioisomers isolated in the second fraction. The 
regioisomer assignment of this monoepoxide fraction was made on the basis of the NMR experiments 
(see above), therefore the two resulting alkenes can be assigned to as 19E-DHA and 7E-DHA (obtained 
in the crude reaction with a 71:29 ratio). 
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Figure S16. GC chromatographic region corresponding to monotrans DHA isomer obtained from the 
dibromination-elimination reaction on EDP-Me regioisomer isolated in the third fraction. The 
regioisomer assignment of this monoepoxide fraction was made on the basis of the NMR experiments 
(see above), therefore the resulting alkene can be assigned to 4E-DHA, with analytical characteristics 
identical with the commercially available compound. 
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5.7. Gas Chromatography Mass Spectrometry (GC-MS) 
Analyses of Mono-Trans DHA Regioisomers 
 
 
Figure S17. GC-MS separation. 
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Figure S18. Mass fragmentation at 68.31 min (19E DHA-OMe). 
 
 
 
 
 
Figure S19. Mass fragmentation at 70.39 min (16E DHA-OMe). 
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Figure S 20. Mass fragmentation at 70.82 min (4E DHA-OMe). 
 
 
 
 
Figure S21. Mass fragmentation at 71.78 min (13E DHA-OMe). 
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Figure S22. Mass fragmentation at 72.45 min (7E + 10E DHA-OMe). 
 
 
 
 
Figure S23. Mass fragmentation at 70.33 min (all cis DHA-OMe). 
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5.8. 
13
C – NMR Spectra 
Fish Oil Isomerization and Trans-Containing Triglyceride Analysis 
A DHA-rich fish oil used as material for functional foods and supplements was used as a 
triglyceride source in order to carry out the thiyl radical catalyzed isomerization and analyze the 
monotrans DHA-containing triglycerides in comparison with the monotrans isomers of DHA 
methyl ester.   
 
 
 
 
 
Figure S24. 
13
C NMR spectrum of DHA-containing triglycerides. 
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Figure S25. 
13
C NMR spectrum of DHA-containing triglycerides after isomerization. 
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5.9. Analysis of Omega-3 Containing Supplements 
The mono-trans DHA library was used to identify the trans geometrical isomer content in DHA-
containing nutraceutical formulas. Commercially available products sold as omega-3 supplement 
were examined: products 1-6 are present in the Italian market, products 7-19 are present in the 
Spanish market. 
 
 
Table S2.  Fatty acid content (%rel) determined in omega-3 containing supplements commercially 
available in Italy. Analyses performed in triplicates (n=3). 
*Fatty acid methyl esters (FAME) expressed as relative percentages of the peak areas detected in the 
chromatograms (>98% of the total peak areas of the chromatogram recognized by appropriate FAME 
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references). Monotrans isomers recognized in comparison with the appropriate library as described in the 
main text; nd= not detectable. 
 
 
 
Table S3. Fatty acid content (%rel) determined in omega-3 containing supplements commercially 
available in Spain. Analyses performed in triplicates (n=3) of the same sample. 
*Fatty acid methyl esters (FAME) expressed as relative percentages of the peak areas detected in the 
chromatograms (>98% of the total peak areas of the chromatogram recognized by appropriate FAME references). 
§ Mono-trans isomers recognized in comparison with the appropriate library as described in the main text; nd= 
not detectable. 
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Figure S26. Representative GC chromatogram of FAME in fish oil material obtained according to 
Method A (helium as carrier gas). Tables S2 and S3 summarize the results of the analyses. 
 
 
 
 
 
Figure S27. Partial GC trace showing the separation of the C22-24 FAME according to Method A 
(helium as carrier gas). Separation of C24:1 and superimposition of some mono-trans DHA isomers and 
of C24:0 are shown. 
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Figure S28. Representative GC chromatogram of FAME in fish oil obtained according to Method B 
(hydrogen as carrier gas). Tables S2 and S3 summarize the results of the analyses. 
 
 
 
 
Figure S29. Partial GC trace showing the separation of the C22-24 FAME according to Method B (hydrogen 
as carrier gas). Superimposition of 16 mono-trans DHA isomer with cis-DHA and good separation of the 
C22:5 ω3 are shown, whereas C22:5 ω-6, C24:0 and C24:1 do not elute in the DHA window. 
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5.10. Gas Chromatographic Identification of FAMEs in 20 % 18:0-22:6 
PC/16:0-18:1 PC Composition of Vesicles 
 
 
 
Figure S30. GC chromatogram of FAMEs obtained after incubation of 20 % 18:0-22:6 PC/16:0-
18:1 PC liposomes at 37°C under anaerobic condition in the presence of 0.15 mM Cu-TPMA-Phen 
and 10 mM 2-mercaptoethanol. In the blue box the GC chromatograms of (I) all cis-DHA in 20 % 
18:0-22:6 PC/16:0-18:1 PC liposomes (starting material – no reaction); (II) reference mixture of 
monotrans DHA methyl ester isomers obtained by photolysis in the presence of thiyl radicals in 
solution (III) mixture of all cis and monotrans DHA in 20 % 18:0-22:6 PC/16:0-18:1 PC liposomes 
obtained after 2 hr of reaction (IV) mixture of all cis, monotrans and poly-trans of DHA in 20 % 
18:0-22:6 PC/16:0-18:1 PC liposomes obtained after 8 hr of reaction (as presented in the full 
chromatogram). 
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Part II – Studies on DNA Damage 
 
5.11. Agarose Gel Electrophoresis 
Studies on Cleavage Properties – Absence of Reductant 
 
 
Figure S31. 400 ng pUC19 supercoiled DNA was treated with increasing concentrations (10, 20, 30, 40, 
50 µM) of Cu-TPMA-Bipy, Cu-TPMA-PD, Cu-TPMA-Phen, Cu-TPMA-DPQ and Cu-TPMA-DPPZ in 
the absence of 1 mM Na-L-ascorbate and incubated at 37 °C for 30 min. Electrophoresis carried out as 
previously stated. 
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Studies on Cleavage Properties – Presence of Reductant 
Herein, the gel electrophoresis for Cu-TPMA-Bipy and Cu-TPMA-PD in the presence of 
reductant are presented. These two complexes appear to have the less efficient nuclease 
reactivity. 
 
 
 
Figure S32. 400 ng pUC19 supercoiled DNA was treated with increasing concentrations (0.25 
µM –25 µM) of Cu-TPMA-Bipy and Cu-TPMA-PD in the presence of 1 mM Na-L-ascorbate and 
incubated at 37 °C for 30 min. Electrophoresis carried out as previously stated. 
 
Enzymatic Controls of Endonucleases Reactivity 
 
 
Figure S33. 400 ng pUC19 supercoiled DNA (lane 1) in the presence of 1 mM Na-Lascorbate and 2U 
of either FpG (lane 2), Endo III (lane 3), Endo IV (lane 4), EndoV (lane 5) or hAAG (lane 6). The full 
experimental conditions are described in Chapter 4. 
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5.12. High Pressure Liquid Chromatography (H.P.L.C.) 
Supercoiled plasmid pUC19 was knicked by two different artificial chemical nucleases (Cu-
TPMA-Phen or Cu-Oda) in the presence of reductant. The damaged dsDNA was enzymatically 
digested to nucleosides for subsequent detection and quantification of oxidative lesions 8-oxo-
Pus and cdPus. The quantification was executed in two independent steps, increasing the overall 
sensitivity of the method. First, the sample was analysed by an HPLC-UV system coupled with a 
sample collector. According to this clean-up step, the quantification of the unmodified 
nucleosides took place, based on their absorbance at 260 nm, whereas the time-windows when 
the damaged lesions are eluted were collected and pooled. 
 
 
 
Figure S34. A representative optimal HPLC separation (monitored at 260 nm) of the 2'-deoxynucleosides 
(dA, dC, Thy and dG), purine 5',8-cyclo-2'-deoxynucleosides (5'R-cdA, 5'S-cdA,5'R-cdG and 5'S-cdG) 
and the purine 8-oxo-2'-deoxynucleosides (8-oxo-dA, 8-oxo-dG). 8-oxo-dG was used as a control against 
8-oxo-dA. The analysis was performed on a 4.6 mm x 150 mm Atlantis® dC18, 100 Å column (5 μm 
particle size, Waters) loaded with a 4.6 mm x 20 mm Guard Column 2pK (Atlantis® dC18 5μm, Waters) 
on a Waters Alliance ® HPLC System (Waters e2695 Separations Module) including a Waters 2998 
Photodiode Array (PDA) detector; mobile phase: 2 mM ammomium formate, acetonitrile and methanol. 
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5.13. Liquid Chromatography Tandem–mass Spectrometry (LC-MS/MS) 
The collected fractions were freeze-dried, pooled, freeze-dried again and re-dissolved in Milli-Q 
water. The concentrated samples containing the modified DNA damage lesion were injected 
subsequently to LC-MS/MS to be analysed independently. Figure S35 illustrates the MRM 
chromatograms of the corresponding mass transitions for 5’R-cdG, 5’S-cdG, 5’R-cdA and 5’S-
cdA, as  well  as  their  isotope-labelled  [
15
N5]-5’R-cdG, [
15
N5]-5’S-cdG, [
15
N5]-5’R-cdA, [
15
N5]-
5’S-cdA, which were acquired during LC-MS/MS analysis of the samples.  
 
 
Figure S35. MRM chromatograms of quantification ions obtained by LC–MS/MS analysis: 
Quantification transitions (Upper part) m/z 266 → m/z180 (5'R-cdG and 5'S-cdG), m/z 250 → m/z 164 
(5'R-cdA and 5'S-cdA); (Lower part) m/z 271 → m/z 185 ([15N5]-5'R-cdG and [
15
N5]-5'S-cdG) and m/z 
255 → m/z 169 ([15N5]-5'R-cdA and [
15
N5]-5'S-cdA). 
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As shown in Figure S36, the fragment ions of m/z =164 and 180 (together with 169 and 185 for 
the labelled cdA and cdG, data not shown) are resulting from the cleavage of both the N-
glycosidic bond and C4’–C5’ bond of the 2-deoxyribose unit. 
 
 
 
Figure S36. MS/MS fragmentation spectra (ESI-MS/MS of the [M+H]
+
 ion) of 5'R-cdA (m/z 
250→164) and 5'R-cdG (m/z 266→180) lesions (similar fragment ions were observed for 5'S-cdA 
and 5'S-cdG lesions). 
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Additionally to cPu lesions, we measured by LC-MS/MS the levels of 8-oxo-dA and 8-oxo-dG, 
which is a commonly used oxidative DNA damage markers and substrate of base excision repair 
(BER). As it can be seen in Figure S37, the 8-oxo-dA was eluted at 25.2 min and the m/z = 
267→151 transition for this lesion was monitored. The [15N5]-8-oxo-dA was eluted at the same 
time, monitored by 272→156 transition (data not shown). 
 
 
 
Figure S37.  MRM chromatogram of the mass transition m/z 267 → m/z 151 obtained by LC-MS/MS 
analysis and MS/MS fragmentation spectrum (ESI-MS/MS of the [M + H]+ ion) of 8-oxo-dA. 
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